WO1990001564A1 - Methods for multiple target analyses through nucleic acid hybridization - Google Patents

Methods for multiple target analyses through nucleic acid hybridization Download PDF

Info

Publication number
WO1990001564A1
WO1990001564A1 PCT/US1989/003378 US8903378W WO9001564A1 WO 1990001564 A1 WO1990001564 A1 WO 1990001564A1 US 8903378 W US8903378 W US 8903378W WO 9001564 A1 WO9001564 A1 WO 9001564A1
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
probes
dipstick
hybridization
target
Prior art date
Application number
PCT/US1989/003378
Other languages
French (fr)
Inventor
Trevor H. Adams
Dennis E. Schwartz
Nicolaas M. J. Vermeulen
Charles R. Petrie
Original Assignee
Microprobe Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microprobe Corporation filed Critical Microprobe Corporation
Publication of WO1990001564A1 publication Critical patent/WO1990001564A1/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/705Specific hybridization probes for herpetoviridae, e.g. herpes simplex, varicella zoster
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/708Specific hybridization probes for papilloma
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6834Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips

Definitions

  • This invention provides for technical improvements for conducting nucleic acid hybridization assays.
  • the improvements are designed to provide for a multiple target mode of conducting hybridization assays wherein a multiplicity of different nucleic acid probes for the site-specific capture of target nucleic acids are conjugated to specific locations upon a single dipstick or device.
  • the use of a dipstick has substantial mechanical advantages over prior art formats for nucleic acid hybridizations.
  • the dipsticks are composed of a handle, a nonporous support coated with a solid surface having at least one discrete region of nucleic acids covalently bound thereto.
  • the improvements also provide means for covalently attaching nucleic acids to solid supports, improved hybridization buffers, improved support surfaces, methods for reducing nonspecific background and methods for quantifying assay results.
  • the nucleic acid hybridizations described herein require the immobilization of a capture nucleic acid to a solid support surface.
  • Methods for the immobilization of nucleic acid to solid supports are known. Bischoff, R. et al., Introduction of 5'-Terminal Functional Groups into Synthetic Oligonucleotides for Selective Immobilization. Anal. Biochem. 164:336-344 (1987); Wolf, S.F. et al., Rapid Hybridization Kinetics of DNA Attached to Submicron Latex Particles, Nuc. Acids Res. 15:2911-2926 (1987); and J. N. Kremsky et al., Immobilization of DNA via Oligonucleotides Containing an Aldehyde or Carboxylic Acid Group at the 5' Terminus. Nuc. Acids Res. 15:2891-2910 (1987).
  • EP 200,381 A method for maintaining discrete regions of nucleic acid in a solid matrix for nucleic acid hybridization assays was disclosed in EP 200,381.
  • the invention of EP 200,381 involves the linking of nuclic acid to microspheres which are then entrapped in a porous matrix.
  • alkylammonium salts to influence the reannealing of nucleic acids. Orosz, J.M. and Wetmur, J.G., DNA Melting Temperatures and Renaturation Rates in Concentrated Alkylammonium Salt Solutions, Biopolymers 16:1183-1199 (1977); Chang, Chiang-Tung, et al., Effects of Microscopic and Macroscopic Viscosity on the Rate of Renaturation of DNA, Biopolymers, 13:1847-1858 (1974); EP 228,075 (page 3); and Wood et al., PNAS, 82:1585-1588 (1985).
  • Figure 1 is a multiple target assay system.
  • This invention provides for a dipstick for nucleic acid hybridization assays comprising: (a) a handle connected to a solid non-porous support coated with a solid surface having a porosity which does not effect the diffusion of the free nucleic acids and comprising at least one and preferably a multiplicity of discrete regions having nucleic acid probes covalently bound thereto. It is preferred that the thickness of the dipstick be between about .6 mm and about 10 mm, but more preferably between 1 and 2 mm.
  • the dipstick is generally longer than it is wide.
  • the portion of the dipstick immersed into test solutions is about 5 to about 10 times longer than it is wide.
  • the discrete regions of nucleic acid are generally uniformly spaced apart and the regions may be either a rectangular or circular pattern on the solid surface.
  • the nonporous solid support can be of the same material as the handle and can be any size or shape. It is preferably elongated and adapted for dipping into small volumes of liquid.
  • the solid support could be plastic, metal, or paper, and is preferably unchanged when exposed to hybridization media.
  • nonporous it is meant that nucleic acid in the sample solution does not become entrapped below the surface of the support.
  • a solid support having extremely small pores would also fall within this functional definition as it would be effectively nonporous.
  • the solid surface is preferably selected from the following group: polystyrene/latex; polystyrene; immobilized latex beads; carboxyl modified latex microspheres; carboxyl modified glass; and carboxyl modified teflon.
  • the surface may optionally be of the same material as the solid support.
  • the dipstick's solid surface preferably avoids a porosity which interferes with the diffusion rate of the free nucleic acids such that porosity is not a rate limiting factor in the nucleic acid hybridization assay.
  • the avoidance of a rate limiting porosity can be achieved by selecting large or small pores. By “small,” the porosity can be nonexistent (nonporous) or of such diameter that the surface is effectively nonporous.
  • the preferred size is an average pore diameter in excess of about 100 microns.
  • the surface charge of the dipstick is preferably neutral or positive when exposed to a neutral pH (about 6.0 to about 8.0).
  • the handle is an extension of the solid support to provide a means for transferring the dipstick from one solution to another solution without touching the surface having nucleic acid bound thereto.
  • the handle can be in the shape of a "t" or circular to maximize its surface area for grasping.
  • the dipstick of this invention preferably has nucleic acid covalently bound to it through spacer arms.
  • the preferred spacer arms are derived from thiol reactive substituents linked to a tethered nucleophilic amine on the 5' ends of the nucleic acid probes and are of the formula:
  • X is -NH- or -NHC:O(CH 2 ) m NH-
  • Y is a thiol reactive moiety
  • m is 2-12 inclusive
  • n is 2-12 inclusive. It is particularly preferred that n is six and X is -NH-.
  • a preferred thiol reactive moiety has a reactive group of either an ⁇ halo-acyl or an a, ß-unsaturated carbonyl.
  • the most preferred thiol-reactive moieties are selected from the group comprising haloacetamidobenzoyl and 4-(N-maleimidomethyl)-cyclohexane-1-carbonyl.
  • This invention also provides for a dipstick as described above wherein the solid surface is derivatized with sulfhydryl containing moieties.
  • the chemical structure of the sulfhydryl containing moieties is non-critical so long as the sulfhydryl group or groups are available to react with thiol reactant moieties. It is preferred that the sulfhydryl containing moieties are polymeric compounds having a multiplicity of sulfhydryl groups.
  • the sulfhydryl groups are particularly useful when proteins are conjugated thereto.
  • the preferred proteins include thiolated bovine serum albumin; casein; and liquid gelatin.
  • This invention also provides for a dipstick as described above wherein the nucleic acid probes are complementary to regions of RNA found within ribosomes including both the 16S and 23S RNA.
  • the nucleic acid probes may be complementary to either hypervariable or conserved regions of the ribosomal RNA.
  • This invention also provides methods for assaying the presence of target nucleic acids, the method comprising contacting a hybridization medium containing target nucleic acids with a dipstick comprising a solid surface having a multiplicity of discrete regions with different nucleic acid probes covalently bound thereto.
  • a dipstick comprising a solid surface having a multiplicity of discrete regions with different nucleic acid probes covalently bound thereto.
  • different it is meant that the nucleic acid probes do not have identical nucleic acid sequences and will preferentially bind to different target nucleic acid.
  • This method is preferably conducted using the solid surfaces described above for the dipstick and is most preferably conducted using carboxyl modified latex microspheres.
  • the surface for conducting this method preferably does not inhibit the diffusion of nucleic acid. Most preferably, the surface has a porosity of the size ranges described above for the dipstick.
  • the method disclosed herein is preferably conducted using nucleic acid probes that are covalently bound to the solid surface through spacer arms.
  • the spacer arms are as described above for the dipstick.
  • the disclosed method has proteins conjugated to the solid surface through sulfhydryl bonding.
  • the preferred proteins are as described for the dipstick.
  • This method is preferably useful when the nucleic acid probes are complementary to sequences of nucleic acid indicative of pathogenic state in mammals. More preferred are nucleic acid probes which are complementary to sequences of RNA found within ribosomes. The preferred ribosomal RNA and the preferred regions of the RNA are as previously described for the dipstick. There is a particular preference for using the hypervariable sequences of the 16S rRNA derived from bacteria found in the human mouth. There is also application for this method to detect virus using nucleic acid probes that are complementary to sequences of viral nucleic acid such as probes which are complementary to sequences of human papilloma virus DNA.
  • This method can be conducted in two modes.
  • the method, described above can involve the use of a hybridization medium having both the target nucleic acid and the detectable nucleic acid present.
  • the detectable nucleic acid is complementary to sequences of the target nucleic acid that are different from the sequences to which the immobilized probe nucleic acid are complementary.
  • the hybridization of the target nucleic acid and the detectable nucleic acid are achieved in separate steps.
  • detectable nucleic acid is mixed with undetectable nucleic acid that bind in competition with each other onto the target nucleic acid.
  • the preferred size for the immobilized or capture nucleic acid is about between 12 and 100 nucleotide bases.
  • the above method may take place in a hybridization buffer comprising an ammonium salt selected from the group consisting of trialkylammonium salt and tetraalkyl-ammonium salt wherein the alkyl groups are the same or different and are comprised of between 1 and 3 carbon atoms inclusive.
  • the anionic portions of the salts are selected from the group comprising acetate, iodide, perchlorate, thiocyanate, chloride and bromide.
  • the preferred trialkylammonium salt is triethylammonium chloride.
  • the method and the dipstick can be surface modified by covalently binding a surface-modifying moiety through a covalent bond selected from the group consisting of disulfide linkage and thiol ether.
  • the surface-modifying moiety can be hydrophilic, hydrophobic, ionic or metallic. By hydrophobic it is meant that the dielectric constant for the relevant moiety is below 30, preferably between 1 and 30, and by hydrophilic it is meant that the dielectric constant is above 30, preferably between 30 and 80.
  • Metallic surface-modifying moieties include copper, gold, iron, chrome, silver and aluminum.
  • the preferred surface-modifying moiety is of the formula:
  • the method described above is preferably conducted in a multiple target mode wherein the reactive surface comprises a solid surface comprising a multiplicity of discrete regions each having different pathogen specific nucleic acid probes covalently bound thereto.
  • the solid surface is preferably selected from the solid surfaces described above for the dipstick.
  • the means for attaching the nucleic acid probes are preferably as previously described for the dipstick.
  • the solid support include surface-modifying moieties bound to surface through a covalent bond selected from the group consisting of disulfide linkage and thiol ether. These surface-modifying moieties are as previously described.
  • a method for decreasing the sensitivity of a nucleic acid hybridization assay by a known amount comprising adding a predetermined ratio of unlabeled polynucleotide signal probes to labeled polynucleotide signal probes, permitting the signal probes to bind to their complementary sequences, and detecting hybridization of the labeled signal probe.
  • Sandwich assays are a preferred format for reduction of sensitivity.
  • Bacterial nucleic acid is the preferred target. Kits having containers of signal probes with varying ratios of label to unlabeled probes are also described.
  • nucleic acid polynucleotide and oligonucleotide are interchangeable except where a specific size range is indicated by language context.
  • This invention discloses a nucleic acid hybridization assay format which uses a dipstick.
  • the dipstick format has mechanical advantages over other formats presently being used. It permits ready agitation without additional mechanical devices.
  • the handle permits easy transfer from the various solutions used in hybridizations.
  • the dipstick offers a more mechanically stable support than previously available technology.
  • the dipstick permits mechanical devices to rapidly read the results, such as by insertion of the dipstick in a reflectometer or similar device.
  • the dipstick permits extremely small amounts of sample solution (less than 500 ⁇ l) to be tested.
  • This invention also relates to means for and methods of detecting multiple and differing nucleic acid targets simultaneously in a single hybridization assay.
  • the detection of pathogenic microorganisms in biological specimens using nucleic acid hybridization assays is becoming increasingly widespread. Such assays are relatively simple in theory requiring only the release of intact nucleic acid from the specimen which is then hybridized with detectable nucleic acid probes specific for the pathogenic organism under question. By detecting specific hybridization binding between the probes and the extracted nucleic acids, the presence of the microorganisms is established.
  • the biological samples of interest include virtually any type of specimen which may contain microorganisms of interest.
  • Exemplary biological samples include fecal samples, blood, sputum, saliva, urine, semen, plaque samples, tissue samples, and the like.
  • the methods of the present invention will not differ regardless of whether exogenous or endogenous nucleic acid is being detected and hence the simultaneous detection of viral, bacterial or host nucleic acid is made possible.
  • Pathogenic viruses and microorganisms which may be detected in fecal or gastric samples, or as contaminants of foods, beverages or water, or the like, and include viruses, such as adenovirus, rotavirus and the like; bacteria, such as Salmonella spp. (S. typhimurium, S. typhi, S. paratyphi A, etc.), Shigella spp. (S. dysenteriae, S. flexneri, S. boydii, S sonnei, etc.), Campylobacter spp. (C. jejuni, C. coli, C.
  • viruses such as adenovirus, rotavirus and the like
  • bacteria such as Salmonella spp. (S. typhimurium, S. typhi, S. paratyphi A, etc.), Shigella spp. (S. dysenteriae, S. flexneri, S. boydii, S sonnei, etc.), Campylobacter
  • Clostridium difficile Clostridium difficile, Escherichia coli, Yersinia enterolitica, and the like; fungi, such as Candida albicans, and the like; and protozoans, such as Giardia lamblia, Entamoeba histolytica, Microsporidium spp., and the like.
  • Pathogenic viruses and microorganisms infecting the lung, bronchial and upper respiratory areas which may be detected in saliva, sputum or respiratory lavage samples include viruses, such as adenovirus, respiratory syncytial virus, human papillovavirus, human immunodeficiency virus, human T-cell lymphotrophic viruses, cytomegalovirus, hepatitis A and B virus, epstein-barr virus, and the like; bacteria, such as Streptococcus pyogenes (Group A beta-hemolytic streptococci), Haemophilus influenzae, Staphylococcus aureus, Klebsiella pneumoniae, Pseudomonas aeruginosa, Neisseria meningitidis, Mycobacterium tuberculosis, Spirochaetales, such as Treponema spp., and the like; fungi, such as Candida albicans, Histoplasma capsulatum and the like;
  • Pathogenic viruses and microorganisms which may be detected in blood (cells, serum and /or plasma), include: viruses, such as Human Immunodeficiency Virus, Hepatitis A and B Virus, Human T-Cell Lymphotrophic Viruses, and the like; bacteria, such as Escherichia coli, Staphylococcus aureus, Klebsiella pneumonie, and the like; and, protozoans, such as Toxoplasma gondii, and the like.
  • viruses such as Human Immunodeficiency Virus, Hepatitis A and B Virus, Human T-Cell Lymphotrophic Viruses, and the like
  • bacteria such as Escherichia coli, Staphylococcus aureus, Klebsiella pneumonie, and the like
  • protozoans such as Toxoplasma gondii, and the like.
  • Pathogenic microorganisms which may be detected in plaque samples include Actinobacillus actinomycetemcomitans, Bacteroides intermedius, Eikenella corrodens, Wolinella recta, Fusobacterium nucleatum, Bacteroides gingivalis, Bacteroides forsythus, and the like.
  • nucleic acid hybridization technology to produce a nucleic acid probe assay (e.g., using a single dipstick) which can detect at least one and preferably multiple pathogens simultaneously is a substantial improvement over the presently available assays which are capable of detecting only a single pathogen at a time.
  • dipsticks described herein will typically involve sandwich assays. Such assays utilize a covalently immobilized "capture” nucleic acid and labelled nucleic acid in solution. The clinical sample will provide the "target” nucleic acid. The "capture” nucleic acid and labelled nucleic acid probe hybridize with the "target” nucleic acid to form a “sandwich” hybridization complex.
  • This invention relates to nucleic acid hybridization assays which allow for the detection of multiple target nucleic acids (i.e., pathogens) on a single dipstick.
  • Accepted means for conducting such assays in a single target mode are known and general overviews of the technology can be had from a review of Nucleic Acid Hybridization: A practical Approach, Ed. Hames, B.D. and Higgins, S.J., IRL Press, 1985; Hybridization of Nucleic acids Immobilized on Solid Supports, Meinkoth, J. and Wahl, G, Analytical Biochemistry, Vol. 238, 267-284, 1984 and U.S. Patent No. 4,358,535 which are incorporated herein by reference.
  • Target polynucleotides can be obtained from a variety of biological sources, depending upon the particular target one desires to detect.
  • Sources include all manner of biological materials which may harbor polynucleotide targets.
  • Polynucleotide targets can be: endogenous nonpathogenic nucleic acid sequences; mutations of the normal wild-type population, regardless of whether they are phenotypically expressed; or nucleic acid sequences arising from the presence of pathogens, such as viruses, bacteria, mycoplasmas, protozoa, rickettsia or fungi.
  • pathogens such as viruses, bacteria, mycoplasmas, protozoa, rickettsia or fungi.
  • Clinical samples of microbes, cells, tissue and the like can be obtained with standard techniques, such as lavage, scraping or biopsy.
  • the samples are typically dispersed in a buffer, which provides a biologically compatible solution.
  • a typical dispersal buffer solution would be 150mM NaCl, 20mM Tris-HCl (pH 7.5), 10mM EDTA, 10mM EGTA, or 150mM NaCl, 20mM NaPO 4 (pH7.5), 10mM EDTA, 10mM EGTA.
  • Samples may require exposure to a lysing solution in order to free target nucleic acid. Lysing buffers are known in the art. EP 199,439; Potts, T.V. and Berry, Em. Internat. J. Sys. Bacter., 33:765-771 (1983); Bonta, Y., et al., J. Dent.
  • these buffers are between pH 7.0 and 8.0, containing both chelating agents and surfactants.
  • a lysing solution is a buffered solution of detergent and a divalent metal chelator or a buffered chaotrophic salt solution containing a detergent, a reducing agent, and a divalent metal chelator.
  • Heat denaturing is optional as is the use of N-acetyl-muramidase (lysozyme).
  • Probes are either DNA or RNA oligonucleotides or polynucleotides, containing naturally occurring nucleotides or their analogs, such as 7-deazaguanosine or inosine. Probes typically have sufficient complementarity with their target polynucleotides such that stable and specific binding occurs between target and probe.
  • the degree of homology required for formation of a stable hybridization complex (duplex) varies with the stringency of the hybridization medium and/or wash medium.
  • Polynucleotide or oligonucleotide probes for use in this invention can be obtained from the entire sequence or portions thereof of an organism's genome, from messenger RNA, or from cDNA obtained by reverse transcription of messenger RNA. After isolation of genomic DNA or cDNA fragments, the fragments are typically inserted into a replication vector, such as lambda phage, pBR322, M13, or vectors containing the SP6 or T7 promoter and cloned as a library in a bacterial host. Following appropriate screening procedures, a recombinant vector with the desired probe insert is isolated and labelled as described below. The vector is then grown in a suitable host. The probe and its vector are purified from the host cells by cell lysis and nucleic acid extraction. Following isolation, the probe can be purified away from the vector by digestion with selected restriction enzymes and sequenced. Further isolation of the probe can be achieved by using gel electrophoresis or high pressure liquid chromatography.
  • a replication vector such as lambda phage
  • DNA probes are preferably chemically synthesized using commercially available methods and equipment.
  • the solid phase phosphoramidite method can be used to produce short probes of between 15 and 50 bases and have a molecular weight of less than 16,000 daltons. These are referred to herein as "short probes.” (Caruthers, et al., Cold Spring Harbour Symp. Quant. Biol., 47:411-418, 1982, and Adams, et al., J. Am. Chem. SOC, 105:661, 1983).
  • nucleotide sequence When synthesizing a probe for a specific target, the choice of nucleotide sequence will determine the specificity of the test. For example, by comparing DNA sequences from several virus isolates, one can select a sequence for virus detection that is either type specific or genus specific. Comparisons of DNA regions and sequences can be achieved using commercially available computer programs.
  • Probes may be labelled by any one of several methods typically used to detect the presence of hybrid polynucleotides. The most common method of detection is the use of autoradiography with 3 H, 125 I, 35 S, 14 C, or
  • 32 P labelled probes or the like The choice of radioactive isotope depends on research preferences due to ease of synthesis, varying stability, and half lives of the selected isotopes.
  • Other labels include ligands which bind to labelled antibodies, fluorophores, chemiluminescent agents, enzymes, and antibodies which can serve as specific binding pair members for a labelled ligand. The choice of label depends on sensitivity required, ease of conjugation with the probe, stability requirements, and available instrumentation.
  • Radioactive probes are typically made using commercially available nucleotides containing the desired radioactive isotope.
  • the radioactive nucleotides can be incorporated into probes by several means such as by nick translation of double-stranded probes; by copying single-stranded M13 plasmids having specific inserts with the Klenow fragment of DNA polymerase in the presence of radioactive dNTP; by transcribing cDNA from RNA templates using reverse transcriptase in the presence of radioactive dNTP; by transcribing RNA from vectors containing SP6 promoters or T7 promoters using SP6 or T7 RNA polymerase in the presence of radioactive rNTP; by tailing the 3'ends of probes with radioactive nucleotides using terminal transferase; or by phosphorylation of the 5' ends of probes using [gamma 32P]-ATP and polynucleotide kinase
  • Non-radioactive probes are often labelled by indirect means.
  • a ligand molecule is covalently bound to the probe.
  • the ligand then binds to an anti-ligand molecule which is either inherently detectable or covalently bound to a signal system, such as a detectable enzyme, a fluorescent compound, or a chemiluminescent compound.
  • Ligands and anti-ligands may be varied widely. Where a ligand has a natural anti- ligand, for example, biotin, thyroxine, and cortisol, it can be used in conjunction with the labelled, naturally occurring anti-ligands. Alternatively, any haptenic or antigenic compound can be used in combination with an antibody.
  • Probes can also be conjugated directly to signal generating compounds, e.g., by conjugation with an enzyme or fluorophore ("labeled signal probes").
  • Enzymes of interest as labels will primarily be hydrolases, particularly phosphatases, esterases and glycosidases, or oxidoreductases, particularly peroxidases.
  • Fluorescent compounds include fluorescein and its derivatives, rhodamine and its derivatives, dansyl, umbelliferone, etc.
  • Chemiluminescent compounds include luciferin, and 2,3-dihydrophthalazinediones, e.g.. luminol.
  • hybridization solutions comprising from about 20 to 60% volume, preferably 30%, of a polar organic solvent.
  • a common hybridization solution employs about 30-60% v/v formamide, about 0.5 to 1M sodium chloride, about 0.05 to 0.1M buffers, such as sodium citrate, Tris HCl, PIPES or HEPES, about 0.05 to 0.5% detergent, such as sodium dodecylsulfate, and between 1-10 mM EDTA, 0.01 to 5% ficoll (about 300-500 kilodaltons), 0.1 to 5% polyvinylpyrrolidone (about 250-500 kdal), and 0.01 to 10% bovine serum albumin.
  • the amount of labelled probe which is present in the hybridization solution may vary widely. Generally, substantial excesses of probe over the stoichiometric amount of the target nucleic acid will be employed to enhance the rate of binding of the probe to the target DNA.
  • degrees of stringency of hybridization can be employed. As the conditions for hybridization become more stringent, there must be a greater degree of complementarity between the probe and the target for the formation of a stable duplex.
  • the degree of stringency can be controlled by temperature, ionic strength, the inclusion of polar organic solvents, and the like. For example, temperatures employed will normally be in the range of about 20° to 80oC, usually 25o to 75oC. For probes of 15-50 nucleotides in 50% formamide, the optimal temperature range can vary from 22-65oC. With routine experimentation, one can define conditions which permit satisfactory hybridization at room temperature.
  • the stringency of hybridization is also conveniently varied by changing the ionic strength and polarity of the reactant solution through manipulation of the concentration of formamide within the range of 20% to 50%.
  • the glass, plastic, or filter support to which the probe-target hybrid is attached is introduced into a wash solution typically containing similar reagents (e.g., sodium chloride, buffers, organic solvents and detergent), as provided in the hybridization solution.
  • reagents e.g., sodium chloride, buffers, organic solvents and detergent
  • the time period for which the support is maintained in the wash solutions may vary from minutes to several hours or more.
  • the probe may be conjugated directly with the label.
  • the label is radioactive
  • the dipstick with associated hybridization complex substrate is exposed to X-ray film.
  • the label is fluorescent
  • the sample is detected by first irradiating it with light of a particular wavelength. The sample absorbs this light and then emits light of a different wavelength which is picked up by a detector (Physical Biochemistry, Freifelder, D., W.H. Freeman & Co., 1982, pp. 537-542).
  • the label is an enzyme
  • the sample is detected by incubation with an appropriate substrate for the enzyme.
  • the signal generated may be a colored precipitate, a colored or fluorescent soluble material, or photons generated by bioluminescence or chemiluminescence.
  • the preferred label for dipstick assays generates a colored precipitate to indicate a positive reading.
  • alkaline phosphatase will dephosphorylate indoxyl phosphate which then will participate in a reduction reaction to convert tetrazolium salts to highly colored and insoluble formazans.
  • Detection of a hybridization complex may require the binding of a signal generating complex to a duplex of target and probe polynucleotides or nucleic acids. Typically, such binding occurs through ligand and anti-ligand interactions as between a ligand-conjugated probe and an anti-ligand conjugated with a signal.
  • the binding of the signal generation complex is also readily amenable to accelerations by exposure to ultrasonic energy.
  • the multiple target assay system described uses the sandwich assay format which is well known in the art of immunoassays and DNA probe assays.
  • the first description of a sandwich format for immunoassays was described in 1968 by Miles et al., Nature 219:186-189, while the first description of this format for the detection of nucleic acids was described by Dunn et al., Cell, 15:511-526 (1978).
  • a sandwich assay using DNA probes for the detection of single pathogens in clinical samples was described by Ranki et al., Gene, 21:77-85, 1983; Curr. Top. Microbiol. Immunol., 104:307- 318 (1983), and patents were issued to the same group in 1982 (U.S.
  • Patent No. 4,486,539) and 1986 U.S. Patent No. 4,563,419). These patents, however, were limited to a one-step assay for the detection of a single pathogen within a sample. No description was given of the potential for the detection of multiple pathogens within a single test sample using DNA/RNA probes in a sandwich type of format.
  • the first DNA probe subsequently is immobilized to a solid support and, when conducting a clinical assay, is used to capture a target nucleic acid from a complex cell lysate via hybridization to form a specific duplex.
  • the second DNA probe also hybridized with the target nucleic acid to form a specific duplex.
  • This second DNA probe is labeled and can be detected directly through a probe-linked label such as an enzyme, or indirectly through a biotin:labeled-streptavidin system.
  • the amount of the target nucleic acid (i.e., the pathogen) present in the clinical sample is indicated by the amount of labeled, second DNA probe which is contained within the hybridization complex.
  • the sandwich format can be used to develop assays which detect multiple targets simultaneously.
  • a principle feature of this assay is that discrimination of multiple nucleic acid targets (DNA and/or RNA) is achieved by site specific sequestering on a solid surface of the target nucleic acid itself.
  • Probe 1 An example of a multiple target assay for each of the 16S ribosomal RNA (rRNA) of three microbes is shown in Figure 1.
  • Probe 1, probe 3, and probe 5 are designed to hybridize only with the 16S rRNA of microbe A, microbe B and microbe C, respectively.
  • these probes are immobilized at three specific areas on a dipstick.
  • the sample is mixed with an appropriate hybridization reagent and the dipstick is immersed in the resulting solution.
  • Hybridization immediately proceeds between the dipstick-immobilized probes 1, 3 and 5 and the 16S rRNAs released from microbes A, B and C, respectively.
  • each 16S rRNA is sequestered precisely at the area on the dipstick which contains it immobilized and complementary probe. Once immobilized, each target 16S rRNA can be detected specifically with signal-generating probes 2, 4 and 6 which also are complementary, respectively, to the 16S rRNAs of microbes A, B and C.
  • the sample is mixed directly in a solution with an unlabeled DNA probe immobilized on a solid surface (e.g., a dipstick), a labeled solution-free DNA probe, and protease(s), hydrolases, detergent(s) and /or chaotropic agent(s) to rapidly lyse the cells and release target DNA or RNA.
  • Hybridization starts immediately after cell disruption, and the target DNA or RNA is simultaneously sequestered at the solid surface (by hybridizing to the immobilized first DNA probe) and labeled with signal (by hybridizing to the labeled second DNA probe).
  • the unbound labeled probe is washed away, and the amount of target DNA or RNA is quantified by the amount of bound (hybridized) labeled DNA probe.
  • the lysis buffer may limit the selection of a detectable label.
  • the use of proteases or chaotropic agents in the lysing step may preclude the use of enzymes as labels unless appropriate inhibitors are added after lysis.
  • the second DNA probe can be labelled with biotin. After hybridization and removal of proteases and/or chaotropic agents by a washing step, the hybridized biotin-labeled DNA probe can be detected with avidin conjugated with a signal generating system as described below for the two-step assay.
  • the two-step assay also can be run in an alternative mode - - after cell lysis, the target nucleic acid can be hybridized first with the signal-generating probe, and second with the immobilized probe.
  • any target probe as well as any signal-generating probes can be, but does not have to be, highly specific.
  • the flexibility arises because specificity of the assay for a particular microbe can be achieved in different ways as shown in the Table below. TABLE 1
  • Probe Signal Probe a) One/Two step Specific Specific* b) One/Two step Specific Non-Specific* c) One/Two step Partially Specific Specific* d) One/Two step Non-Specific Specific - - - - - -
  • nucleic acids having significant variations in their respective G:C and A:U or A:T ratios The influence upon hybridization due to differing compositions is most readily viewed between nucleic acids having the same length.
  • the G:C hydrogen bonding is more stable under typical salt conditions than the A:U or A:T bonding. Therefore nucleic acids having significantly different compositions will have significantly different ability to stably hybridize under similar hybridization conditions.
  • the most preferred salt is tetraethylammonium chloride which works best at 30-40oC in concentrations of between 2 and 3 moles per liter most preferably about 2.4 moles per liter.
  • the preferred nucleic acid chain length is about 15-50 nucleotides most preferably about 24 nucleotides.
  • test system can be made less sensitive by mixing the labeled signal probe (biotinylated) with unlabeled signal probe (not biotinylated) of the same sequence. During hybridization the unlabeled probe will compete with the labeled probe for hybridization with the target nucleic acid. Once hybridized, this probe will not produce signal and will thus make the test assay less sensitive.
  • E. coli bacteria is a common contaminant of water and foodstuffs; however, the presence of this microbe is only a health hazard when present above acceptable levels. Using these methods, one can readily desensitize an assay to reflect positive when the E._ coli concentration exceeds acceptable levels.
  • E._ coli concentration exceeds acceptable levels.
  • several microbes are associated with bacterial vaginosis which is a vaginal infection curable by treatment with the proper antibiotics. In the disease condition these organisms are typiclally present at different abnormally high levels.
  • a diagnostic assay based upon visualization of color can be constructed using either the single or multiple target modes, preferably the multiple target mode.
  • cutoff limits such that a positive test (eg., a detectable or specific shade of color on the dipstick) for a disease state will be indicated only when the concentration of a microbe exceeds a certain value.
  • This type of label dilution can be used to desensitize virtually any assay and can be individually and independently applied to any of the nucleic acid targets undergoing detection in the multiple target test.
  • label dilution will work for any type of label.
  • biotinylated probes or enzyme conjugated probes can be diluted in this fashion.
  • a stoichiometric dilution may not give exactly the desired result.
  • the rate of hybridization of the bulky enzyme-conjugated probe will be less than that of the smaller, unlabeled probe.
  • the solid support surface for the preferred multiple target mode of this invention is modified with sulfhydryl groups for subsequent reaction with the thiol- reactive oligonucleotide described below in section II part B.
  • the preferred method is to modify the surface with disulfide derivatives containing nucleophilic amines which participate in conjugation, and then to reduce the disulfide groups to monothiols by treatment with, for example, dithiothreitol, in order for the thiol reactive portion of the activated oligonucleotide to covalently bind to the surface.
  • Membranes polystyrene beads, teflon, polystyrene/latex beads, latex beads or any solid support possessing an activated carboxylate, sufonate or phosphate are suitable for use as solid surface substratum.
  • Porous membranes possessing pre-activated surfaces may be obtained commercially (eg. Pall
  • the following chemical moieties can be attached to the solid support surface: any aminoalkyl or aryl disulfides (for coupling of the oligonucleotides), any mercaptans (for surface modification), any amino thiol alcohols (for coupling of oligonucleotides), amino aryl disulfides (for coupling of the oligonucleotides), any NH2-R12-S-S-R13-SH where R12 and R13 are the same or different.
  • R 12 and R 13 are noncritical moieties that are not to be viewed as a limitation of this invention. They are typically organic radicals that vary in size, charge and polarity in accordance with the user's needs and objectives.
  • R 12 and R 13 are preferably as defined in the Summary of the Invention above.
  • the diamino substituted disulfide can be used to react with either the preactivated membranes or the carboxylated solid surfaces.
  • a direct substitution reaction occur according to reaction conditions described by the manufacturer.
  • the carboxyl group is first activated and then derivatized by reaction with the disubstituted aminodisulfide.
  • a reactive sulfhydryl group is generated by reacting the membrane with a reducing agent such as beta-mercaptoethanol, dithioerythritol, or dithiothreitol at 0.0001 to 0.001 moles/cm 2 in buffered neutral or basic aqueous solution for 30 to 60 minutes at 20o to 30oC. Unreacted material is removed by repeated washings in the presence of a detergent.
  • a reducing agent such as beta-mercaptoethanol, dithioerythritol, or dithiothreitol
  • filtration manifolds include those commercially available from Bio-Rad Laboratories (Richmond, CA) which is referred to as the Bio-Dot SF apparatus or the Minifold 11 apparatus which is available from Schleicher & Schuell (Keene, NH).
  • Bio-Rad Laboratories Richmond, CA
  • Minifold 11 apparatus which is available from Schleicher & Schuell (Keene, NH).
  • dots" or "slots” are formed on the membrane surface which contain only one oligonucleotide.
  • the membranes are then cut mechanically such that any configuration of the dipstick may be obtained.
  • the membrane may then be immobilized onto a plastic, glass or ceramic support with the use of appropriate adhesives.
  • the activated beads are exposed to 0.01 to 1 molar solution of an aminoalkyldisulfide or an aminoalkylmercaptan preferably cystamine or cysteamine (2-aminoethanethiol) in a non-amine containing buffer such as sodium borate, sodium phosphate or sodium carbonate at about pH 7 to 9 and allowed to react for 1 to 24 hours.
  • an aminoalkyldisulfide or an aminoalkylmercaptan preferably cystamine or cysteamine (2-aminoethanethiol
  • a non-amine containing buffer such as sodium borate, sodium phosphate or sodium carbonate
  • the disulfide of the conjugated cystamine is reduced to a sulfhydryl using a reducing agent such as 0.01 to 0.1 M dithiothreitol or dithioerythritol If cysteamine was employed in the last step, the beads do not require a reduction step.
  • Support surfaces described above without activatable carboxylate groups can also be activated. These supports can be any shape or size.
  • the surfaces are first coated with a solution of latex polymer which contains carboxyl groups (Carboxylate-Modified Tube Coating (CML), Seradyne, Inc. Indianapolis, IN). Following drying, the carboxyl groups on such coated surfaces can be activated, and then conjugated with modified oligonucleotides as explained below in section IV part C.
  • CML coating is a preferred mode of producing a multiple target dipstick.
  • the CML Tube Coating is diluted with alcohol such as 50% ethanol to make the desired dilution to optimize the properties of the CML Tube Coating for application to a desired surface.
  • CML Tube Coating After application to the solid surface, excess CML Tube Coating is removed and the CML Tube Coating is allowed to dry without the use of heat.
  • the carboxyl groups on the CML Coating are activated using any appropriate chemical activator such as 1-ethyl-3-(3-diethylaminopropyl)carbodiimide (EDC), and then reacted with an aminoalkyldisulfide or an amino alkylmercaptan, preferably cystamine or cysteamine followed by reduction in the case of the disulfide conjugate as described above for the beads.
  • EDC 1-ethyl-3-(3-diethylaminopropyl)carbodiimide
  • the CML Coating is applied to distinct regions of the plastic surface and then specific activated oligonucleotides are applied to the appropriate regions of CML coating.
  • the preferred method is to prepare unique plastic sheets of one specific oligonucleotide immobilized on the CML Coating on the solid support. The sheets are then cut and processed. A multiple target dipstick is prepared by attaching onto the appropriate dipstick device the individual plastic oligo-containing pieces. ii. Plastic, Glass. Ceramic Frits or Magnetic Frits or Beads
  • the frits are coated with CML and are processed in bulk with one specific oligonucleotide as described above.
  • the individual frits possessing the desired specific oligonucleotides are assembled in to the appropriate dipstick device giving rise to a multiple target dipstick.
  • CML Coating is applied and processed as described above and to each well a different or the same type oligonucleotide sequence may be covalently immobilized. This permits the formation of a device in which 96, 48, 24, or 8 different specific oligonucleotides may be immobilized and used in hybridization assays.
  • the solid surfaces now contain a sulfhydryl group ready to be activated with a thiol reactive oligonucleotide as described below in Section IV, Part C.
  • the preferred capture nucleic acids for use in this invention are synthetic oligonucleotides of between 20 and 100 bases.
  • a linker arm containing a blocked amine group can be coupled using conventional chemistry to the 5'-hydroxyl group of an oligonucleotide.
  • the activated oligonucleotides used as starting materials for this invention can be derived through several methods.
  • the reagents for the attachment of primary linker arms terminating in a primary amine are commercially available.
  • a primary amine is the preferred group for attachment to the heterobifunctional reagent, and its attachment via a hexyl arm is preferred.
  • Starting materials suitable for use in this invention are described in PCT U.S. 86/01290; Nucl.
  • an oligonucleotide possessing a 5'-terminal structure such as
  • X is an NH or NHC:O(CH 2 ) n NH
  • Y is a thiol reactive moiety
  • A is a poly or oligonucleotide
  • n and m are between 2 and 12, inclusive.
  • the oligonucleotide can range between about 9 and 50 bases, preferably between about 15-30 bases, with only the 5'-hydroxyl requiring modification for attachment.
  • the preferred thiol reactive moieties are an alpha-halo-acyl or an alpha- or beta-unsaturated carbonyl or alpha- or beta-unsaturated lactones.
  • thiol reactive moieties are alpha-haloacetamidobenzoyl and 4-(N-maleimidomethyl) cyclohexane-1-carbonyl.
  • Preferred halogens are iodine and bromine.
  • the thiol-reactive oligonucleotides are referred to as activated oligonucleotides.
  • an oligonucleotide can be modified at its 3 'end with a linker arm containing a blocked amine group. This can be accomplished by conducting DNA synthesis on a solid support containing a conjugated ribonucleotide. After removal from the solid support, a DNA oligonucleotide is obtained which contains a single 3'-terminal ribonucleotide.
  • This can be modified with a linker arm containing a nucleophilic amine by, for example, 1) oxidizing the ribonucleotide cis-glycol with periodate, 2) treating oligonucleotide so modified with, for example, butane diamine to form a Schiff base, and 3) treating with sodium borohydride or cyanoborohydride to form a stable reduced Schiff base derivative in which one of the amines is left free for subsequent conjugation.
  • DNA bases can also be modified to become thiol reactive before or after preparation in a DNA synthesizer.
  • natural nucleic acids DNA and RNA
  • molecularly cloned nucleic acids as well as synthetic nucleic acids, can be modified.
  • cytosine a more nucleophilic amine is linked to the 4-position of cytosine by a variety of chemistries. The amine can be added by treatment with hydrazine to generate N-4-aminocytosine (Sverdlov, E.D., et al., FEBS Letters, 62, p. 212. Feb. 1976). This reaction is catalyzed by bisulfite.
  • an amine can be added to the 4-position by bisulfite catalyzed transamination reactions where a diaminoalkane is added to the 4-position (Shapiro and Weisgras, Biochemical and Biophysical Research Communications, 40:839, 1970).
  • Bi-functional semicarbazide can also be used to add nucleophilic amines to the 4-position of cytosine (Hayatsu and Ukita, Biochemical and Biochemical Research Communications, 14:198, 1964).
  • the base with the free amino group in the oligo is then made thiol reactive through the reaction of the nucleophilic amine and a NHS ester of a carboxylic acid derivative substituted with a alpha- or beta-unsaturated carbonyl, or alpha-halocarbonyl groups or the like.
  • nucleic acid bases with nucleophilic amines on other positions can be used for reactions with NHS esters of a carboxylic acid derivative substituted with a alpha- or beta-unsaturated carbonyl, or alpha-halo ⁇ acyls.
  • NHS esters of a carboxylic acid derivative substituted with a alpha- or beta-unsaturated carbonyl, or alpha-halo ⁇ acyls For instance, 5-[N-(7-aminohexyl)-1-acrylamido]-2'-deoxyuridine 5 '-triphosphate (Calbiochem, La Jolla, CA) can be added to the 5' end of oligonucleotides in reactions with terminal deoxnucleotidyl transferase ("Molecular Cloning, A Laboratory Manual," T. Maniatis, et al. eds., Cold Spring Harbor Laboratory, p. 148, 1982).
  • oligonucleotide bearing the tethered amine is covalently bound to a reagent having two different types of functional groups.
  • These bifunctional reagents typically have an N-hydroxysuccinimidyl (NHS) ester, which is amine reactive as the first functional group, and a thiol reactive group, as the second functional group.
  • NHS ester acylates the free amine of the 5' end of the oligonucleotide.
  • the acylating conditions are well known and highly selective.
  • the exocyclic amines on adenine and cytosine bases are not nucleophilic and do not readily react with the NHS ester.
  • the thiol reactive functional group is available for conjugation with surfaces containing free sulfhydryl groups.
  • An oligonucleotide with a tethered nucleophilic amine linked to its 5' end can be derivatized with such thiol-reactive groups by relatively simple chemistry.
  • a reagent such as SIAB is added to the oligonucleotide in aqueous solutions at a 10 to 100 fold molar excess.
  • the pH is buffered between about 6 and 9 and the temperature is between about 20° and 30oC. After a reaction period of about 30 to 90 minutes the excess unreacted reagent is removed by exclusion gel filtration.
  • the preferred thiol reactive moiety is an alpha-halo-acyl compound or an alpha- or beta-unsaturated carbonyl compound.
  • the thiol reactive group may include: maleimides, pyridyl sulfides, and active halogens, alpha- or beta-unsaturated lactones and the like.
  • the active halogens are typically alpha-haloacyl.
  • Useful halogens include chlorine, bromine iodine, and fluorine with iodine and bromine being preferred.
  • Reagents useful for this invention can be purchased from Pierce Chemical Co., Rockford, IL. Examples include:
  • the thiolated surface of section IV, part A is reacted with the activated oligonucleotide, using a 5 to 100-fold excess of activated oligonucleotide over the maximum oligonucleotide binding capacity of the solid support.
  • This method gives 5 to 100 micrograms of oligonucleotide (for a 24-mer) per cm 2 for a Pall Immunodyne membrane or 0.05 to 1 microgram per cm 2 for undiluted Seragen CML Tube Coating.
  • the reaction occurs in aqueous buffer between ph 5.5 and 9.5 (with the pH range of 7-8 being preferred) and is allowed to proceed from 1 to 16 hours at about 19o to 24 oC. Volumes of the reaction are held to a minimum.
  • the conjugate is separated from free oligonucleotide by repeated washings in buffers containing ionic detergents such as sodium dodecyl sulfate, sodium laurylsulfate or hexadecyltrimethylammonium bromide (CTAB) or nonionic detergents such as Tween 20, with a final wash in water.
  • ionic detergents such as sodium dodecyl sulfate, sodium laurylsulfate or hexadecyltrimethylammonium bromide (CTAB) or nonionic detergents such as Tween 20, with a final wash in water.
  • CTAB hexadecyltrimethylammonium bromide
  • Tween 20 hex
  • Oligonucleotides modified with thiol-reactive groups can be conjugated to the derivatized solid support by a variety of means. These include slow filtration in the case of membranes, immersion in a solution of functionalized oligo when plastics frits are used or overlaying the activated oligo solution on the activated surface of a flat plastic, glass or ceramic sheet.
  • nucleic acid hybridization assays of all types. These assays have numerous applications in the medical and biological sciences as well as in numerous industrial settings. A general review of these procedures can be found in Nucleic Acid Hybridization, A Practical Approach, Eds. Hames, B.D. and Higgins, S.J., IRL Press, Washington D.C. (1985); Hybridization of Nucleic Acids Immobilized on Solid Supports, Meinkoth, J. and Wahl, G., Anal. Biochem., 238:267-284 (1984); and U.S. Patent No. 4,358,535.
  • the thiolated surface on it's own possesses very low background levels of non-specific binding of nucleic acid due to the negative charge of the surface at solution pH values of 7.2 or greater.
  • the amount of capture oligonucleotide conjugated to a surface can be increased in the following way.
  • a polymer, possessing appropriate side groups which may be activated chemically to form thiols, may be conjugated to an active surface through a terminal or internal primary amine. After immobilization, the polymer can be treated to produce reactive thiols and these can be reacted with thiol-reactive capture oligonucleotides. — Using this type of procedure higher levels of immobilized capture oligonucleotides can be obtained.
  • Poly-S-CBZ-L-cysteine is a preferred polymer. Reaction conditions are as described above for aminoalkyl mercaptans and aminoalkyldisulfides.
  • D. Postmodification of the Surface of the Solid Support After conjugation of the surface of the solid support with a capture DNA probe, there is a large excess of free sulfhydryl groups. The ratio of these remaining sulfhydryl groups to covalently coupled capture oligonucleotide can range from 10:1 to 1,000,000:1. The presence of these excess thiol groups permits a second modification of the surface of the solid support by the selective chemical coupling of R-SH groups, where R is any chemical functionality. This chemical coupling can be either irreversible (e.g., by reaction with a maliemide derivative) or reversible (e.g., by formation of a disulfide bond).
  • the ability to conduct a second modification of the surface of the solid support is important for achieving a variety of desired surface properties on the solid support.
  • the following are illustrative of some possible examples:
  • the thiolated surface provides the chemical means for irreversible modification in the second conjugation step by treatment modification of the residual thiols with the appropriate reagent to provide covalent bonds. Such conjugations can modify the charge, hydrophobicity, hydrophilicity, color, reflectance, transmittance, porosity, frictional coefficient, porosity, conductivity and heat capacity of the surface.
  • the thiolated surface also provides the means whereby proteins, nucleic acids, antibodies, antigens or other macromolecules of interest may be irreversibly coupled to the solid support. Such modified surfaces will control, in part, the rate of hybridization of target nucleic acid to the capture probe on the solid surface support and will be important in reducing the level of nonspecific background arising during the detection of the hybridized labelled probe.
  • the thiolated surface also provides the chemical means for reversible modification in the second conjugation step by the formation of disulfide bonds between the surface and a desired reagent (e.g., formation of surface-S-S-R bonds). Such conjugations can modify transmittance, frictional coefficient, porosity, conductivity and heat capacity of the surface.
  • the thiolated surface also provides the means whereby specific proteins, nucleic acids, antibodies, antigens or other macromolecules of interest may be reversibly coupled to the solid support. These types of moieties may serve as receptors, ligands, or substrates in the signal development processes.
  • the reversibly modified surface described directly above in Section 2 can be further modulated after sequestering of the target nucleic acid via the formation of the hybridization complex with the immobilized capture probe and the labeled probe.
  • the solid surface is "chemically cleansed” by selective reduction of only those groups coupled by disulfide bonds to the surface. This will have important consequences in the reduction of undesired background typically arising in DNA probe assays.
  • the dipstick can be used in a sandwich assay to capture target nucleic acid and hybridized labeled probe.
  • any labeled probe which has bound non-specifically to the protein on the dipstick can be removed by treating with a reducing agent such as dithiothreitol. During such treatment, the disulfide bond between the protein and the dipstick is cleaved and the protein is released into the solution with its non-specifically associated labeled DNA probe.
  • this type of “chemical cleansing” (disulfide reduction to remove specific conjugated groups), in addition to removing background signal, can also be used to alter the charge, hydrophilicity, hydrophobicity, color, reflectance, transmittance, friction coefficient, porosity, conductivity and heat capacity of the surface of the solid support.
  • the following serves to illustrate more specifically the reversible "chemical cleansing" described directly above.
  • the surface is placed in a neutral or basic buffer (if aqueous conditions are required), or organic solvent containing 0.0001-0.1 M thiolated bovine serum albumin (BSA) with 0.001-0.1 M iodosobenzoate, and mixed for 10 to 60 minutes at 15 to 50oC.
  • BSA bovine serum albumin
  • the iodosobenzoate promotes an oxidation reaction which produces a disulfide bond between the dipstick and the BSA.
  • Excess reagents are removed by alcoholic washes followed by aqueous washes containing ionic detergents. Surfaces modified in this way contain irreversibly conjugated capture probe and reversibly conjugated BSA-protein.
  • all disulfides on the surface may be cleaved by treatment with dithiothreitol, beta-mercaptoethanol or the like. This highly specific cleavage removes much of the labeled DNA probes which is non-specifically bound to the dipstick surface. Such treatment allows the development of DNA probe assays which have high signal to noise ratios, and hence are extremely sensitive.
  • This cleansing is particularly advantageous where the target nucleic acid to be detected is present within a complex mixture of biological materials.
  • complex mixtures which are expected in both clinical and industrial settings include sputum, saliva, blood, urine, fecal material, foodstuffs, water supplies, and the like.
  • the surface may be made hydrophilic by the introduction of a hydrophilic functionality such as thioglucose.
  • the surface may be made a different color by the introduction of a colored functionality or the reduction of compounds known as tetrazolium salts or other compounds which maintain a color upon reduction.
  • the reflectance of the surface may be modified by the introduction of, for example, metal containing complexes such as Fe, Cu, Ag or the like via sulfhydryl group reaction.
  • the porosity of the surface of the solid support may be modulated by the introduction of the large polymeric molecules such as polycysteine.
  • the solid supports used to construct the dipstick described herein can be polystyrene, polypropylene, polycarbonate sheet plastic or plastics, or glass and ceramics in any conformation or shape amenable to the desired dipstick format.
  • Examples include porous polypropylene frits or porous glass, and nonporous material such as flat polystyrene sheets, microtiter plates and wells, glass tubes and the like.
  • the rate of hybridization of nucleic acids in solution to a complementary nucleic acid immobilized on a solid support is normally a three step process depending on the nature of the solid support. If the solid support is a filter membrane such as those commercially available from Pall or Millipore, the rate limiting steps leading to hybridization consist of the following:
  • the rate of hybridization of nucleic acids in solution to a solid support is substantially limited by external and internal diffusional control. Therefore, to maximize the efficiency and rate of hybridization, several key parameters of the sandwich assay system have been defined.
  • concentrations of the nucleic acids should be kept as high as possible.
  • the volumes should be minimized to the fullest extent.
  • the distances should be minimized between the surface and the target nucleic acid in solution.
  • polymeric forms of capture nucleotides will provide good kinetics for hybridizing to target probes.
  • the capturing polymers are then sequestered on the dipstick.
  • the preferred polymer is polyethyleneamine having capturing oligonucleotides covalently bound thereto.
  • porosity of the solid support should be at or of a size that does not impose internal diffusional control on the rate of reaction.
  • Preferred surfaces should have an average porosity that are in excess of 100 microns. It should be noted that the upper and lower ranges of the preferred porosity range will vary in accordance with the length of the oligonucleotides and target nucleic acids in solution.
  • Capture probe was covalently conjugated to a CML surface (carboxy modified latex) coated within a polyethylene frit or to a Pall Immunodyne membrane. In both experiments, the probe was immobilized at the same concentration per unit of surface area, yet the probe on the CML surface hybridized 18-24 times faster than the probe conjugated to the Pall membrane surface.
  • Example 1 Derivatization (Thiolation) of the Pall Immunodyne Membrane and Other Solid Supports.
  • the beads were then washed extensively with PBS containing 0.1% Tween and then reduced with 0.1 M DTT for 30 minutes at 22oC and again extensively washed with PBS/Tween.
  • the DTNB assay (described above) indicated 5 X 10- 11 moles of cystamine were bound (and reduced) to the beads.
  • Cystamine binding to the Carbox-Modified Tube Coating (CML, Seragen Diagnostics, Inc. Indianapolis, IN) was similarly demonstrated after painting polyethylene frits (0.28 cm squared) with a 1 to 5 dilution of the stock CML paint, drying and processing the frits as described for the polystyrene/latex beads. Approximately 2.5 X 10 -10 moles of cystamine were bound per frit.
  • This example involves the direct conjugation of an oligonucleotide to a solid support involves conjugation via heterobifunctional reagents.
  • the first step is to modify a synthetic probe with a linker arm reagent attached to its terminal 5'-hydroxyl group.
  • An aminohexyl linker arm with a terminal amino group is attached to the 5'-hydroxyl of the synthetic oligonucleotide via a phosphodiester linkage on an automated DNA synthesizer during the last step in the synthesis.
  • the reagent used for the introduction is 6- (methoxytritylamino)hexyl 2-cyanoethyl N,N-disopropylphosoramidite, prepared from 6-aminohexanol in a manner similar to the synthesis of the 3- (methoxytritylamino)propyl m e t h y l N , N -diisopropylphosphoramidite, as described by Connolly, Nucleic Acids Research., 15:3131 (1987).
  • the linker arm was attached to the probe, and the deprotected probe purified in a method similar to the methods described in the Connolly reference.
  • the synthetic probe chosen for this study was a DNA sequence complementary to a hypervariable region of the 16S RNA of Bacteriodes gingivitis.
  • the probe was designated Bg5B6N and has the following sequence: 5'XCCGATGCTTATTCTTACGGTACAT 3' where X denotes the hexyl arm linker.
  • SIAB-oligonucleotide is prepared by adding 0.1 to 2.0 grams of Sulfo-SIAB to 50 micrograms of the oligonucleotide described above in 300 microliters of Na Borate buffered aqueous solution at pH 8.3 and reacting for 1 hour in the dark at ambient temperature. The excess reagent is removed by desalting (size exclusion) on a G-25 Sephadex column in PBS or PBS containing 3M NaCl.
  • Example 3 Conjugation of the Activated Oligonucleotide to the Solid Support.
  • the activated oligonucleotide can be bound to the solid support by two methods: (a) immersion if polystyrene/latex beads, CML coated surfaces or porous membranes are employed or (b) filtration if porous membrane is used.
  • oligonucleotide binding was monitored by 32 P radioactivity as the oligonucleotide was labelled at the 3' end with 32 P-cordycepin phosphate. 0.12 to 1.2 ⁇ g of Bg5B6n was applied in 1 to 10 microliter volumes by filtration to 2-aminoethanethiol derivatized Pall
  • Example 5 Modification of the Solid Support Via Oxidation of the Surface Sulfhydryl Groups.
  • the Pall membrane was derivatized with 2-aminoethanethiol, conjugated with SIAB-Bg5B6N (as described above) and then the remaining free sulfhydryl groups capped as follows:
  • the 0.28 cm squared membrane discs were placed in either 0.01 M triphenylmethyl mercaptan (TMM) or 0.01 M dimethylaminoethanethiol (DMAE) in 10% ethanol containing also 0.01 M iodosobenzoate.
  • TMM triphenylmethyl mercaptan
  • DMAE dimethylaminoethanethiol
  • the reaction temperature was immediately brought to 90 oC and then cooled to 22oC during a 15 minute incubation period.
  • the filters were washed with PBS and then an aqueous buffered solution containing SDS.
  • a DNTB assay indicated the degree of capping: TABLE 2
  • TMM hydrophobic triphenylmethyl mercaptan
  • DMEA dimethylaminoethanethiol
  • Example 6A The Multiple Target Dipstick for Detecting Peridontal Bacteria.
  • the steps for the binding of capture oligonucleotides to the multiple target dipstick are identical to the steps described above for Examples 2 and 3 above with the physical separation of the four different capture nucleotides being applied to four of the painted regions of the dipstick. Unreacted oligonucleotide is then removed by washing the dipstick in a wash solution of hybridization buffer containing 0.01 M Tris-HCl pH 8.0, 5 mM EDTA, 0.09 M NaCl and 0.5% SDS.
  • the dipsticks can be stored dry and should be washed with distilled water prior to drying. The dipstick is stable for long period when stored dry or when stored at 4oC in appropriate buffers.
  • Curette scrapings of bacterial plaque from human teeth are either cultured or placed directly into 1 ml of 20 mM Tris-HCL, 150 mM NaCl, 10 mM EDTA, 10 mM EGTA.
  • the sample can be frozen until use.
  • 100 ng of an unrelated carrier 24 mer oligonucleotide is added to the sample if the bacterial count is low.
  • 500 ul of sucrose lysis buffer is added comprising: 75% sterile sucrose, 10 mM EDTA, 10 mM EGTA, and 50 mM Tris-HCl at pH 8.0. The sample is vortexed briefly.
  • the bacterial nucleic acids (.01-10 ng/ml) are then placed into a hybridization solution containing 30% formamide, 0.09 M NaCl, 0.01 M Tris-HCl, 5 mM EDTA, 0.1% SDS, 1X Denhardt's solution at pH 8.0.
  • Oligonucleotides, complementary to the conserved regions of the bacterial rRNA: CACGA(G/A) CTGACGACA ( G/A ) CCATGC and TACGGNTACCTTGTTACGAC and conjugated to horse radish peroxidase are added to a concentration of .01-.2 ⁇ g/ml. Conjugation can be achieved using known techniques.
  • Example 6B Demonstration of a Multiple Target Dipstick Using Four Specific Oligonucleotides Covalently Immobilized on Pall Membrane for the Detection of Specific Bacteria in Patient Plaque Samples.
  • the dipsticks were then placed in 1.0 ml sonicated solutions containing 3 M GnSCN, 50 mM EDTA, 50 mM Trip pH 8.0, 2% Sarcosyl and 1 x 10 8 cultured bacterial cells described above (or a mixture in any possible permutation of the cell types described above), or, species typed plaque samples possessing from 100 to 1 x 10 8 cells of the type described above in addition to other oral flora.
  • the hybridization solution was then brought to 100 ng/ml of 5'-terminal linked biotinylated oligonucleotide (18 to 20 nucleotides in length possessing a universal sequence, four different oligonucleotides per hybridization).
  • the dipsticks were incubated with constant agitation at 19 oC for 4 hours.
  • the dipsticks were then washed 3 times with filter wash solution (0.09 M NaCl, 50 mM Tris pH 8.0, 50 mM EDTA) and then 3 times with filter wash solution containing 0.5% SDS.
  • the filters were then probed with 5 mg/ml of Streptavidin/horseradish peroxidase conjugate in filter wash containing 0.5% SDS. The incubation was for 1 hour at 19 oC.
  • the dipsticks were then washed at ambient temperature 3 times with SDS/filter wash and three times with filter was without SDS.
  • the filters were developed as described in Example 7 below.
  • One 24-nucleotide species specific sequence from the hypervariable region of each of the 16s rRNAs from Actinobacillus actinomycetemcomitans, Bacteroides gingivalis, Eikenella corrodens, and Bacteroides intermedius is synthesized possessing a 5'-terminal primary amine hexyl-linker as described in Example 6.
  • Each oligonucleotide is covalently immobilized on a Pall membrane as described in Examples 1-5 above using a Minifold 11 slot blot apparatus (Schleicher & Schuell, Keene, NH) .
  • each type of the 24-mer oligonucleotide is immobilized per slot and each slot is approximately 1 cm in length separated by a distance of 3 cm.
  • the Pall membrane is cut such that each strip of membrane possesses the four different oligonucleotide regions. Each strip is then used in a separate hybridization assay.
  • the dipsticks are then placed in 1.5 ml solutions containing 30% formamide, 0.09 M NaCl, 0.01 M Tris, pH8.0, 5 mM EDTA, 0.1% SDS, 1X Denhardt's solution and 0.2 ug of a 48-mer synthetic oligonucleotide complementary to the 24 nucleotide sequence immobilized on the membrane as well as a 24 nucleotide length oligonucleotide which has been covalently conjugated to horseradish peroxidase (HRP).
  • HRP horseradish peroxidase
  • the filter membranes were developed in 0.1 M Na Citrate pH 5.5, 0.5 mg/ml 4-methoxy-l-naphthol, 0.02 mg/ml 3-methyl-2-benzo-thiazolinone hydrazone and 0.0135% hydrogen peroxide.
  • a multiple target dipstick for different types of HPV's can be prepared as described in Example 6 from three different S'-aminohexyloligonucleotides listed below: TABLE 4
  • the dipsticks immobilized with different combinations of the three capture oligonucleotides are placed into a hybridization solution containing a mixture of HPV6, 16 and 18 plasmid DNA's (0.01-10 ng/ml), 30% formamide, 0,09M NaCl, 0.01M Tris-HCl, 5mM EDTA, 0.1% SDS, IX Denhardt's solution at pH 8.0 at 42oC for 1-24 hours and the unhybridized nucleic acids are removed by repeated washing with hybridization media minus formamide and SDS.
  • polypropylene frits possessing an average pore size of 125 microns were obtained from the Porex Corporation.
  • the frits were coated with CML and derivatized with capture oligonucleotide as described in Example 1.
  • the rate of hybridization of the immobilized capture probe on the frit to complementary nucleic acid in solution was then determined and compared to the rate obtained with the Pall membrane. As shown in Table 2, the rate of hybridization was increased approximately 25-fold when the polypropylene or polyethylene frit was used in place of the membrane as the solid support.
  • a solid support which possesses no porosity was also examined (a flat polyethylene sheet) as a solid support and was derivatized with a capture oligo as described above using CML coating.
  • the rate of hybridization was determined to occur approximately 50 times faster than when the membrane support was employed (Table 2) .
  • Capture probe immobilized to polyethylene beads which were used in solution hybridization were taken as the control for rate comparison.
  • the beads in solution were determined to possess a reaction T1/2 of about 2 minutes as described in Table 2.
  • Poly-S-CBZ-L-cysteine was obtained from Sigma Chemical Company (St. Louis, MO) and dissolved at a concentration of 20 mg/ml in dimethyl formimide and 50 microliter volumes were applied to 0.28 cm squared discs of Pall membrane and incubated at ambient temperature for 15 minutes. The membrane discs were then incubated in 5 ml of concentrated ammonium hydroxide for 30 minutes at 20 degrees C. to de-block the CBZ groups and generate the free sulfhydryl groups.
  • a DTNB assay indicated the presence of the sulfhydryl groups on the polymer covalently attached to the surface of the membrane.
  • Activated oligonucleotide (SIAB-oligo) was then bound to the derivatized Pall membrane by immersion as described in Example 1. Radioactivity monitoring of the membrane after the conjugation indicated that the filter possessed approximately a 10-fold increase in capture oligo concentration over the membrane that was derivatized with cysteine. Thus, the use of a homomeric polymer of cysteine allowed a significant increase in capture oligo concentration on the solid support.
  • Example 11 Demonstration of Reduction of Nonspecific Background by Chemical Reduction of the Solid Support Surface.
  • Pall membrane discs were prepared as described in Example 5 and were either left uncapped or capped to the 100% level with either 2-aminoethanethiol or thiocholestrol.
  • the three types of filters were then incubated in duplicate with 50 ng/ml of a 4 to 5 million molecular weight Streptavidin/horseradish peroxidase conjugate in filter wash (0.09 M NaCl, 50 mM Tris pH 8.0, 50 mM EDTA) for 1 hour at 10oC.
  • SDS or detergent or a blocking agent such as BSA this leads to a very high level of nonspecific binding of the conjugate to the surface of the solid support.
  • the filters were then washed 3 times with filter wash containing 0.5% SDS.
  • Example 12 The Equalization of Melting Characteristics of Probes with Different GC Content in TEABR.
  • the filters were probed with either P-32 labelled Bg5B or Bg8B in 2.8 to 3.4 M TEABR solutions (in 0.1 M increments) containing 50 mM Tris pH 8.0, 2 mM EDTA, 0.1% SDS for 30 minutes at 29oC.
  • the filters were then washed once with their respective TEABR solution at 29oC and then with three non-stringent washes containing the buffer described above with 0.9 M NaCl replacing the TEABR.
  • the filters were then monitored for radioactivity. Similar extents of hybridization were observed only for the TEABR concentration of 3.1 M indicating the melting temperatures were equalized leading to comparable rates and extents of hybridization of Bg5B and Bg8B.
  • HPV18A3B 3' CCT GTC GTG CTC GGTTGCAGCACG 5 '

Abstract

This invention provides for technical improvements for conducting nucleic acid hybridization assays. The improvements are designed to provide for a multiple target mode of conducting hybridization assays wherein a multiplicity of different nucleic acid probes for the site-specific capture of target nucleic acids are conjugated to specific locations upon a single dipstick or device. The use of a dipstick has substantial mechanical advantages over prior art formats for nucleic acid hybridizations. The dipsticks are composed of a handle, a nonporous support coated with a solid surface having at least one discrete region of nucleic acids covalently bound thereto. The improvements also provide means for covalently attaching nucleic acids to solid supports, improved hybridization buffers, improved support surfaces, methods for reducing nonspecific background and methods for quantifying assay results.

Description

METHODS FOR MULTIPLE TARGET
ANALYSIS THROUGH NUCLEIC ACID HYBRIDIZATION BACKGROUND OF THE INVENTION
Field of the Invention
This invention provides for technical improvements for conducting nucleic acid hybridization assays. The improvements are designed to provide for a multiple target mode of conducting hybridization assays wherein a multiplicity of different nucleic acid probes for the site-specific capture of target nucleic acids are conjugated to specific locations upon a single dipstick or device. The use of a dipstick has substantial mechanical advantages over prior art formats for nucleic acid hybridizations. The dipsticks are composed of a handle, a nonporous support coated with a solid surface having at least one discrete region of nucleic acids covalently bound thereto. The improvements also provide means for covalently attaching nucleic acids to solid supports, improved hybridization buffers, improved support surfaces, methods for reducing nonspecific background and methods for quantifying assay results.
Information Disclosure
The nucleic acid hybridizations described herein require the immobilization of a capture nucleic acid to a solid support surface. Methods for the immobilization of nucleic acid to solid supports are known. Bischoff, R. et al., Introduction of 5'-Terminal Functional Groups into Synthetic Oligonucleotides for Selective Immobilization. Anal. Biochem. 164:336-344 (1987); Wolf, S.F. et al., Rapid Hybridization Kinetics of DNA Attached to Submicron Latex Particles, Nuc. Acids Res. 15:2911-2926 (1987); and J. N. Kremsky et al., Immobilization of DNA via Oligonucleotides Containing an Aldehyde or Carboxylic Acid Group at the 5' Terminus. Nuc. Acids Res. 15:2891-2910 (1987).
A method for maintaining discrete regions of nucleic acid in a solid matrix for nucleic acid hybridization assays was disclosed in EP 200,381. However, unlike the present invention, the invention of EP 200,381 involves the linking of nuclic acid to microspheres which are then entrapped in a porous matrix.
Methods of linking oligonucleotides to solid supports have been previously described: P.T. Gilham, J. Am. Chem. Soc., 86:4982-4985 (1964); P.T. Gilham, Biochemistry, 7:2809-2813 (1968); J.A. Langdale and A.D.B. Malcolm, Gene, 36:201-210 (1985); B.C.F. Chu et al., Nucleic Acids Research, 11:6513-6529 (1983); L. Clerici et al., Nucleic Acids Research, 6:247-258 (1979); B.A. Connolly, Nucleic Acids Research, 13:4485-4502 (1985); L.M. Smith et al., Nucleic Acids Research, 13:2399-2412 (1985); R. Bischoff et al., Analytical Biochemistry, 164:336-344 (1987).
The use of alkylammonium salts to influence the reannealing of nucleic acids is known. Orosz, J.M. and Wetmur, J.G., DNA Melting Temperatures and Renaturation Rates in Concentrated Alkylammonium Salt Solutions, Biopolymers 16:1183-1199 (1977); Chang, Chiang-Tung, et al., Effects of Microscopic and Macroscopic Viscosity on the Rate of Renaturation of DNA, Biopolymers, 13:1847-1858 (1974); EP 228,075 (page 3); and Wood et al., PNAS, 82:1585-1588 (1985).
BRIEF DESCRIPTION OF THE DRAWING
Figure 1 is a multiple target assay system.
SUMMARY OF THE INVENTION
This invention provides for a dipstick for nucleic acid hybridization assays comprising: (a) a handle connected to a solid non-porous support coated with a solid surface having a porosity which does not effect the diffusion of the free nucleic acids and comprising at least one and preferably a multiplicity of discrete regions having nucleic acid probes covalently bound thereto. It is preferred that the thickness of the dipstick be between about .6 mm and about 10 mm, but more preferably between 1 and 2 mm. The dipstick is generally longer than it is wide. The portion of the dipstick immersed into test solutions is about 5 to about 10 times longer than it is wide. The discrete regions of nucleic acid are generally uniformly spaced apart and the regions may be either a rectangular or circular pattern on the solid surface.
The nonporous solid support can be of the same material as the handle and can be any size or shape. It is preferably elongated and adapted for dipping into small volumes of liquid. The solid support could be plastic, metal, or paper, and is preferably unchanged when exposed to hybridization media. By nonporous it is meant that nucleic acid in the sample solution does not become entrapped below the surface of the support. A solid support having extremely small pores would also fall within this functional definition as it would be effectively nonporous.
The solid surface is preferably selected from the following group: polystyrene/latex; polystyrene; immobilized latex beads; carboxyl modified latex microspheres; carboxyl modified glass; and carboxyl modified teflon. The surface may optionally be of the same material as the solid support.
The dipstick's solid surface preferably avoids a porosity which interferes with the diffusion rate of the free nucleic acids such that porosity is not a rate limiting factor in the nucleic acid hybridization assay. The avoidance of a rate limiting porosity can be achieved by selecting large or small pores. By "small," the porosity can be nonexistent (nonporous) or of such diameter that the surface is effectively nonporous. The preferred size is an average pore diameter in excess of about 100 microns.
The surface charge of the dipstick is preferably neutral or positive when exposed to a neutral pH (about 6.0 to about 8.0).
The handle is an extension of the solid support to provide a means for transferring the dipstick from one solution to another solution without touching the surface having nucleic acid bound thereto. The handle can be in the shape of a "t" or circular to maximize its surface area for grasping.
The dipstick of this invention preferably has nucleic acid covalently bound to it through spacer arms. The preferred spacer arms are derived from thiol reactive substituents linked to a tethered nucleophilic amine on the 5' ends of the nucleic acid probes and are of the formula:
— (CH2)n— X— Y
wherein X is -NH- or -NHC:O(CH2)mNH-, Y is a thiol reactive moiety, m is 2-12 inclusive, and n is 2-12 inclusive. It is particularly preferred that n is six and X is -NH-. A preferred thiol reactive moiety has a reactive group of either an α halo-acyl or an a, ß-unsaturated carbonyl. The most preferred thiol-reactive moieties are selected from the group comprising haloacetamidobenzoyl and 4-(N-maleimidomethyl)-cyclohexane-1-carbonyl.
This invention also provides for a dipstick as described above wherein the solid surface is derivatized with sulfhydryl containing moieties. The chemical structure of the sulfhydryl containing moieties is non-critical so long as the sulfhydryl group or groups are available to react with thiol reactant moieties. It is preferred that the sulfhydryl containing moieties are polymeric compounds having a multiplicity of sulfhydryl groups. The sulfhydryl groups are particularly useful when proteins are conjugated thereto. The preferred proteins include thiolated bovine serum albumin; casein; and liquid gelatin.
This invention also provides for a dipstick as described above wherein the nucleic acid probes are complementary to regions of RNA found within ribosomes including both the 16S and 23S RNA. The nucleic acid probes may be complementary to either hypervariable or conserved regions of the ribosomal RNA.
This invention also provides methods for assaying the presence of target nucleic acids, the method comprising contacting a hybridization medium containing target nucleic acids with a dipstick comprising a solid surface having a multiplicity of discrete regions with different nucleic acid probes covalently bound thereto. By "different" it is meant that the nucleic acid probes do not have identical nucleic acid sequences and will preferentially bind to different target nucleic acid. This method is preferably conducted using the solid surfaces described above for the dipstick and is most preferably conducted using carboxyl modified latex microspheres. The surface for conducting this method preferably does not inhibit the diffusion of nucleic acid. Most preferably, the surface has a porosity of the size ranges described above for the dipstick.
The method disclosed herein is preferably conducted using nucleic acid probes that are covalently bound to the solid surface through spacer arms. The spacer arms are as described above for the dipstick.
In a preferred mode of operation, the disclosed method has proteins conjugated to the solid surface through sulfhydryl bonding. The preferred proteins are as described for the dipstick. This method is preferably useful when the nucleic acid probes are complementary to sequences of nucleic acid indicative of pathogenic state in mammals. More preferred are nucleic acid probes which are complementary to sequences of RNA found within ribosomes. The preferred ribosomal RNA and the preferred regions of the RNA are as previously described for the dipstick. There is a particular preference for using the hypervariable sequences of the 16S rRNA derived from bacteria found in the human mouth. There is also application for this method to detect virus using nucleic acid probes that are complementary to sequences of viral nucleic acid such as probes which are complementary to sequences of human papilloma virus DNA.
This method can be conducted in two modes. The method, described above, can involve the use of a hybridization medium having both the target nucleic acid and the detectable nucleic acid present. In this mode the detectable nucleic acid is complementary to sequences of the target nucleic acid that are different from the sequences to which the immobilized probe nucleic acid are complementary. In the second mode, the hybridization of the target nucleic acid and the detectable nucleic acid are achieved in separate steps. To optionally control the sensitivity of these methods, it is preferred that detectable nucleic acid is mixed with undetectable nucleic acid that bind in competition with each other onto the target nucleic acid.
The preferred size for the immobilized or capture nucleic acid is about between 12 and 100 nucleotide bases.
To control the effect of different GC contents between the nucleic acid reactants, the above method may take place in a hybridization buffer comprising an ammonium salt selected from the group consisting of trialkylammonium salt and tetraalkyl-ammonium salt wherein the alkyl groups are the same or different and are comprised of between 1 and 3 carbon atoms inclusive. The anionic portions of the salts are selected from the group comprising acetate, iodide, perchlorate, thiocyanate, chloride and bromide. The preferred trialkylammonium salt is triethylammonium chloride. The preferred tetraalkylammonium salts are tetramethylammonium chloride or tetraethylammonium chloride. The preferred concentration of tetraalkylammonium salt is between about 2 and 3.5 moles per liter.
The method and the dipstick can be surface modified by covalently binding a surface-modifying moiety through a covalent bond selected from the group consisting of disulfide linkage and thiol ether. The surface-modifying moiety can be hydrophilic, hydrophobic, ionic or metallic. By hydrophobic it is meant that the dielectric constant for the relevant moiety is below 30, preferably between 1 and 30, and by hydrophilic it is meant that the dielectric constant is above 30, preferably between 30 and 80. Metallic surface-modifying moieties include copper, gold, iron, chrome, silver and aluminum. The preferred surface-modifying moiety is of the formula:
-C:O-N(H)-R12-S-S-R13
wherein R and R are different and are comprised of organic residues. These organic residues are non-critical features of this invention. There is virtually no limit to the substitutions which could be made so long as the ability to retain the thiol ether or thiol linkage is preserved. Practical limits preclude molecular weights in excess of 1000 daltons. The specific substituents for R12 and R13 will vary in accordance with the needs and convenience of the situation. With the understanding that R12 is a divalent radical, such as methylene, and R13 is a monovalent radical, preferred substituents include for R12: methylene [-(CH2)n-], (Cl-C10); alkylaryl (C7-C14); aryl (C6-C10); and for R13: alkyl (C1-C10); alkylcarboxyl (C1-C10); aryl (C6-C10); aminoalkyl (C2-C10); N-alkylaminoalkyl (C3-C15), N,N-dialkylaminoalkyl (C4-C15); substituted aryl (C6-C9) wherein the substituents are the same or different, the number of substituents are 1-3 and are alkyl (C1-C3), amino, N-alkylamino, N,N-dialkylaminoalkyl, thio, carboxyl, nitro, sulfo, halo, acyl of R14-C=0- or acyloxy of R15-(C=O)-O- where R14 and R15 may be the same or different and are alkyl (C1-C10), or alkylcarboxyl (C2-C6). R13 can also be a dicarboxylic chelator for the binding of metal ions where R13 is R16-(C:OOH)n where R16 is an methylene (C1-C5). Preferred surface modifying moieties include where R13 is triphenylmethyl, dimethylaminoethyl, 2-aminoethyl, thio-cholesteryl or 2-amino-3-methylbuteryl.
All moieties referred to in terms of carbon length (C#-C#) can be branched or unbranched and are inclusive of the range given such that C1-C3 includes both methyl and propyl. "Halo" refers to chloro, iodo, bromo and fluoro substituents.
This invention also provides for a method to reduce non-specific background in a nucleic acid hybridization assay utilizing a reactive surface comprising immobilized probe nucleic acid, the method comprising linking proteins to the surface through disulfide bonds and releasing the proteins through thiol reduction after hybridization of the probe nucleic acid to target nucleic acid. The sulfhydryl groups are preferably those described above for surface modification. The preferred proteins are bovine serum albumin, casein and liquid gelatin.
The method described above is preferably conducted in a multiple target mode wherein the reactive surface comprises a solid surface comprising a multiplicity of discrete regions each having different pathogen specific nucleic acid probes covalently bound thereto. The solid surface is preferably selected from the solid surfaces described above for the dipstick. The means for attaching the nucleic acid probes are preferably as previously described for the dipstick.
The above method when conducted in a multiple target mode preferably uses a solid surface derivatized with sulfhydryl containing moieties. The preferred multiple targets are as described above and include viral targets and bacterial targets (particularly the ribosomal RNA) . When conducting the assay in the multiple target mode, it is preferred that the ammonium salts previously described are used when needed to offset different GC contents between the reactants.
When using a dipstick or other solid support and when conducting the disclosed methods, it is preferred that the solid support include surface-modifying moieties bound to surface through a covalent bond selected from the group consisting of disulfide linkage and thiol ether. These surface-modifying moieties are as previously described.
There is also described herein a method for decreasing the sensitivity of a nucleic acid hybridization assay by a known amount, the method comprising adding a predetermined ratio of unlabeled polynucleotide signal probes to labeled polynucleotide signal probes, permitting the signal probes to bind to their complementary sequences, and detecting hybridization of the labeled signal probe. This permits one to adjust the sensitivity of an assay to permit sensitivity cutoffs to be set. Sandwich assays are a preferred format for reduction of sensitivity. Bacterial nucleic acid is the preferred target. Kits having containers of signal probes with varying ratios of label to unlabeled probes are also described.
Throughout this document the terms nucleic acid, polynucleotide and oligonucleotide are interchangeable except where a specific size range is indicated by language context.
DETAILED DESCRIPTION
This invention discloses a nucleic acid hybridization assay format which uses a dipstick. The dipstick format has mechanical advantages over other formats presently being used. It permits ready agitation without additional mechanical devices. The handle permits easy transfer from the various solutions used in hybridizations. The dipstick offers a more mechanically stable support than previously available technology. The dipstick permits mechanical devices to rapidly read the results, such as by insertion of the dipstick in a reflectometer or similar device. Finally, the dipstick permits extremely small amounts of sample solution (less than 500 μl) to be tested. Although dipsticks have been used for other medical assays, they have not been used or suggested for nucleic acid assays.
Currently available technology did not render the dipstick format as a practical format for nucleic acid hybridization assays. Problems which were overcome to establish the dipstick as an alternative format included improved means to covalently bind the capture probes to the dipstick, better means to detect the target using colorimetric labels, better methods for reducing nonspecific binding, and improved kinetics for the rates of hybridization. The following details provide improvements which rendered the dipstick a valuble format for conducting nucleic acid by hybridization assays.
This invention also relates to means for and methods of detecting multiple and differing nucleic acid targets simultaneously in a single hybridization assay. The detection of pathogenic microorganisms in biological specimens using nucleic acid hybridization assays is becoming increasingly widespread. Such assays are relatively simple in theory requiring only the release of intact nucleic acid from the specimen which is then hybridized with detectable nucleic acid probes specific for the pathogenic organism under question. By detecting specific hybridization binding between the probes and the extracted nucleic acids, the presence of the microorganisms is established.
The biological samples of interest include virtually any type of specimen which may contain microorganisms of interest. Exemplary biological samples include fecal samples, blood, sputum, saliva, urine, semen, plaque samples, tissue samples, and the like. The methods of the present invention will not differ regardless of whether exogenous or endogenous nucleic acid is being detected and hence the simultaneous detection of viral, bacterial or host nucleic acid is made possible.
Pathogenic viruses and microorganisms which may be detected in fecal or gastric samples, or as contaminants of foods, beverages or water, or the like, and include viruses, such as adenovirus, rotavirus and the like; bacteria, such as Salmonella spp. (S. typhimurium, S. typhi, S. paratyphi A, etc.), Shigella spp. (S. dysenteriae, S. flexneri, S. boydii, S sonnei, etc.), Campylobacter spp. (C. jejuni, C. coli, C. pylori), Clostridium difficile, Escherichia coli, Yersinia enterolitica, and the like; fungi, such as Candida albicans, and the like; and protozoans, such as Giardia lamblia, Entamoeba histolytica, Microsporidium spp., and the like.
Pathogenic viruses and microorganisms infecting the lung, bronchial and upper respiratory areas which may be detected in saliva, sputum or respiratory lavage samples include viruses, such as adenovirus, respiratory syncytial virus, human papillovavirus, human immunodeficiency virus, human T-cell lymphotrophic viruses, cytomegalovirus, hepatitis A and B virus, epstein-barr virus, and the like; bacteria, such as Streptococcus pyogenes (Group A beta-hemolytic streptococci), Haemophilus influenzae, Staphylococcus aureus, Klebsiella pneumoniae, Pseudomonas aeruginosa, Neisseria meningitidis, Mycobacterium tuberculosis, Spirochaetales, such as Treponema spp., and the like; fungi, such as Candida albicans, Histoplasma capsulatum and the like; and protozoans, such as Pneumocystis carinii, and the like. Pathogenic viruses and microorganisms, which may be detected in blood (cells, serum and /or plasma), include: viruses, such as Human Immunodeficiency Virus, Hepatitis A and B Virus, Human T-Cell Lymphotrophic Viruses, and the like; bacteria, such as Escherichia coli, Staphylococcus aureus, Klebsiella pneumonie, and the like; and, protozoans, such as Toxoplasma gondii, and the like.
Pathogenic microorganisms which may be detected in plaque samples include Actinobacillus actinomycetemcomitans, Bacteroides intermedius, Eikenella corrodens, Wolinella recta, Fusobacterium nucleatum, Bacteroides gingivalis, Bacteroides forsythus, and the like.
At the present time, it is possible to detect and to discriminate only a single pathogenic microorganism in a clinical sample using DNA probes. However, there is a need for improved assays for simultaneously detecting and discriminating in a single test between multiple and different pathogens in clinical samples. The application of nucleic acid hybridization technology to produce a nucleic acid probe assay (e.g., using a single dipstick) which can detect at least one and preferably multiple pathogens simultaneously is a substantial improvement over the presently available assays which are capable of detecting only a single pathogen at a time.
Commercially useful dipsticks described herein will typically involve sandwich assays. Such assays utilize a covalently immobilized "capture" nucleic acid and labelled nucleic acid in solution. The clinical sample will provide the "target" nucleic acid. The "capture" nucleic acid and labelled nucleic acid probe hybridize with the "target" nucleic acid to form a "sandwich" hybridization complex.
To produce a commercially practical multiple target dipstick of this invention, new techniques for immobilizing the capture nucleic acid to a solid support are provided. To avoid nonspecific binding of target nucleic acid, a solid surface capable of being chemically cleaned by disulfide reduction is provided. To permit the use of a universal hybridization media, the addition of alkylammonium salts is provided. The use of solid supports having a porosity which does not inhibit the diffusion of the target nucleotides is also disclosed. Finally, a method for controlling the sensitivity of the assay is provided. I. GENERAL METHODS FOR NUCLEIC ACID HYBRIDIZATION
This invention relates to nucleic acid hybridization assays which allow for the detection of multiple target nucleic acids (i.e., pathogens) on a single dipstick. Accepted means for conducting such assays in a single target mode are known and general overviews of the technology can be had from a review of Nucleic Acid Hybridization: A practical Approach, Ed. Hames, B.D. and Higgins, S.J., IRL Press, 1985; Hybridization of Nucleic acids Immobilized on Solid Supports, Meinkoth, J. and Wahl, G, Analytical Biochemistry, Vol. 238, 267-284, 1984 and U.S. Patent No. 4,358,535 which are incorporated herein by reference.
A. Sample Collection and Preparation
Target polynucleotides can be obtained from a variety of biological sources, depending upon the particular target one desires to detect. Sources include all manner of biological materials which may harbor polynucleotide targets. Polynucleotide targets can be: endogenous nonpathogenic nucleic acid sequences; mutations of the normal wild-type population, regardless of whether they are phenotypically expressed; or nucleic acid sequences arising from the presence of pathogens, such as viruses, bacteria, mycoplasmas, protozoa, rickettsia or fungi. In addition to assaying under industrial conditions or for public health and safety, clinical applications in the medical sciences are anticipated. Clinical samples of microbes, cells, tissue and the like, can be obtained with standard techniques, such as lavage, scraping or biopsy.
The samples are typically dispersed in a buffer, which provides a biologically compatible solution. A typical dispersal buffer solution would be 150mM NaCl, 20mM Tris-HCl (pH 7.5), 10mM EDTA, 10mM EGTA, or 150mM NaCl, 20mM NaPO4 (pH7.5), 10mM EDTA, 10mM EGTA. Samples may require exposure to a lysing solution in order to free target nucleic acid. Lysing buffers are known in the art. EP 199,439; Potts, T.V. and Berry, Em. Internat. J. Sys. Bacter., 33:765-771 (1983); Bonta, Y., et al., J. Dent. Res., 64:793-798 (1985). Generally, these buffers are between pH 7.0 and 8.0, containing both chelating agents and surfactants. Typically a lysing solution is a buffered solution of detergent and a divalent metal chelator or a buffered chaotrophic salt solution containing a detergent, a reducing agent, and a divalent metal chelator. Heat denaturing is optional as is the use of N-acetyl-muramidase (lysozyme).
B. Polynucleotide Probes
Probes are either DNA or RNA oligonucleotides or polynucleotides, containing naturally occurring nucleotides or their analogs, such as 7-deazaguanosine or inosine. Probes typically have sufficient complementarity with their target polynucleotides such that stable and specific binding occurs between target and probe. The degree of homology required for formation of a stable hybridization complex (duplex) varies with the stringency of the hybridization medium and/or wash medium.
Polynucleotide or oligonucleotide probes for use in this invention can be obtained from the entire sequence or portions thereof of an organism's genome, from messenger RNA, or from cDNA obtained by reverse transcription of messenger RNA. After isolation of genomic DNA or cDNA fragments, the fragments are typically inserted into a replication vector, such as lambda phage, pBR322, M13, or vectors containing the SP6 or T7 promoter and cloned as a library in a bacterial host. Following appropriate screening procedures, a recombinant vector with the desired probe insert is isolated and labelled as described below. The vector is then grown in a suitable host. The probe and its vector are purified from the host cells by cell lysis and nucleic acid extraction. Following isolation, the probe can be purified away from the vector by digestion with selected restriction enzymes and sequenced. Further isolation of the probe can be achieved by using gel electrophoresis or high pressure liquid chromatography.
Once the appropriate sequences are determined, DNA probes are preferably chemically synthesized using commercially available methods and equipment. For example, the solid phase phosphoramidite method can be used to produce short probes of between 15 and 50 bases and have a molecular weight of less than 16,000 daltons. These are referred to herein as "short probes." (Caruthers, et al., Cold Spring Harbour Symp. Quant. Biol., 47:411-418, 1982, and Adams, et al., J. Am. Chem. SOC, 105:661, 1983).
When synthesizing a probe for a specific target, the choice of nucleotide sequence will determine the specificity of the test. For example, by comparing DNA sequences from several virus isolates, one can select a sequence for virus detection that is either type specific or genus specific. Comparisons of DNA regions and sequences can be achieved using commercially available computer programs.
Probes may be labelled by any one of several methods typically used to detect the presence of hybrid polynucleotides. The most common method of detection is the use of autoradiography with 3H, 125I, 35S, 14C, or
32 P labelled probes or the like. The choice of radioactive isotope depends on research preferences due to ease of synthesis, varying stability, and half lives of the selected isotopes. Other labels include ligands which bind to labelled antibodies, fluorophores, chemiluminescent agents, enzymes, and antibodies which can serve as specific binding pair members for a labelled ligand. The choice of label depends on sensitivity required, ease of conjugation with the probe, stability requirements, and available instrumentation.
The choice of label dictates the manner in which the label is bound to the probe. Radioactive probes are typically made using commercially available nucleotides containing the desired radioactive isotope. The radioactive nucleotides can be incorporated into probes by several means such as by nick translation of double-stranded probes; by copying single-stranded M13 plasmids having specific inserts with the Klenow fragment of DNA polymerase in the presence of radioactive dNTP; by transcribing cDNA from RNA templates using reverse transcriptase in the presence of radioactive dNTP; by transcribing RNA from vectors containing SP6 promoters or T7 promoters using SP6 or T7 RNA polymerase in the presence of radioactive rNTP; by tailing the 3'ends of probes with radioactive nucleotides using terminal transferase; or by phosphorylation of the 5' ends of probes using [gamma 32P]-ATP and polynucleotide kinase.
Non-radioactive probes are often labelled by indirect means. Generally, a ligand molecule is covalently bound to the probe. The ligand then binds to an anti-ligand molecule which is either inherently detectable or covalently bound to a signal system, such as a detectable enzyme, a fluorescent compound, or a chemiluminescent compound. Ligands and anti-ligands may be varied widely. Where a ligand has a natural anti- ligand, for example, biotin, thyroxine, and cortisol, it can be used in conjunction with the labelled, naturally occurring anti-ligands. Alternatively, any haptenic or antigenic compound can be used in combination with an antibody.
Probes can also be conjugated directly to signal generating compounds, e.g., by conjugation with an enzyme or fluorophore ("labeled signal probes"). Enzymes of interest as labels will primarily be hydrolases, particularly phosphatases, esterases and glycosidases, or oxidoreductases, particularly peroxidases. Fluorescent compounds include fluorescein and its derivatives, rhodamine and its derivatives, dansyl, umbelliferone, etc. Chemiluminescent compounds include luciferin, and 2,3-dihydrophthalazinediones, e.g.. luminol.
C. Hybridization Conditions
Various hybridization solutions may be employed, comprising from about 20 to 60% volume, preferably 30%, of a polar organic solvent. A common hybridization solution employs about 30-60% v/v formamide, about 0.5 to 1M sodium chloride, about 0.05 to 0.1M buffers, such as sodium citrate, Tris HCl, PIPES or HEPES, about 0.05 to 0.5% detergent, such as sodium dodecylsulfate, and between 1-10 mM EDTA, 0.01 to 5% ficoll (about 300-500 kilodaltons), 0.1 to 5% polyvinylpyrrolidone (about 250-500 kdal), and 0.01 to 10% bovine serum albumin. Also included in the typical hybridization solution will be unlabelled carrier nucleic acids from about 0.1 to 5 mg/ml, e.g., partially fragmented calf thymus or salmon sperm, DNA, and/or partially fragmented yeast RNA and optionally from about 0.5 to 2% wt./vol. glycine. Other additives may also be included, such as volume exclusion agents which include a variety of polar water-soluble or swellable agents, such as anionic polyacrylate or polymethylacrylate, polystyrene sulfonic acid and charged saccharidic polymers, such as dextran sulfate. The particular hybridization technique is not essential to the invention. Hybridization techniques are generally described in Nucleic Acid Hybridization, A Practical Approach, Ed. Hames, B.D. and Higgins, S.J., IRL Press, 1985; Gall and Pardue (1969), Proc. Natl. Acad. Sci., U.S.A., 63:378-383, and John, Burnsteil and Jones (1969) Nature, 223:582-587. As improvements are made in hybridization techniques, they can readily be applied.
The amount of labelled probe which is present in the hybridization solution may vary widely. Generally, substantial excesses of probe over the stoichiometric amount of the target nucleic acid will be employed to enhance the rate of binding of the probe to the target DNA.
Various degrees of stringency of hybridization can be employed. As the conditions for hybridization become more stringent, there must be a greater degree of complementarity between the probe and the target for the formation of a stable duplex. The degree of stringency can be controlled by temperature, ionic strength, the inclusion of polar organic solvents, and the like. For example, temperatures employed will normally be in the range of about 20° to 80ºC, usually 25º to 75ºC. For probes of 15-50 nucleotides in 50% formamide, the optimal temperature range can vary from 22-65ºC. With routine experimentation, one can define conditions which permit satisfactory hybridization at room temperature. The stringency of hybridization is also conveniently varied by changing the ionic strength and polarity of the reactant solution through manipulation of the concentration of formamide within the range of 20% to 50%.
Treatment with ultrasound by immersion of the reaction vessel into commercially available sonication baths can often times accelerate the hybridization rates. After hybridization at a temperature and time period appropriate for the particular hybridization solution used, the glass, plastic, or filter support to which the probe-target hybrid is attached is introduced into a wash solution typically containing similar reagents (e.g., sodium chloride, buffers, organic solvents and detergent), as provided in the hybridization solution. These reagents may be at similar concentrations as the hybridization medium, but often they are at lower concentrations when more stringent washing conditions are desired. The time period for which the support is maintained in the wash solutions may vary from minutes to several hours or more.
Either the hybridization or the wash medium can be stringent. After appropriate stringent washing, the correct hybridization complex may now be detected in accordance with the nature of the label.
The probe may be conjugated directly with the label. For example, where the label is radioactive, the dipstick with associated hybridization complex substrate is exposed to X-ray film. Where the label is fluorescent, the sample is detected by first irradiating it with light of a particular wavelength. The sample absorbs this light and then emits light of a different wavelength which is picked up by a detector (Physical Biochemistry, Freifelder, D., W.H. Freeman & Co., 1982, pp. 537-542). Where the label is an enzyme, the sample is detected by incubation with an appropriate substrate for the enzyme. The signal generated may be a colored precipitate, a colored or fluorescent soluble material, or photons generated by bioluminescence or chemiluminescence. The preferred label for dipstick assays generates a colored precipitate to indicate a positive reading. For example, alkaline phosphatase will dephosphorylate indoxyl phosphate which then will participate in a reduction reaction to convert tetrazolium salts to highly colored and insoluble formazans.
Detection of a hybridization complex may require the binding of a signal generating complex to a duplex of target and probe polynucleotides or nucleic acids. Typically, such binding occurs through ligand and anti-ligand interactions as between a ligand-conjugated probe and an anti-ligand conjugated with a signal. The binding of the signal generation complex is also readily amenable to accelerations by exposure to ultrasonic energy.
The label may also allow indirect detection of the hybridization complex. For example, where the label is a hapten or antigen, the sample can be detected by using antibodies. In these systems, a signal is generated by attaching fluorescent or enzyme molecules to the antibodies or in some cases, by attachment to a radioactive label. (Tijssen, P., Practice and Theory of Enzyme Immunoassays, Laboratory Techniques in Biochemistry and Molecular Biology, Burdon, R.H., van Knippenberg, P.H. , Eds., Elsevier, 1985, pp. 9-20).
II. THE MULTIPLE TARGET DIPSTICK
A. The Sandwich Assay
The multiple target assay system described uses the sandwich assay format which is well known in the art of immunoassays and DNA probe assays. The first description of a sandwich format for immunoassays was described in 1968 by Miles et al., Nature 219:186-189, while the first description of this format for the detection of nucleic acids was described by Dunn et al., Cell, 15:511-526 (1978). In 1983 a sandwich assay using DNA probes for the detection of single pathogens in clinical samples was described by Ranki et al., Gene, 21:77-85, 1983; Curr. Top. Microbiol. Immunol., 104:307- 318 (1983), and patents were issued to the same group in 1982 (U.S. Patent No. 4,486,539) and 1986 (U.S. Patent No. 4,563,419). These patents, however, were limited to a one-step assay for the detection of a single pathogen within a sample. No description was given of the potential for the detection of multiple pathogens within a single test sample using DNA/RNA probes in a sandwich type of format.
The sandwich hybridization format using DNA probes provides a rapid diagnostic method which allows the detection of virtually any pathogen in crude cell lysates without prior isolation of the nucleic acid. In this format, two non-overlapping sequences complementary to the target nucleic acid are identified and at least two DNA/RNA probes are cloned or synthesized.
The first DNA probe subsequently is immobilized to a solid support and, when conducting a clinical assay, is used to capture a target nucleic acid from a complex cell lysate via hybridization to form a specific duplex. At the same time or at a subsequent time, the second DNA probe also hybridized with the target nucleic acid to form a specific duplex. This second DNA probe is labeled and can be detected directly through a probe-linked label such as an enzyme, or indirectly through a biotin:labeled-streptavidin system. The amount of the target nucleic acid (i.e., the pathogen) present in the clinical sample is indicated by the amount of labeled, second DNA probe which is contained within the hybridization complex.
B. Assay Discrimination is Achieved bv Site-Specific Sequestering.
The sandwich format can be used to develop assays which detect multiple targets simultaneously. A principle feature of this assay is that discrimination of multiple nucleic acid targets (DNA and/or RNA) is achieved by site specific sequestering on a solid surface of the target nucleic acid itself.
An example of a multiple target assay for each of the 16S ribosomal RNA (rRNA) of three microbes is shown in Figure 1. Probe 1, probe 3, and probe 5 are designed to hybridize only with the 16S rRNA of microbe A, microbe B and microbe C, respectively. As shown in Figure 1, these probes are immobilized at three specific areas on a dipstick. Following lysis of the microbes in the patient sample, the sample is mixed with an appropriate hybridization reagent and the dipstick is immersed in the resulting solution. Hybridization immediately proceeds between the dipstick-immobilized probes 1, 3 and 5 and the 16S rRNAs released from microbes A, B and C, respectively. As a result of such hybridization, each 16S rRNA is sequestered precisely at the area on the dipstick which contains it immobilized and complementary probe. Once immobilized, each target 16S rRNA can be detected specifically with signal-generating probes 2, 4 and 6 which also are complementary, respectively, to the 16S rRNAs of microbes A, B and C.
C. Types of Sandwich Assays
i. One-Step Hybridization Assay
In a one-step sandwich format, the sample is mixed directly in a solution with an unlabeled DNA probe immobilized on a solid surface (e.g., a dipstick), a labeled solution-free DNA probe, and protease(s), hydrolases, detergent(s) and /or chaotropic agent(s) to rapidly lyse the cells and release target DNA or RNA. Hybridization starts immediately after cell disruption, and the target DNA or RNA is simultaneously sequestered at the solid surface (by hybridizing to the immobilized first DNA probe) and labeled with signal (by hybridizing to the labeled second DNA probe). When hybridization is complete, the unbound labeled probe is washed away, and the amount of target DNA or RNA is quantified by the amount of bound (hybridized) labeled DNA probe.
For the one step assay, the lysis buffer may limit the selection of a detectable label. The use of proteases or chaotropic agents in the lysing step may preclude the use of enzymes as labels unless appropriate inhibitors are added after lysis. However, the second DNA probe can be labelled with biotin. After hybridization and removal of proteases and/or chaotropic agents by a washing step, the hybridized biotin-labeled DNA probe can be detected with avidin conjugated with a signal generating system as described below for the two-step assay.
ii. Two-Step Hybridization Assay
In the two-step hybridization assay, the hybridizations of the unlabeled, immobilized probe and the labeled probe with the target nucleic acid are conducted separately. For example, the samples can be mixed with disruption agents to lyse cells and release nucleic acid, and the unlabeled, surface-immobilized probe can be immersed such that hybridization proceeds in the presence of the disruption agents. After the sequestering of the target nucleic acid on the surface, the surface is washed and the second hybridization is allowed to proceed between the sequestered target nucleic acid and the labeled probe in solution.
The two-step assay is required when the assay uses a probe labeled with an enzyme which would be deleteriously affected by proteases or chaotropic agents in the lysing buffer. In this case, a second hybridization is conducted in a medium which will be compatible with the maintenance of activity of the enzyme linked to the probe.
The two-step assay also can be run in an alternative mode - - after cell lysis, the target nucleic acid can be hybridized first with the signal-generating probe, and second with the immobilized probe.
A number of important characteristics of the multiple target dipstick assay used in either the one- step or two-step modes should be pointed out: 1. Only One Label is Reguired for Signal Generation.
An important feature of the multiple target assay system is that only one type of signal may be required in the system. This occurs because the specificity of the assay is achieved by the site-specific sequestering of the target. For example, probes 2, 4 and 6 in Figure 1 can each be conjugated with the enzyme alkaline phosphatase. After hybridization, the presence of a 16S rRNA and hence the microbe is determined with the use of a substrate which forms a blue precipitate in the presence of alkaline phosphatase. As shown In the example, bands 1 and 3 will become blue, but band 2 will remain colorless. Therefore, microbe A and C are present, but not microbe B.
The use of one signal in a multiple target test will provide several advantages. First, it will be much easier to quantitate microbes. Second, the reproducibility of tests will be much more consistent. Third, the setting of "cutoff limits" for the detection of certain microbes will be easier and more accurate. Fourth, it will be possible to develop multiple target assays around highly sensitive signal generation system such as chemiluminescence or time-resolved fluorescence. Finally, the effort and cost of manufacture of probes containing signal will be significantly reduced.
2. Specificity Considerations
Another important feature of the sandwich assay is that any target probe as well as any signal-generating probes can be, but does not have to be, highly specific. The flexibility arises because specificity of the assay for a particular microbe can be achieved in different ways as shown in the Table below. TABLE 1
Assay Type Capture Probe Signal Probe a) One/Two step Specific Specific* b) One/Two step Specific Non-Specific* c) One/Two step Partially Specific Specific* d) One/Two step Non-Specific Specific - - - - -
*Preferred
When conducting the multiple target assay, it may be necessary to use a signal-generating probe which is highly specific for its target 16S rRNA. This specificity will be important if the immobilized probe exhibits some cross-hybridization with heterologous 16S rRNAs or other RNAs or DNAs.
In contrast, if the immobilized probe is highly specific for its target 16S rRNA, it will not be necessary to have a highly specific labeled probe. In this case, the labeled probe can be designed to hybridize with a conserved region of 16S rRNAs. such a probe will hybridize effectively with all microbial 16S rRNAs and, in effect, will detect the presence of any 16S rRNA site-specifically sequestered on a surface during the multiple target assay.
Finally, it will be possible to use multiple, labeled probes simultaneously for the detection of multiple different conserved regions of 16S rRNA. This feature has two implications. First, it will allow the development of more highly sensitive multiple target assays since many different labeled probes can be used, each complementary to a different conserved region of 16S rRNA. Second, it will be possible to develop a generic or "universal cocktail" of labeled probes for the detection of the 16S and 23S rRNA from any microbe.
3. Signal-Generating Systems
As described above, either enzyme-linked oligonucleotides, conjugates or biotin-linked oligonucleotide: streptavidin linked enzyme system are generally used to produce signal.
A final observation is that the probes complementary to conserved regions of 16S rRNA could be used to detect all microbial 16S rRNAs. It thus follows that the signal-generating probe could be replaced by any signal-generating system that generically detects ribosomal nucleic acid. For example, it will be possible to detect sequestering of a specific 16S rRNA after hybridization with an immobilized probe using a labeled antibody which binds to 1) the uridines in 16S rRNA, 2) the ribose sugars in 16S rRNA, or 3) the "odd" bases in
16S rRNA. Such labeling systems will detect only the target RNA after its sequestering on the dipstick surface, and will not detect the immobilized capture DNA probe.
D. Procedures for Using Multiple DNA Probes for the Detection of Multiple Targets
The multiple target assay is possible because (as described below) conditions can be provided in which DNA probe hybridizations depend only on chain length. Thus mixtures of many DNA probes can be formulated since all probes of the same length will have similar hybridization properties. i. The Use of Alkyl Ammonium Salts to Eliminate Variations in Hybridization Specificity Due to Differing Ratios of G:C and A:U or A:T.
The capturing of a multiplicity of different nucleic acids in a single multiple target assay will often times involve nucleic acids having significant variations in their respective G:C and A:U or A:T ratios. The influence upon hybridization due to differing compositions is most readily viewed between nucleic acids having the same length. The G:C hydrogen bonding is more stable under typical salt conditions than the A:U or A:T bonding. Therefore nucleic acids having significantly different compositions will have significantly different ability to stably hybridize under similar hybridization conditions.
Tertiary and quaternary alkyl ammonium salts are able to stabilize the A:T base pair to the point where it is equivalent to the stability of the G:C base pair. The cations of these salts include akyls of 1-4 carbons, inclusive, with both branched and straight chain. The individual alkyl substituents may be the same or different. The anions are non-critical and include acetate, iodide, perchlorate, thiocyanate, chloride and bromide and the like. The most preferred anions are bromide or chloride. The most preferred salt is tetraethylammonium chloride which works best at 30-40ºC in concentrations of between 2 and 3 moles per liter most preferably about 2.4 moles per liter. The preferred nucleic acid chain length is about 15-50 nucleotides most preferably about 24 nucleotides. The effects of various alkylammonium salts upon nucleic acid hybridization are known and generally reviewed in Biopolymers 16:1183-1199 (1977). ii. Cutoff Limits
Another feature of the multiple target assay is that it will be possible to set cutoff limits for the detection of individual microbes in the assay. Cutoff limits will be important for the detection of contaminants or diseases which are caused by, or diagnosed by, the overabundance of a etiologic agent such as microbes or fungi. The most straight forward method for setting cutoff limits would be to force the labeled nucleic acids to compete for binding sites under a controlled system which is quantifiable.
For example, it is possible to set cutoff limits for any microbe (single target modes) or combination of microbes (multiple target modes) in the following way when using the sandwich format. The greatest level of assay sensitivity will result when all of the available non-capturing (signal) probes are labeled probes containing a detectable agent such as biotin. If desired, however, the test system can be made less sensitive by mixing the labeled signal probe (biotinylated) with unlabeled signal probe (not biotinylated) of the same sequence. During hybridization the unlabeled probe will compete with the labeled probe for hybridization with the target nucleic acid. Once hybridized, this probe will not produce signal and will thus make the test assay less sensitive.
More particularly the use of labeled probe to unlabeled probe with a stoichiometric ratio of 1:1, 1:9 and 1:99 will reduce the sensitivity of an assay (as compared to using only labeled probe) for any given microbe by two fold, ten fold, and 100 fold, respectively. This calculation, of course, relies upon the assumption that the labelled and unlabelled probe hybridize with target at the same rate. In practice, depending upon the steric bulk of the label, there may be a rate difference and this difference must be determined empirically.
The need to quantify the relative quantity of a microbe can be critical for nonclinical needs as well as clinical needs. E. coli bacteria is a common contaminant of water and foodstuffs; however, the presence of this microbe is only a health hazard when present above acceptable levels. Using these methods, one can readily desensitize an assay to reflect positive when the E._ coli concentration exceeds acceptable levels. To illustrate clinical application, it is known that several microbes are associated with bacterial vaginosis which is a vaginal infection curable by treatment with the proper antibiotics. In the disease condition these organisms are typiclally present at different abnormally high levels. Using the procedures described above, a diagnostic assay based upon visualization of color can be constructed using either the single or multiple target modes, preferably the multiple target mode. In such assays, it will be possible to set cutoff limits such that a positive test (eg., a detectable or specific shade of color on the dipstick) for a disease state will be indicated only when the concentration of a microbe exceeds a certain value.
To further illustrate the usefulness of the cutoff limits, assume that an infection becomes clinically important when 106 molecules/ml of that microbe's 16S rRNA are present in a patient sample. Also, assume that the use of a labeled probe (without dilution) can just detect 104/ml of that microbe's 16S rRNA using the deposition of colored precipitate as an indicator. To achieve a simple cutoff limit, wherein the test only produces a positive result when there are 106/ml molecules of that microbial 16S rRNA, it will theoretically only be necessary to mix one equivalent of labeled probe per 99 equivalents of unlabeled probe. This will decrease the sensitivity of the assay 100 fold, and will move the cutoff limit for molecules of that microbe's 16S rRNA from 104/ml to 106/ml These ratios assume that the labelled and unlabelled probe hybridize at the same rates and form stable duplexes with the target. In practice the rates may differ and the setting of appropriate cut off limits will require empirical determination of the ratios of labeled to unlabelled probe.
This type of label dilution can be used to desensitize virtually any assay and can be individually and independently applied to any of the nucleic acid targets undergoing detection in the multiple target test. In addition, such setting of cutoff limits by label dilution will work for any type of label. For example biotinylated probes or enzyme conjugated probes can be diluted in this fashion. However, for molecules which are bulky such as enzyme-conjugated probes, a stoichiometric dilution may not give exactly the desired result. In this case, the rate of hybridization of the bulky enzyme-conjugated probe will be less than that of the smaller, unlabeled probe. These differences, however, can be empirically determined such that the proper dilution can easily be make during manufacturing to give the desired desensitization of the assay test for any microbe.
Finally, it also will be possible to set diagnostic cutoff limits for any specific etiologic agent, such as a microbe, by use of a soluble probe (free in solution) having the same sequence as the probe immobilized on the solid surface. In this case, addition of the soluble probe to the clinical sample at the time of immersion of the dipstick into the clinical sample will allow a hybridization competition for the target 16S rRNA to take place between the dipstick-immobilized probe and the soluble probe. The relative rate of competition again will have to be established empirically. However in the preferred case, where the two probes have the same length, the rate of hybridization of the dipstick- immobilized probe is expected to be at least 10 fold less than that of the soluble probe.
IV. MODIFICATION OF SURFACES AND IMMOBILIZATION OF CAPTURE NUCLEIC ACID
A. Functionalizing of a Solid Support Surface
The solid support surface for the preferred multiple target mode of this invention is modified with sulfhydryl groups for subsequent reaction with the thiol- reactive oligonucleotide described below in section II part B. The preferred method is to modify the surface with disulfide derivatives containing nucleophilic amines which participate in conjugation, and then to reduce the disulfide groups to monothiols by treatment with, for example, dithiothreitol, in order for the thiol reactive portion of the activated oligonucleotide to covalently bind to the surface.
Virtually any solid surface can be used in this invention, including metals and plastics. Three types of solid surfaces are available for modification, namely:
a) Membranes, Nytran® (Schleicher & Schuell, Inc., Keene, NH 03431) polystyrene beads, teflon, polystyrene/latex beads, latex beads or any solid support possessing an activated carboxylate, sulfonate, phosphate or similar activatable group are suitable for use as solid surface substratum.
b) Membranes, polystyrene beads, teflon, polystyrene/latex beads, latex beads or any solid support possessing an activated carboxylate, sufonate or phosphate are suitable for use as solid surface substratum.
c) Porous membranes possessing pre-activated surfaces and may be obtained commercially (eg. Pall
Immunodyne Immunoaffinity Membrane, Pall, Pall BioSupport Division, East Hills, NY, or Immobilon Affinity membranes from Millipore, Bedford, Mass.)
The following chemical moieties can be attached to the solid support surface: any aminoalkyl or aryl disulfides (for coupling of the oligonucleotides), any mercaptans (for surface modification), any amino thiol alcohols (for coupling of oligonucleotides), amino aryl disulfides (for coupling of the oligonucleotides), any NH2-R12-S-S-R13-SH where R12 and R13 are the same or different. R12 and R13 are noncritical moieties that are not to be viewed as a limitation of this invention. They are typically organic radicals that vary in size, charge and polarity in accordance with the user's needs and objectives. R12 and R13 are preferably as defined in the Summary of the Invention above.
The diamino substituted disulfide can be used to react with either the preactivated membranes or the carboxylated solid surfaces. In the former case, a direct substitution reaction occur according to reaction conditions described by the manufacturer. In the latter case, the carboxyl group is first activated and then derivatized by reaction with the disubstituted aminodisulfide.
A preactivated Pall membrane is derivatized with 0.0001 to 0.001 moles/cm2 cystamine or 2-aminoethanethiol (or any other dithiobis (alkylamine) or aminoalkylmercaptans) typically in an alkaline aqueous buffer for 30 to 60 minutes at 20º to 30ºC. In the case of derivatizing with diaminoalkyldisulfides a reactive sulfhydryl group is generated by reacting the membrane with a reducing agent such as beta-mercaptoethanol, dithioerythritol, or dithiothreitol at 0.0001 to 0.001 moles/cm2 in buffered neutral or basic aqueous solution for 30 to 60 minutes at 20º to 30ºC. Unreacted material is removed by repeated washings in the presence of a detergent.
In the case of membranes, distinct sites possessing different specific "capture" oligonucleotides or polynucleotides can be prepared using filtration manifolds. Such manifolds include those commercially available from Bio-Rad Laboratories (Richmond, CA) which is referred to as the Bio-Dot SF apparatus or the Minifold 11 apparatus which is available from Schleicher & Schuell (Keene, NH). In this way "dots" or "slots" are formed on the membrane surface which contain only one oligonucleotide. The membranes are then cut mechanically such that any configuration of the dipstick may be obtained. The membrane may then be immobilized onto a plastic, glass or ceramic support with the use of appropriate adhesives.
In the case of spheres or beads consisting of Nytran®, polystyrene, polystyrene/latex, latex, or any other polymer possessing an activatable carboxy group, the procedure of J.V. Staros et al.. Analytical Biochemistry 156:220-222 (1986) is employed. The beads are placed in a 100,000 to 1,000,000 molar excess of 1- ethyl-3-(3-diethylaminopropyl)carbodiimide (EDC), or other carboxyl activating reagent, in aqueous buffer at pH 5.0 to 5.5 for 2 minutes at 20º to 30º C. The excess and unreacted EDC is then removed by centrifugation or filtration of the beads. The activated beads are exposed to 0.01 to 1 molar solution of an aminoalkyldisulfide or an aminoalkylmercaptan preferably cystamine or cysteamine (2-aminoethanethiol) in a non-amine containing buffer such as sodium borate, sodium phosphate or sodium carbonate at about pH 7 to 9 and allowed to react for 1 to 24 hours.
After appropriate washing steps, followed by centrifugation or filtration, the disulfide of the conjugated cystamine is reduced to a sulfhydryl using a reducing agent such as 0.01 to 0.1 M dithiothreitol or dithioerythritol If cysteamine was employed in the last step, the beads do not require a reduction step.
Support surfaces described above without activatable carboxylate groups can also be activated. These supports can be any shape or size. The surfaces are first coated with a solution of latex polymer which contains carboxyl groups (Carboxylate-Modified Tube Coating (CML), Seradyne, Inc. Indianapolis, IN). Following drying, the carboxyl groups on such coated surfaces can be activated, and then conjugated with modified oligonucleotides as explained below in section IV part C. The use of the CML coating is a preferred mode of producing a multiple target dipstick. The CML Tube Coating is diluted with alcohol such as 50% ethanol to make the desired dilution to optimize the properties of the CML Tube Coating for application to a desired surface. After application to the solid surface, excess CML Tube Coating is removed and the CML Tube Coating is allowed to dry without the use of heat. The carboxyl groups on the CML Coating are activated using any appropriate chemical activator such as 1-ethyl-3-(3-diethylaminopropyl)carbodiimide (EDC), and then reacted with an aminoalkyldisulfide or an amino alkylmercaptan, preferably cystamine or cysteamine followed by reduction in the case of the disulfide conjugate as described above for the beads. i. Plastic Sheets
In the case of plastic sheets or plastic strips the CML Coating is applied to distinct regions of the plastic surface and then specific activated oligonucleotides are applied to the appropriate regions of CML coating. Alternatively, the preferred method is to prepare unique plastic sheets of one specific oligonucleotide immobilized on the CML Coating on the solid support. The sheets are then cut and processed. A multiple target dipstick is prepared by attaching onto the appropriate dipstick device the individual plastic oligo-containing pieces. ii. Plastic, Glass. Ceramic Frits or Magnetic Frits or Beads
In the case of plastic, glass, porous glass or ceramic frits, the frits are coated with CML and are processed in bulk with one specific oligonucleotide as described above. The individual frits possessing the desired specific oligonucleotides are assembled in to the appropriate dipstick device giving rise to a multiple target dipstick. iii. Microtiter Plateε and Wells
In the case of plastic 96, 48, 24 or 8 well microtiter plates or individual microtiter wells or well strips, CML Coating is applied and processed as described above and to each well a different or the same type oligonucleotide sequence may be covalently immobilized. This permits the formation of a device in which 96, 48, 24, or 8 different specific oligonucleotides may be immobilized and used in hybridization assays.
The solid surfaces now contain a sulfhydryl group ready to be activated with a thiol reactive oligonucleotide as described below in Section IV, Part C.
B. Functionalization of the Capture Oligonucleotide
The preferred capture nucleic acids for use in this invention are synthetic oligonucleotides of between 20 and 100 bases. During synthesis a linker arm containing a blocked amine group can be coupled using conventional chemistry to the 5'-hydroxyl group of an oligonucleotide. The activated oligonucleotides used as starting materials for this invention can be derived through several methods. The reagents for the attachment of primary linker arms terminating in a primary amine are commercially available. A primary amine is the preferred group for attachment to the heterobifunctional reagent, and its attachment via a hexyl arm is preferred. Starting materials suitable for use in this invention are described in PCT U.S. 86/01290; Nucl. Acids Res., 15:3131 (1987); Nucl. Acids Res., 15:2891 (1987); and Nucl. Acids Res., 14:7985 (1986). Specifically, an oligonucleotide possessing a 5'-terminal structure such as
Figure imgf000038_0001
is employed where X is an NH or NHC:O(CH 2)nNH, Y is a thiol reactive moiety, A is a poly or oligonucleotide, and n and m are between 2 and 12, inclusive. The oligonucleotide can range between about 9 and 50 bases, preferably between about 15-30 bases, with only the 5'-hydroxyl requiring modification for attachment. The preferred thiol reactive moieties are an alpha-halo-acyl or an alpha- or beta-unsaturated carbonyl or alpha- or beta-unsaturated lactones. The attachment of thiol reactive substituents upon the primary amines has been described in detail in U.S. Serial No. 07/148,258, filed January 25, 1988 (see pages 4-8), all of which is incorporated by reference herein. The most preferred thiol reactive moieties are alpha-haloacetamidobenzoyl and 4-(N-maleimidomethyl) cyclohexane-1-carbonyl. Preferred halogens are iodine and bromine. The thiol-reactive oligonucleotides are referred to as activated oligonucleotides.
Alternatively, an oligonucleotide can be modified at its 3 'end with a linker arm containing a blocked amine group. This can be accomplished by conducting DNA synthesis on a solid support containing a conjugated ribonucleotide. After removal from the solid support, a DNA oligonucleotide is obtained which contains a single 3'-terminal ribonucleotide. This can be modified with a linker arm containing a nucleophilic amine by, for example, 1) oxidizing the ribonucleotide cis-glycol with periodate, 2) treating oligonucleotide so modified with, for example, butane diamine to form a Schiff base, and 3) treating with sodium borohydride or cyanoborohydride to form a stable reduced Schiff base derivative in which one of the amines is left free for subsequent conjugation.
DNA bases can also be modified to become thiol reactive before or after preparation in a DNA synthesizer. Using the post-synthesis approach, natural nucleic acids (DNA and RNA) and molecularly cloned nucleic acids, as well as synthetic nucleic acids, can be modified. In the case of cytosine, a more nucleophilic amine is linked to the 4-position of cytosine by a variety of chemistries. The amine can be added by treatment with hydrazine to generate N-4-aminocytosine (Sverdlov, E.D., et al., FEBS Letters, 62, p. 212. Feb. 1976). This reaction is catalyzed by bisulfite. Alternatively, an amine can be added to the 4-position by bisulfite catalyzed transamination reactions where a diaminoalkane is added to the 4-position (Shapiro and Weisgras, Biochemical and Biophysical Research Communications, 40:839, 1970). Bi-functional semicarbazide can also be used to add nucleophilic amines to the 4-position of cytosine (Hayatsu and Ukita, Biochemical and Biochemical Research Communications, 14:198, 1964). The base with the free amino group in the oligo is then made thiol reactive through the reaction of the nucleophilic amine and a NHS ester of a carboxylic acid derivative substituted with a alpha- or beta-unsaturated carbonyl, or alpha-halocarbonyl groups or the like.
Other nucleic acid bases with nucleophilic amines on other positions can be used for reactions with NHS esters of a carboxylic acid derivative substituted with a alpha- or beta-unsaturated carbonyl, or alpha-halo¬acyls. For instance, 5-[N-(7-aminohexyl)-1-acrylamido]-2'-deoxyuridine 5 '-triphosphate (Calbiochem, La Jolla, CA) can be added to the 5' end of oligonucleotides in reactions with terminal deoxnucleotidyl transferase ("Molecular Cloning, A Laboratory Manual," T. Maniatis, et al. eds., Cold Spring Harbor Laboratory, p. 148, 1982).
Chemical immobilization of the preferred oligonucleotide is accomplished by the following procedure. The oligonucleotide bearing the tethered amine is covalently bound to a reagent having two different types of functional groups. These bifunctional reagents typically have an N-hydroxysuccinimidyl (NHS) ester, which is amine reactive as the first functional group, and a thiol reactive group, as the second functional group. The NHS ester acylates the free amine of the 5' end of the oligonucleotide. The acylating conditions are well known and highly selective. The exocyclic amines on adenine and cytosine bases are not nucleophilic and do not readily react with the NHS ester. After acylation to the oligonucleotide, the thiol reactive functional group is available for conjugation with surfaces containing free sulfhydryl groups.
An oligonucleotide with a tethered nucleophilic amine linked to its 5' end can be derivatized with such thiol-reactive groups by relatively simple chemistry. For example a reagent such as SIAB is added to the oligonucleotide in aqueous solutions at a 10 to 100 fold molar excess. The pH is buffered between about 6 and 9 and the temperature is between about 20° and 30ºC. After a reaction period of about 30 to 90 minutes the excess unreacted reagent is removed by exclusion gel filtration.
The preferred thiol reactive moiety is an alpha-halo-acyl compound or an alpha- or beta-unsaturated carbonyl compound. The thiol reactive group may include: maleimides, pyridyl sulfides, and active halogens, alpha- or beta-unsaturated lactones and the like. The active halogens are typically alpha-haloacyl. Useful halogens include chlorine, bromine iodine, and fluorine with iodine and bromine being preferred. Reagents useful for this invention can be purchased from Pierce Chemical Co., Rockford, IL. Examples include:
N-Succinimidyl 4-(iodoacetamido)benzoate (SIAB).
Sulfosuccinimidyl (4-iodoacetamido) benzoate (Sulfo-SIAB)
C. Conjugation of the Activated Oligonucleotide to the Thiolated Solid Support Surface
The thiolated surface of section IV, part A, is reacted with the activated oligonucleotide, using a 5 to 100-fold excess of activated oligonucleotide over the maximum oligonucleotide binding capacity of the solid support. This method gives 5 to 100 micrograms of oligonucleotide (for a 24-mer) per cm2 for a Pall Immunodyne membrane or 0.05 to 1 microgram per cm2 for undiluted Seragen CML Tube Coating.
The reaction occurs in aqueous buffer between ph 5.5 and 9.5 (with the pH range of 7-8 being preferred) and is allowed to proceed from 1 to 16 hours at about 19º to 24 ºC. Volumes of the reaction are held to a minimum. The conjugate is separated from free oligonucleotide by repeated washings in buffers containing ionic detergents such as sodium dodecyl sulfate, sodium laurylsulfate or hexadecyltrimethylammonium bromide (CTAB) or nonionic detergents such as Tween 20, with a final wash in water. The solid supports can be stored dry. The supports are stable indefinitely when stored dry or stored in the appropriate buffers at 4ºC.
Oligonucleotides modified with thiol-reactive groups can be conjugated to the derivatized solid support by a variety of means. These include slow filtration in the case of membranes, immersion in a solution of functionalized oligo when plastics frits are used or overlaying the activated oligo solution on the activated surface of a flat plastic, glass or ceramic sheet.
Once the oligonucleotide is covalently bound to the solid support surface it is useful as a probe in nucleic acid hybridization assays of all types. These assays have numerous applications in the medical and biological sciences as well as in numerous industrial settings. A general review of these procedures can be found in Nucleic Acid Hybridization, A Practical Approach, Eds. Hames, B.D. and Higgins, S.J., IRL Press, Washington D.C. (1985); Hybridization of Nucleic Acids Immobilized on Solid Supports, Meinkoth, J. and Wahl, G., Anal. Biochem., 238:267-284 (1984); and U.S. Patent No. 4,358,535.
Also, after the oligonucleotide is covalently bound to the solid support surface, the thiolated surface on it's own possesses very low background levels of non-specific binding of nucleic acid due to the negative charge of the surface at solution pH values of 7.2 or greater. Nucleic acids possess a negative charge at physiological pHs and above and hence charge repulsion between the surface of the solid support and the nucleic acid gives rise to extremely low backgrounds.
It is desirable to increase the quantity of capture oligonucleotides on a surface because this will increase the capturing efficiency of target nucleic acids which, in turn, will increase the assay sensitivity. The amount of capture oligonucleotide conjugated to a surface can be increased in the following way. A polymer, possessing appropriate side groups which may be activated chemically to form thiols, may be conjugated to an active surface through a terminal or internal primary amine. After immobilization, the polymer can be treated to produce reactive thiols and these can be reacted with thiol-reactive capture oligonucleotides. — Using this type of procedure higher levels of immobilized capture oligonucleotides can be obtained. Poly-S-CBZ-L-cysteine is a preferred polymer. Reaction conditions are as described above for aminoalkyl mercaptans and aminoalkyldisulfides. D. Postmodification of the Surface of the Solid Support After conjugation of the surface of the solid support with a capture DNA probe, there is a large excess of free sulfhydryl groups. The ratio of these remaining sulfhydryl groups to covalently coupled capture oligonucleotide can range from 10:1 to 1,000,000:1. The presence of these excess thiol groups permits a second modification of the surface of the solid support by the selective chemical coupling of R-SH groups, where R is any chemical functionality. This chemical coupling can be either irreversible (e.g., by reaction with a maliemide derivative) or reversible (e.g., by formation of a disulfide bond).
The ability to conduct a second modification of the surface of the solid support is important for achieving a variety of desired surface properties on the solid support. The following are illustrative of some possible examples:
1. The thiolated surface provides the chemical means for irreversible modification in the second conjugation step by treatment modification of the residual thiols with the appropriate reagent to provide covalent bonds. Such conjugations can modify the charge, hydrophobicity, hydrophilicity, color, reflectance, transmittance, porosity, frictional coefficient, porosity, conductivity and heat capacity of the surface. The thiolated surface also provides the means whereby proteins, nucleic acids, antibodies, antigens or other macromolecules of interest may be irreversibly coupled to the solid support. Such modified surfaces will control, in part, the rate of hybridization of target nucleic acid to the capture probe on the solid surface support and will be important in reducing the level of nonspecific background arising during the detection of the hybridized labelled probe.
2. In contrast to the irreversible modification described directly above in Section 1 , the thiolated surface also provides the chemical means for reversible modification in the second conjugation step by the formation of disulfide bonds between the surface and a desired reagent (e.g., formation of surface-S-S-R bonds). Such conjugations can modify transmittance, frictional coefficient, porosity, conductivity and heat capacity of the surface. The thiolated surface also provides the means whereby specific proteins, nucleic acids, antibodies, antigens or other macromolecules of interest may be reversibly coupled to the solid support. These types of moieties may serve as receptors, ligands, or substrates in the signal development processes.
3. The reversibly modified surface described directly above in Section 2 can be further modulated after sequestering of the target nucleic acid via the formation of the hybridization complex with the immobilized capture probe and the labeled probe. In this case, the solid surface is "chemically cleansed" by selective reduction of only those groups coupled by disulfide bonds to the surface. This will have important consequences in the reduction of undesired background typically arising in DNA probe assays.
For example, after the solid surface of a dipstick first is irreversibly conjugated to an oligonucleotide using the chemistry described in Section IV, part C, the excess sulfhydryls remaining on the dipstick can be reversibly conjugated with an agent such as a protein through the formation of disulfide bonds. Following this second modification, the dipstick can be used in a sandwich assay to capture target nucleic acid and hybridized labeled probe. Prior to detection of specifically-bound (hybridized) probe, any labeled probe which has bound non-specifically to the protein on the dipstick can be removed by treating with a reducing agent such as dithiothreitol. During such treatment, the disulfide bond between the protein and the dipstick is cleaved and the protein is released into the solution with its non-specifically associated labeled DNA probe.
It should be noted that this type of "chemical cleansing" (disulfide reduction to remove specific conjugated groups), in addition to removing background signal, can also be used to alter the charge, hydrophilicity, hydrophobicity, color, reflectance, transmittance, friction coefficient, porosity, conductivity and heat capacity of the surface of the solid support.
The following serves to illustrate more specifically the reversible "chemical cleansing" described directly above. After the activated oligonucleotide is irreversibly coupled to the support surface, the surface is placed in a neutral or basic buffer (if aqueous conditions are required), or organic solvent containing 0.0001-0.1 M thiolated bovine serum albumin (BSA) with 0.001-0.1 M iodosobenzoate, and mixed for 10 to 60 minutes at 15 to 50ºC. The iodosobenzoate promotes an oxidation reaction which produces a disulfide bond between the dipstick and the BSA. Excess reagents are removed by alcoholic washes followed by aqueous washes containing ionic detergents. Surfaces modified in this way contain irreversibly conjugated capture probe and reversibly conjugated BSA-protein.
After formation of the hybridization complex between immobilized probe, target nucleic acid and labeled probe, all disulfides on the surface may be cleaved by treatment with dithiothreitol, beta-mercaptoethanol or the like. This highly specific cleavage removes much of the labeled DNA probes which is non-specifically bound to the dipstick surface. Such treatment allows the development of DNA probe assays which have high signal to noise ratios, and hence are extremely sensitive.
This cleansing is particularly advantageous where the target nucleic acid to be detected is present within a complex mixture of biological materials. Examples of complex mixtures which are expected in both clinical and industrial settings include sputum, saliva, blood, urine, fecal material, foodstuffs, water supplies, and the like.
Additional examples of the use of irreversible surface modification serve to illustrate the benefit of this technology:
1) If the surface possesses a net negative charge at physiological pH values by the introduction of a chemical functionality (R) with an appropriate pKa, very low background levels are observed with nucleic acids due to charge repulsion.
2) If the surface possesses a net positive charge by the introduction of a chemical functionality (R) with an appropriate pKa, the rate of hybridization may be increased due to charge attraction.
3) If the solid support is to be stored dry and requires rapid and uniform rehydration, the surface may be made hydrophilic by the introduction of a hydrophilic functionality such as thioglucose.
4) The surface may be made a different color by the introduction of a colored functionality or the reduction of compounds known as tetrazolium salts or other compounds which maintain a color upon reduction.
5) The reflectance of the surface may be modified by the introduction of, for example, metal containing complexes such as Fe, Cu, Ag or the like via sulfhydryl group reaction.
6) The porosity of the surface of the solid support may be modulated by the introduction of the large polymeric molecules such as polycysteine.
E. Solid Supports and Optimization of Hybridization Rates
The solid supports used to construct the dipstick described herein can be polystyrene, polypropylene, polycarbonate sheet plastic or plastics, or glass and ceramics in any conformation or shape amenable to the desired dipstick format. Examples include porous polypropylene frits or porous glass, and nonporous material such as flat polystyrene sheets, microtiter plates and wells, glass tubes and the like.
The rate of hybridization of nucleic acids in solution to a complementary nucleic acid immobilized on a solid support is normally a three step process depending on the nature of the solid support. If the solid support is a filter membrane such as those commercially available from Pall or Millipore, the rate limiting steps leading to hybridization consist of the following:
1) The rate of external diffusion of the target nucleic acid to the dipstick device surface;
2) The rate of internal diffusion of the target nucleic acid within the solid support.
3) The rate of nucleation between the target nucleic acid and the immobilized capture probe.
In contrast to solution-phase nucleic acid hybridizations, which are only marginally rate limited by diffusion, the rate of hybridization of nucleic acids in solution to a solid support (mixed phase) is substantially limited by external and internal diffusional control. Therefore, to maximize the efficiency and rate of hybridization, several key parameters of the sandwich assay system have been defined. First, the concentrations of the nucleic acids should be kept as high as possible. Second, the volumes should be minimized to the fullest extent. Third, the distances should be minimized between the surface and the target nucleic acid in solution. Fourth, we have found that polymeric forms of capture nucleotides will provide good kinetics for hybridizing to target probes. The capturing polymers are then sequestered on the dipstick. The preferred polymer is polyethyleneamine having capturing oligonucleotides covalently bound thereto. Finally, the porosity of the solid support should be at or of a size that does not impose internal diffusional control on the rate of reaction.
Preferred surfaces should have an average porosity that are in excess of 100 microns. It should be noted that the upper and lower ranges of the preferred porosity range will vary in accordance with the length of the oligonucleotides and target nucleic acids in solution.
An example of the effect of porosity is illustrated by the experiments described in Table 2. Capture probe was covalently conjugated to a CML surface (carboxy modified latex) coated within a polyethylene frit or to a Pall Immunodyne membrane. In both experiments, the probe was immobilized at the same concentration per unit of surface area, yet the probe on the CML surface hybridized 18-24 times faster than the probe conjugated to the Pall membrane surface. These results are consistent with rapid diffusion occurring in the CML coated polyethylene frit which has high porosity, and with slower diffusion occurring in the Pall membrane which has lower porosity. The example above illustrates the important influence on the rate of hybridization, which will play an important role in determining the time necessary to conduct a multiple dipstick assay.
The following examples are offered by way of example and are not to be construed as limitations in any way to the process described herein.
EXAMPLES
Example 1: Derivatization (Thiolation) of the Pall Immunodyne Membrane and Other Solid Supports.
A. Covalent Binding of Cystamine to Pall Immunodyne Immunoaffinitv Membranes
To demonstrate the covalent binding of cystamine to Pall Immunodyne Immunoaffinity membranes a 6.2 X 16 cm piece of membrane was placed in a Schleicher & Schuell Minifold 11 apparatus (S&S Inc., Keene, N.H.) and 5 X 10-10 moles to 2.5 X 10-7 moles of cystamine (Aldrich Chemical Company, Milwaukee, Wisconsin) in 10 μl microliters was applied to the membrane in successive slots. The membrane was removed and washed 4 to 5 times with 15 to 25 ml of PBS (0.01 M sodium phosphate pH 7.4, 0.13 M NaCl) and then reduced with 0.1 M dithiothreitol (DTT) in PBS (15 to 25 ml) for 30 minutes with constant shaking. The membrane was washed 3 to 5 times with PBS and the appropriate slots cut out for analysis. The filter was then placed in 0.5 ml of 5,5'-dithio-bis(2-nitrobenzoic acid) (DTNB, Pierce Chemical Company, Rockford, Illinois) for 15 minutes with constant shaking. 200 μl of the solution was then measured for absorbance at 405 nm to determine the degree of derivatization. The results were compared to a DTNB standard curve generated using DTT. The results indicated that between 7.5 X 10-12 and 2.25 X 10-11 moles of cystamine were covalently bound and reduced to 2-aminoethanethiol per 7 mm2, respectively. B. Binding of Cvstamine to Polystyrene Beads or Polystyrene/Latex Beads
To demonstrate the binding of cystamine to polystyrene beads or polystyrene/latex beads (Interfacial Dynamics Corporation, Portland, Oregon) 200 microliters of beads (4.1% solids) were pelleted at 10,000g and then resuspended in 500 μl of 50mg/ml EDC in PBS at pH 5.5 and incubated 5 minutes at 22 ºC. The beads were then pelleted at 10,000 X g and resuspended in 50mg/ml cystamine in 0.05 M Na borate pH 8.3 and incubated 60 minutes at 40ºC. The beads were then washed extensively with PBS containing 0.1% Tween and then reduced with 0.1 M DTT for 30 minutes at 22ºC and again extensively washed with PBS/Tween. The DTNB assay (described above) indicated 5 X 10-11 moles of cystamine were bound (and reduced) to the beads. Cystamine binding to the Carbox-Modified Tube Coating (CML, Seragen Diagnostics, Inc. Indianapolis, IN) was similarly demonstrated after painting polyethylene frits (0.28 cm squared) with a 1 to 5 dilution of the stock CML paint, drying and processing the frits as described for the polystyrene/latex beads. Approximately 2.5 X 10-10 moles of cystamine were bound per frit.
Example 2: Preparation of the SIAB-Conjugated Oligonucleotide.
This example involves the direct conjugation of an oligonucleotide to a solid support involves conjugation via heterobifunctional reagents. The first step is to modify a synthetic probe with a linker arm reagent attached to its terminal 5'-hydroxyl group.
An aminohexyl linker arm with a terminal amino group is attached to the 5'-hydroxyl of the synthetic oligonucleotide via a phosphodiester linkage on an automated DNA synthesizer during the last step in the synthesis. The reagent used for the introduction is 6- (methoxytritylamino)hexyl 2-cyanoethyl N,N-disopropylphosoramidite, prepared from 6-aminohexanol in a manner similar to the synthesis of the 3- (methoxytritylamino)propyl m e t h y l N , N -diisopropylphosphoramidite, as described by Connolly, Nucleic Acids Research., 15:3131 (1987). The linker arm was attached to the probe, and the deprotected probe purified in a method similar to the methods described in the Connolly reference.
The synthetic probe chosen for this study was a DNA sequence complementary to a hypervariable region of the 16S RNA of Bacteriodes gingivitis. The probe was designated Bg5B6N and has the following sequence: 5'XCCGATGCTTATTCTTACGGTACAT 3' where X denotes the hexyl arm linker. SIAB-oligonucleotide is prepared by adding 0.1 to 2.0 grams of Sulfo-SIAB to 50 micrograms of the oligonucleotide described above in 300 microliters of Na Borate buffered aqueous solution at pH 8.3 and reacting for 1 hour in the dark at ambient temperature. The excess reagent is removed by desalting (size exclusion) on a G-25 Sephadex column in PBS or PBS containing 3M NaCl. Example 3: Conjugation of the Activated Oligonucleotide to the Solid Support.
The activated oligonucleotide can be bound to the solid support by two methods: (a) immersion if polystyrene/latex beads, CML coated surfaces or porous membranes are employed or (b) filtration if porous membrane is used. In this example, oligonucleotide binding was monitored by 32P radioactivity as the oligonucleotide was labelled at the 3' end with 32P-cordycepin phosphate. 0.12 to 1.2 μg of Bg5B6n was applied in 1 to 10 microliter volumes by filtration to 2-aminoethanethiol derivatized Pall
Immunoaffinity membrane in a slot blot apparatus. The filters were washed extensively with an aqueous solution containing 0.5% sodium dodecyl sulfate (SDS) and then radioactivity was monitored by scintillation counting. The results indicate that up to 0.1-1.0 μg of oligonucleotide can be bound per 0.28 cm2 of Pall membrane.
When the same SIAB-oligonucleotide was incubated by immersion with CML coated frits derivatized with 2-aminoethanethiol, up to 0.02 μg of DNA was bound to the frit. Similar results were obtained with derivatized polystyrene/latex beads.
Example 4: Hybridization Properties of the Covalently Conjugated Oligonucleotide.
The ability of the covalently conjugated oligonucleotide to hybridize to complementary DNA or RNA in solution was demonstrated as follows: Pall membrane was derivatized with 2-aminoethanethiol and conjugated with SIAB-Bg5B6n as described above. Discs of the membrane possessing the oligonucleotide were then placed in 250 μl of hybridization solution (0.01 M TRIS-HCl, 0.005 M EDTA, 30% formamide, 0.09 M NaCl 0.1% BSA, 0.5% SDS) containing 0.48 μg of complementary 50-mer oligonucleotide labelled at the 3'-end with 32P. The hybridization was allowed to proceed for 60 minutes at 42ºC at which time the filters were removed and washed with hybridization solution (omitting the formamide) at 50ºC (stringent wash). The filters were then monitored for bound radioactivity by scintillation counting. The results indicate that up to 35% of the input solution target (the 50-mer) stably hybridized to the immobilized capture oligonucleotides. In an identical manner oligonucleotides covalently bound to CML coated polyethylene frits and polystyrene/latex beads (immobilized on frits or in solution) were also shown to hybridize to complementary DNA in solution.
Example 5: Modification of the Solid Support Via Oxidation of the Surface Sulfhydryl Groups.
In this example the Pall membrane was derivatized with 2-aminoethanethiol, conjugated with SIAB-Bg5B6N (as described above) and then the remaining free sulfhydryl groups capped as follows: The 0.28 cm squared membrane discs were placed in either 0.01 M triphenylmethyl mercaptan (TMM) or 0.01 M dimethylaminoethanethiol (DMAE) in 10% ethanol containing also 0.01 M iodosobenzoate. The reaction temperature was immediately brought to 90 ºC and then cooled to 22ºC during a 15 minute incubation period. The filters were washed with PBS and then an aqueous buffered solution containing SDS. A DNTB assay indicated the degree of capping: TABLE 2
Compound % Capping (disulfide formation)
(hydrophobic) triphenylmethyl mercaptan (TMM) 20% (cationic) dimethylaminoethanethiol (DMEA) 66%
(cationic) 2-aminoethanethiol 100%
(hydrophobic) thiocholesterol 100%
(hydrophylic) penicillamine 12% Hybridization assays as described above indicate that the rate of hybridization is increased approximately 1.5-fold when the surface is made hydrophobic with TMM or DMAE.
Example 6A: The Multiple Target Dipstick for Detecting Peridontal Bacteria.
Preparing the multiple target dipstick requires the selection of a semi-rigid plastic stick of polystyrene. The stick is approximately 5 cm long, having two flat sides having a width of between 0.1 and 0.5 cm and a depth of between 0.05 and 0.3 cm.
A commercial preparation of CML Tube coating is diluted with 50% ethanol. The diluted CML Tube Coating is painted upon selected regions of the dipstick. Any excess CML Tube Coating is removed and allow the material is allowed to dry without the use of heat. After drying the carboxy groups of the CML Coating are activated using 1-ethyl-3-(3-diethylaminopropyl)carbodiimide (EDC). The EDC in used in a non-amine containing buffer at 10 to 100 mg/ml at pH 5.0. The reaction is allowed to proceed for 2 minutes at 18º to 25º C and the EDC is then decanted.
Immediately after decanting the EDC add 0.01 to
1 molar cystamine or cysteamine (2-aminoethanethiol) in a non-amine containing buffer at pH 8.0 and allow the reaction to continue for 1 to 24 hours. After appropriate washing steps with phosphate buffered saline followed by water the cystamine is reduced to 2- aminoethanethiol using 0.01 to 0.1 m dithiothreitol or the like. If cysteamine was employed, the solid support will not require a reduction step.
For creating a multiple target dipstick for the detection of four different disease associated periodontal bacteria, the following 24 mer oligonucleotides were synthesized with a 5' terminal primary amine hexyl-linker:
TABLE 3
Bacteria Synthetic Oligonucleotide
Bacteroides gingivalis 5'-CAATACTCGTATCGCCCGTTATTC-3' Actinobacillus (ex. Haemophilus) actinomycetemcomitans 5 '-CTTCGGGCACCAGGGCTAAACCCC-3' Eikenella corrodens 5•-CTACGCTACTAAGCAATCAAGTTG-3'
Bacteroides intermedius
(Type 1) 5 '-GGTCCTTATTCGAAGGGTAAATGC-3'
The steps for the binding of capture oligonucleotides to the multiple target dipstick are identical to the steps described above for Examples 2 and 3 above with the physical separation of the four different capture nucleotides being applied to four of the painted regions of the dipstick. Unreacted oligonucleotide is then removed by washing the dipstick in a wash solution of hybridization buffer containing 0.01 M Tris-HCl pH 8.0, 5 mM EDTA, 0.09 M NaCl and 0.5% SDS. The dipsticks can be stored dry and should be washed with distilled water prior to drying. The dipstick is stable for long period when stored dry or when stored at 4ºC in appropriate buffers.
Curette scrapings of bacterial plaque from human teeth are either cultured or placed directly into 1 ml of 20 mM Tris-HCL, 150 mM NaCl, 10 mM EDTA, 10 mM EGTA. The sample can be frozen until use. When the assay is ready to begin, 100 ng of an unrelated carrier 24 mer oligonucleotide is added to the sample if the bacterial count is low. 500 ul of sucrose lysis buffer is added comprising: 75% sterile sucrose, 10 mM EDTA, 10 mM EGTA, and 50 mM Tris-HCl at pH 8.0. The sample is vortexed briefly.
Bacterial cells are resuspended in a lysis solution (20 mg/ml lysozyme, 25% sucrose, 50 mM Tris, pH 8, 10 mM EDTA), and incubated at 37ºC for 30 minutes. Sodium dodecylsulphate is added to a final concentration of 1-2% and pronase (1 mg/ml) or proteinase K (200 μg/ml) and the solution is incubated 30 min at 37 ºC. The lysates are extracted twice with phenol: chloroform (1:1, v/v) and then ethanol precipitated. Nucleic acid is pelleted, washed with 70% ethanol, and resuspended at approximately 1 mg/ml in 1x TE (10 mM Tris, pH 8.0, 1 mM EDTA).
The bacterial nucleic acids (.01-10 ng/ml) are then placed into a hybridization solution containing 30% formamide, 0.09 M NaCl, 0.01 M Tris-HCl, 5 mM EDTA, 0.1% SDS, 1X Denhardt's solution at pH 8.0. Oligonucleotides, complementary to the conserved regions of the bacterial rRNA: CACGA(G/A) CTGACGACA ( G/A ) CCATGC and TACGGNTACCTTGTTACGAC and conjugated to horse radish peroxidase are added to a concentration of .01-.2 μg/ml. Conjugation can be achieved using known techniques. The preferred means for conjugating horseradish peroxidase was provided in U.S. Serial No. 148,258, filed January 25, 1988, and is hereby incorporated by reference herein. The hybridization reactions are permitted to carry on at 42 ºC for 1 hour and the unhybridized oligonucleotides and nucleic acids are removed by repeated washings with hybridization media minus formamide and SDS. The dipstick is then washed with 0.1 M Na citrate at pH 5.5 and developed in 0.1 M Na citrate, pH 5.5, 0.5 mg/ml 4-methoxy-1-naphthol, 0.02 mg/ml 3-methyl-2-benzo- thiazolinone hydrazone and 0.0135% hydrogen peroxide for 15 minutes. Intense blue precipitate on selected areas of the dipstick confirms the presence of a particular bacteria. Example 6B: Demonstration of a Multiple Target Dipstick Using Four Specific Oligonucleotides Covalently Immobilized on Pall Membrane for the Detection of Specific Bacteria in Patient Plaque Samples.
One 24 nucleotide species specific sequence complementary to the hypervariable region of the 16s rRNAs from Actinobacillus actinomycetemcomitans, Bacteroides gingivalis, Eikenella corrodens, and bacteroides intermedius was synthesized possessing a 5'-terminal amine hexyl linker as described in Examples 1-5 above using a Minifold 11 slot blot apparatus (Schleicher & Schuell, Keene, NH) . Approximately 0.1 micrograms of each type of oligonucleotide was immobilized per slot. The Pall membrane is then cut such that each strip possesses all four different oligonucleotide types forming a dipstick.
The dipsticks were then placed in 1.0 ml sonicated solutions containing 3 M GnSCN, 50 mM EDTA, 50 mM Trip pH 8.0, 2% Sarcosyl and 1 x 108 cultured bacterial cells described above (or a mixture in any possible permutation of the cell types described above), or, species typed plaque samples possessing from 100 to 1 x 108 cells of the type described above in addition to other oral flora. The hybridization solution was then brought to 100 ng/ml of 5'-terminal linked biotinylated oligonucleotide (18 to 20 nucleotides in length possessing a universal sequence, four different oligonucleotides per hybridization). The dipsticks were incubated with constant agitation at 19 ºC for 4 hours.
The dipsticks were then washed 3 times with filter wash solution (0.09 M NaCl, 50 mM Tris pH 8.0, 50 mM EDTA) and then 3 times with filter wash solution containing 0.5% SDS. The filters were then probed with 5 mg/ml of Streptavidin/horseradish peroxidase conjugate in filter wash containing 0.5% SDS. The incubation was for 1 hour at 19 ºC. The dipsticks were then washed at ambient temperature 3 times with SDS/filter wash and three times with filter was without SDS. The filters were developed as described in Example 7 below.
The results indicated that specific bacterial species (one or all the bacterial species described above) could be detected in a complex mixture of cells and organic material using a multiple site dipstick.
Example 7: Demonstration of the Multiple Target.
A. Dipstick Using Four Specific Oligonucleotides Covalently Immobilized on Pall Membrane
One 24-nucleotide species specific sequence from the hypervariable region of each of the 16s rRNAs from Actinobacillus actinomycetemcomitans, Bacteroides gingivalis, Eikenella corrodens, and Bacteroides intermedius is synthesized possessing a 5'-terminal primary amine hexyl-linker as described in Example 6. Each oligonucleotide is covalently immobilized on a Pall membrane as described in Examples 1-5 above using a Minifold 11 slot blot apparatus (Schleicher & Schuell, Keene, NH) . Approximately 0.1 microgram of each type of the 24-mer oligonucleotide is immobilized per slot and each slot is approximately 1 cm in length separated by a distance of 3 cm. The Pall membrane is cut such that each strip of membrane possesses the four different oligonucleotide regions. Each strip is then used in a separate hybridization assay.
The dipsticks are then placed in 1.5 ml solutions containing 30% formamide, 0.09 M NaCl, 0.01 M Tris, pH8.0, 5 mM EDTA, 0.1% SDS, 1X Denhardt's solution and 0.2 ug of a 48-mer synthetic oligonucleotide complementary to the 24 nucleotide sequence immobilized on the membrane as well as a 24 nucleotide length oligonucleotide which has been covalently conjugated to horseradish peroxidase (HRP). Thus, 4 different synthetic 48-mer oligonucleotides specific for each immobilized oligonucleotide are employed which could be probed in the sandwich assay format with the same HRP-oligonucleotide-conjugate.
To test the above apparatus, fifteen 1.5 ml hybridization solutions were prepared in which 1, 2, 3, or 4 oligonucleotides were present in different combinations in the hybridization reaction. The hybridization was carried out at 42 ºC for 1 hour and the unhybridized oligonucleotide was removed by repeated washings. The filters were then probed with 100 nanograms per ml HRP-conjugate in 1.5 ml hybridization solution described above for 1 hour at 42ºC. Again, the filters were washed to remove unhybridized conjugate and the filters were washed with hybridization buffer minus formamide and SDS and finally washed with 0.1 M Na Citrate pH 5.5. The filter membranes were developed in 0.1 M Na Citrate pH 5.5, 0.5 mg/ml 4-methoxy-l-naphthol, 0.02 mg/ml 3-methyl-2-benzo-thiazolinone hydrazone and 0.0135% hydrogen peroxide.
The results indicated that each specific oligonucleotide was able to specifically sequester its complementary 48-mer oligonucleotide in solution in all fifteen hybridizations.
B. A Multiple Target Dipstick for Identifying Human Papilloma Virus (HPV)
A multiple target dipstick for different types of HPV's can be prepared as described in Example 6 from three different S'-aminohexyloligonucleotides listed below: TABLE 4
Capture Signal
Virus Oligo Oligo Synthetic Oligonucleotide %GC
HPV6 + 3'GGTTGAACCGTTTCGGTCCCCTCC5' 62.5
HPV6 + 3'GCTGCCATAACATACTTCCCAATG5' 45.8
HPV 16/33 + 3'GCTGAGTTTCCACTTCAGTATTGC5' 45.8
HPV 16/33 + 3'CACGTCCTTGAGAAAAAGGATTTC5' 41.6
HHPPVV 1188 + 3'GAATGCTCGAAGTCGTCTGCTGAG5' 54
HPV 18 + 3'TCGTCGGGCTGGTAAATGTTGATG5' 50
The signal oligonucleotides are biotinylated using sulfo-NHS-biotin as described in Example 9.
The dipsticks immobilized with different combinations of the three capture oligonucleotides are placed into a hybridization solution containing a mixture of HPV6, 16 and 18 plasmid DNA's (0.01-10 ng/ml), 30% formamide, 0,09M NaCl, 0.01M Tris-HCl, 5mM EDTA, 0.1% SDS, IX Denhardt's solution at pH 8.0 at 42ºC for 1-24 hours and the unhybridized nucleic acids are removed by repeated washing with hybridization media minus formamide and SDS. The dipsticks are now probed with the different biotinylated oligonucleotides in the same hybridization solution replacing a 0.09M NaCl with 0.6M NaCl for 1 to 4 hours. The dipsticks are washed well with 2 X filter wash (0.009 M Tris pH 8.0, 0.18 M NaCl, 2 mM EDTA) and then reacted with streptavidine-horseradish peroxidase conjugate (Zymed Laboratories, Inc., San Francisco, California) 2 μg/ml in 2X filterwash containing 0.1% SDS for 30 minutes. The dipsticks are drained and then washed several times with 0.1% Tween in IX phosphate buffered saline (PBS, 0.01M phosphate pH 7.4, 0.15M NaCl). The color is developed as described in Example 7.
Intense blue precipitates on selected areas of the dipstick confirm the presence of the different HPV nucleic acids. Example 8: Acceleration of the Rate of Hybridization
(T½) .
To establish the impact of porosity upon the kinetics of hybridization, Pall membrane solid supports were derivatized with capture oligo as described above in Example 2 using 0.2, 0.65 and 3.0 micron pore size membranes. The rate of hybridization to complementary nucleic acid in solution was determined for each pore size filter as described in Example 1 above. It was observed that essentially no difference in rate occurred with 0.2 to 3.0 micron pore sized membranes and that internal diffusion was the rate limiting parameter.
To circumvent the constraint of internal diffusion within the membrane, polypropylene frits possessing an average pore size of 125 microns were obtained from the Porex Corporation. The frits were coated with CML and derivatized with capture oligonucleotide as described in Example 1. The rate of hybridization of the immobilized capture probe on the frit to complementary nucleic acid in solution was then determined and compared to the rate obtained with the Pall membrane. As shown in Table 2, the rate of hybridization was increased approximately 25-fold when the polypropylene or polyethylene frit was used in place of the membrane as the solid support. A solid support which possesses no porosity was also examined (a flat polyethylene sheet) as a solid support and was derivatized with a capture oligo as described above using CML coating. The rate of hybridization was determined to occur approximately 50 times faster than when the membrane support was employed (Table 2) . Capture probe immobilized to polyethylene beads which were used in solution hybridization were taken as the control for rate comparison. The beads in solution were determined to possess a reaction T1/2 of about 2 minutes as described in Table 2. TABLE 5
The Kinetic T½ of Different Solid Supports
Solid Support T½
Pall Immunodyne membranes 3-4 hrs
CML on Plastic Sheet 5 min
CML on Polyethylene Frit 10 min
Beads on Polyethylene Frit 10 min
Polyethylene Beads in Solution 2 min
Example 9: The Synthesis of Biotinylated Short Probes.
5'-Aminohexyloligonucleotides at a concentration of 1 mg/ml is reacted with a 100 fold excess of sulfosuccinimidyl-6-(biotinamido) hexonate (NHS-LC-biotin) in 0.1 M carbonate buffer at pH 9.5 for 30 minutes at room temperature. The reaction is monitored by HPLC on a reversed phase C8 300ºA Dynamax, Rainin column with a CH3CN/H2O mobile phase and if reaction is less than 90% completed additional NHS-LC-biotin is added. The biotinylated oligo is HPLC purified as above as a single peak. The organic phase is removed under reduced pressure and the biotinylated oligos redissolved in distilled water for use in assays. Example 10: The Use of Polycysteine as an Amplification System for Increasing the Quantity of Capture Oligo on the Surface of the Solid Support.
Poly-S-CBZ-L-cysteine was obtained from Sigma Chemical Company (St. Louis, MO) and dissolved at a concentration of 20 mg/ml in dimethyl formimide and 50 microliter volumes were applied to 0.28 cm squared discs of Pall membrane and incubated at ambient temperature for 15 minutes. The membrane discs were then incubated in 5 ml of concentrated ammonium hydroxide for 30 minutes at 20 degrees C. to de-block the CBZ groups and generate the free sulfhydryl groups. A DTNB assay (see Example 1) indicated the presence of the sulfhydryl groups on the polymer covalently attached to the surface of the membrane.
Activated oligonucleotide (SIAB-oligo) was then bound to the derivatized Pall membrane by immersion as described in Example 1. Radioactivity monitoring of the membrane after the conjugation indicated that the filter possessed approximately a 10-fold increase in capture oligo concentration over the membrane that was derivatized with cysteine. Thus, the use of a homomeric polymer of cysteine allowed a significant increase in capture oligo concentration on the solid support.
Example 11: Demonstration of Reduction of Nonspecific Background by Chemical Reduction of the Solid Support Surface.
Pall membrane discs were prepared as described in Example 5 and were either left uncapped or capped to the 100% level with either 2-aminoethanethiol or thiocholestrol. the three types of filters were then incubated in duplicate with 50 ng/ml of a 4 to 5 million molecular weight Streptavidin/horseradish peroxidase conjugate in filter wash (0.09 M NaCl, 50 mM Tris pH 8.0, 50 mM EDTA) for 1 hour at 10ºC. In the absence of SDS or detergent or a blocking agent such as BSA, this leads to a very high level of nonspecific binding of the conjugate to the surface of the solid support. The filters were then washed 3 times with filter wash containing 0.5% SDS. One half of the filters were then treated with SDS/filter wash containing 1 mM DTT and the other half of the filter set was incubated with SDS/filter wash without DTT. The filters were then washed 3 times with SDS/filter wash and then 3 times with filter wash alone. The filters were then developed with HRP substrate as described in Example 7.
The results indicated that relative to the uncapped filters or the capped filters not chemically reduced, the filters chemically reduced exhibited a greatly reduced background of bound Streptavidin/HRP. Essentially no color was observed on the chemically reduced capped filters, while the uncapped filters or the capped filters not treated with DTT showed blue color indicating the presence of oxidized 4-methoxynaphthol. Therefore, the cleavage of the disulfide bond leading to the release of 2-aminoethanethiol or thiolcholestrol significantly reduces background to chemical cleansing of the surface of the solid support.
Example 12: The Equalization of Melting Characteristics of Probes with Different GC Content in TEABR.
a) HPV16 Plasmid Immobilized on Nytran Filters
Twenty ng/ml each of two 32p labeled 24 mer probes specific for HPV18 nucleic acid namely HPV18A1B (25% GC content) and HPV18A3B (67% GC content) in hybridization solution containing 0.6 M NaCL 90 mM TRIS pH 8.0, 0.5%
SDS, 5x Denharts solution, 30% formamide and 0.1 mg denatured Salmon sperm DNA are hybridized over night at 42 ºC to HPV16 plasmid DNA immobilized on Nytran filters.
The filters are then washed twice with different concentrations of TEABR solution containing 50mM TRIS pH
8.0, 2mM EDTA, 0.1% SDS, ranging from 2.8M to 3.4M in
0.1M increments for 30 minutes at 29ºC. The filters are monitored for radioactivity. Similar signals are observed only with the wash in 3.1M TEABR for both probes indicating that the melting temperatures are equalized leading to comparable rates and extents of hybridization.
b) Sandwich Assav Capture of B. gingivalis rRNA
Two 24 mer B. gingivalis probes (Bg5B and Bg8B which differ in G+C content to the extent that a 20º difference in Tm is observed between the two probes) were employed on the "signal" side of the sandwich assay to determine the affects of TEABR in the hybridization solution on the extent of hybridization. In this experiment B. gingivalis rRNA was captured using a universal primer sequence of 24 nucleotides immobilized on Pall membrane (0.28 cm squared discs possessing 0.1 micrograms of oligo per disc) under conditions we have previously determined to be stringent (30% formamide, 0.6 m NaCl, 0.5% SDS, 50 mM EDTA, 50 mM Tris pH 8.0 at 42ºC. After the rRNA was hybridized to the immobilized universal primer and the unhybridized material washed away, the filters were probed with either P-32 labelled Bg5B or Bg8B in 2.8 to 3.4 M TEABR solutions (in 0.1 M increments) containing 50 mM Tris pH 8.0, 2 mM EDTA, 0.1% SDS for 30 minutes at 29ºC. The filters were then washed once with their respective TEABR solution at 29ºC and then with three non-stringent washes containing the buffer described above with 0.9 M NaCl replacing the TEABR. The filters were then monitored for radioactivity. Similar extents of hybridization were observed only for the TEABR concentration of 3.1 M indicating the melting temperatures were equalized leading to comparable rates and extents of hybridization of Bg5B and Bg8B.
TABLE 6
Bg5B: 3' CCGATG CTTATT CTTACG GTA CAT 5'
Bg8B: 3' GGT TTT CAC CAT CAGTCATCTACA 5' HPV18A1B: 3' ATT GTC TTAATT CTC TAATCC TAG 5'
HPV18A3B: 3' CCT GTC GTG CTC GGTTGCAGCACG 5'
Example 13: Detection of Bg Specific Nucleotide Sequences in Heated GuSCN Lysate Using a Colorimetric
Sandwich Assay Format.
A lysis solution composed of 3 M GuSCN, 2%
Sarkosyl, 50 mM Tris, pH 7.6, 25 mM EDTA was used to lyse
1 x 108 cells of Bacteroides gingivalis (Bg) in 100 microliter volumes at 19 ºC. The solution was then heated in a 65ºC water bath for 10 minutes. Biotinylated 24-mer oligonucletide probes complementary to conserved regions of bacterial 16s rRNA (signal probes) were added to a final concentration of 100 nanograms per ml to the lysate and to the 3 M GuSCN lysing solution that was to be used as the diluent. Seven, ten-fold serial dilutions were then made. The solutions were incubated with Nytran® discs which had covalently immobilized 1 microgram of Bg specific oligonucleotide probe (capture probe) for 1 hour at ambient temperature. The solid supports were then washed with SDS/FW (sodium dodecyl sulfate and filtered water) at ambient temperature and then incubated with 10 ng/ml of Strepavidin/Horseradish peroxidase (SA/HRP) conjugate in SDS/FW for 30 minutes at ambient temperature. The solid supports were then washed with SDS/FW, FW (filtered water), and then the presence of peroxidase was determined by incubating the filter with a substrate that formed an insoluble product. The results indicated that a level of sensitivity of 1 x 106 bacterial cells was achieved.

Claims

tHAT IS CLAIMED IS:
1. A dipstick for nucleic acid hybridization assays comprising:
a handle connected to a non-porous solid support coated with a solid surface having a porosity which does not effect the diffusion of the free nucleic acids and comprising at least one discrete region having nucleic acid probes covalently bound thereto.
2. A dipstick of claim 1 having a multiplicity of discrete regions having nucleic acid probes covalently bound thereto.
3. A dipstick of claim 1 wherein the solid surface has a positive charge at neutral pH.
4. A dipstick of claim 1 wherein the solid surface has a neutral charge at neutral pH's.
5. A dipstick of claim 1 wherein the nucleic acid probes are bound to a solid surface comprising one of the following group:
a. polystyrene/latex;
b. polystyrene;
c. latex beads;
d. carboxyl modified latex microspheres;
e. carboxyl modified glass; and
f. carboxyl modified teflon.
g. Nytran®.
6. A dipstick of claim 5 wherein the surface is comprised of carboxyl modified latex microspheres.
7. A solid surface of claim 5 having an average pore size in excess of 100 microns.
8. A dipstick of claim 1 wherein the nucleic acid probes are covalently bound to the solid surface through spacer arms.
9. A spacer arm of claim 8 derived from a thiol reactive substituent bound to a tethered nucleophilic amine on the 5' ends of the nucleic acid probes, said substituent having the formula:
— (CH2)n— X— Y
where X is -NH- or -NHC:O(CH2)mNH-, Y is a thiol reactive moiety, m is 2-12 inclusive, and n is 2-12 inclusive.
10. A spacer arm of claim 9 where n is six and X is -NH-.
11. The spacer arm of claim 9 wherein the reactive group upon the thiol-reactive moiety is an α halo-acyl or an α, β-unsaturated carbonyl.
12. The thiol reactive moiety of claim 11 wherein the thiol-reactive moiety is selected from the group comprising haloacetamidobenzoyl and 4-(N-maleimidomethyl)-cyclohexane-1-carbonyl.
13. A dipstick of claim 1 having a solid surface derivatized with sulfhydryl containing moieties.
14. A dipstick of claim 13 wherein the sulfhydryl containing moieties are polymeric compounds having a multiplicity of sulfhydryl groups.
15. A solid surface of claim 14 having proteins conjugated thereto through sulfhydryl bonding.
16. A surface of claim 15 wherein the proteins are selected from the group consisting of bovine serum albumin; casein; and liquid gelatin.
17. A dipstick of claim 1 wherein the nucleic acid probes are complementary to regions of RNA found within ribosomes.
18. A dipstick of claim 17 wherein the regions of RNA are located on the 16S ribosomal RNA of bacterial ribosomes.
19. A dipstick of claim 17 wherein the regions of RNA are located on the 23S ribosomal RNA of bacterial ribosomes.
20. A dipstick of claim 17 wherein the regions of RNA are complementary to hypervariable regions of the RNA.
21. A dipstick of claim 18 wherein the 16S RNA are hypervariable regions derived from bacteria found in the human mouth.
22. A dipstick of claim 17 wherein the regions of RNA are complementary to conserved regions of the RNA.
23. A dipstick of claim 1 having a discrete region of nucleic acid probes comprised of probes having different base sequences such that the probes are complementary to at least two different regions of a target polynucleotide.
24. A method for assaying the presence of target nucleic acids, the method comprising (a) immersing a dipstick comprising a handle connected to a solid support coated with a solid surface having at least one discrete region with nucleic acid probes covalently bound thereto, (b) washing the dipstick free of target nucleic acids not hybridized to the probes, and (c) detecting hybridization of target and probe nucleic acids.
25. A method of claim 24 wherein the nucleic acid probes are bound to a solid surface comprising one of the following group:
a. polystyrene/latex;
b. polystyrene;
c. latex beads;
d. carboxyl modified latex microspheres;
e. carboxyl modified glass; and
f. carboxyl modified teflon.
g. Nytran®.
26. A method of claim 25 wherein the solid surface is comprised of carboxyl modified latex microspheres.
27. A method of claim 26 wherein a solid surface which does not inhibit diffusion of nucleic acid.
28. A method of claim 27 having a solid surface with an average pore size in excess of 100 microns.
29. A method of claim 24 wherein the nucleic acid probes are covalently bound to the solid surface through spacer arms.
30. A method of claim 29 wherein the spacer arms are derived from a thiol-reactive substituent linked to a tethered nucleophilic of amine on the 5' ends of the nucleic acid probes wherein the substituent is of the formula:
— (CH2)n—X-Y
where X is -NH- or -NHC:O(CH2)mNH-, Y is a thiol reactive moiety, m is 2-12 inclusive, and n is 2-12 inclusive.
31. A method of claim 30 where n is six and X is -NH-.
32. The method of claim 30 wherein the reactive group upon the thiol-reactive moiety is an α halo-acyl or an α, β-unsaturated carbonyl.
33. A method of claim 22 wherein the solid surface is derivatized with sulfhydryl containing moieties.
34. A method of claim 33 wherein the sulfhydryl containing moieties are polymeric compounds with a multiplicity of sulfhydryl groups.
35. A method of claim 33 having proteins covalently bound to the solid surface through sulfhydryl bonding.
36. A method of claim 24 comprised of a hybridization step using a hybridization medium comprising target nucleic acid and detectable nucleic acid complementary to sequences of the target nucleic acid that are different from the sequences to which the immobilized probe nucleic acid are complementary.
37. A method of claim 24 further comprising, after the immersing, (a) labeling the target nucleic acid immobilized upon the dipstick by hybridization with detectable nucleic acid complementary to the immobilized target nucleic acid.
38. A method of claim 36 wherein the
detectable nucleic acid are mixed with undetectable nucleic acid that bind in competition with each other onto the target nucleic acid.
39. A method of claim 24 wherein the nucleic acid bound to the dipstick are oligonucleotides of about between 12 and 100 nucleotide bases.
40. A method of claim 24 comprising hybridizing target and probe nucleic acids in a hybridization buffer comprising an ammonium salt selected from the group consisting of trialkylammonium salt and tetraalkylammonium salt wherein the alkyl groups are the same or different and are comprised of between 1 and 3 carbon atoms inclusive.
41. A method of claim 40 wherein the trialkylammonium salt is triethylammonium chloride.
42. A method of claim 40 wherein the salt is a tetraalkylammonium salt.
43. A method of claim 42 wherein the tetraalkylammonium salt is tetramethylammonium chloride or tetraethylammonium chloride.
44. A method of claim 40 wherein the salts are selected from the group comprising acetate, iodide, perchlorate, thiocyanate, chloride and bromide.
45. A method of claim 42 wherein the concentration of alkylammonium salt is between about 2 M and 3.5 Moles.
46. A method for conducting a nucleic acid hybridization assay using nucleic acid probes covalently bound to a solid surface, the method comprising (a) modifying the surface of solid support in a nucleic acid hybridization assay by covalently binding a surface-modifying moiety through a covalent bond selected from the group consisting of disulfide linkage and thiol ether; (b) contacting the solid support with a hybridization medium containing target nucleic acid; (c) removing target nucleic acid not hybridized to the probes; and (d) detecting the hybridization of target to probe.
47. A method of claim 46 wherein the surface-modifying moiety is hydrophilic, hydrophobic, ionic or metallic.
48. A method of claim 46 wherein the surface-modifying moiety is of the formula:
-C:O-NH-R12-S-S-R13
wherein R 12 and R13 are the same or different and are comprised of organic residues.
49. A method of claim 48 wherein R12 is methylene
(C1-C10) alkylaryl (C7-C14) and aryl (C6-C10);
wherein R13 is alkyl (C1-C10), alkylcarboxyl (C1-C10), aryl (C6-C10), aminoalkyl (C2-C10), N-alkylaminoalkyl (C3-C15), N'N dialkylaminoalkyl (C4-C15); substituted aryl
(C6-C9) wherein the substituents are the same or different and are alkyl (C1-C3) , amino, sulfo, halo, acyl of R14- (C=O)- or acyloxy of R15-(C=0-)-O- where R14 and R15 may be the same or different and are alkyl (C 1-C6) or alkylcarboxyl (C2-C6).
50. A method of claim 48 wherein R is R15-(C:OOH)2 where R15 is an alkyl (C1-C5).
51. A method of claim 48 where R is triphenylmethyl, dimethylaminoethyl, 2-aminoethyl, thio¬cholesteryl or 2-amino-3-methylbuteryl.
52. A method for reducing nonspecific background in a nucleic acid hybridization assay comprising: (a) contacting target nucleic acids in a hybridization medium with a reactive solid surface comprising nucleic acid probes complementary to target nucleic acids covalently linked to the surface, and proteins covalently linked to the surface through disulfide bonds; (b) releasing the proteins through thiol reduction after step (a) ; and (c) detecting hybridization between target and probe nucleic acids.
53. A method of claim 52 wherein the proteins linked to the surface are selected from the group comprising bovine serum albumin; casein; or liquid gelatin.
54. A method of claim 52 wherein the reactive surface comprises a solid surface comprising a multiplicity of discrete regions having nucleic acid probes covalently bound thereto.
55. A method of claim 54 wherein the nucleic acid probes are bound to a solid surface comprising one of the following group:
a. polystyrene/latex;
b. polystyrene;
c. immobilized latex beads;
d. carboxyl modified latex microspheres; e. carboxyl modified glass; and
f. carboxyl modified teflon.
g. Nytran®.
56. A method of claim 55 wherein the surface is comprised of carboxyl modified latex microspheres.
57. A method of claim 52 wherein the nucleic acid probes are covalently bound through spacer arms.
58. A method of claim 57 wherein the spacer arms are derived from a thiol reactive substituent linked to a tethered nucleophilic amine on the 5' ends of the nucleic acid probes wherein the substituent is of the formula: — (CH2) n— X - Y
X is -NH- or -NHC:O (CH 2) n NH-, Y is a thiol reactive moiety, m is 2-12 inclusive, and n is 2-12 inclusive.
59. A method of claim 58 having a spacer arm where n is six and X is -NH-.
60. The method of claim 58 wherein the reactive group upon the thiol-reactive moiety is an α halo-acyl or an α, β-unsaturated carbonyl.
61. The thiol reactive moiety of claim 60 wherein the thiol-reactive moiety is selected from the group comprising haloacetamidobenzoyl and 4-(N-maleimidomethyl)-cyclohexane-1-carbonyl.
62. A method of claim 52 having a solid surface derivatized with sulfhydryl containing moieties.
63. A method of claim 52 wherein the nucleic acid probes are complementary to regions of RNA found within ribosomes.
64. A method of claim 63 wherein the regions of RNA are located on the 16S ribosomal RNA of bacterial ribosomes.
65. A method of claim 64 wherein the 16S RNA and 23S RNA are hypervariable regions derived from bacteria found in the human mouth.
66. A method of claim 52 wherein the nucleic acid probes are complementary to sequences of viral nucleic acid.
67. A method of claim 66 wherein the nucleic acid probes are complementary to sequences of human papilloma virus DNA.
68. A method for conducting multiple target nucleic acid hybridizations in a sandwich assay format comprising hybridizing a multiplicity of nucleic acid probes to different target nucleic acids using a hybridization buffer comprising an amount of a salt having an anion and a cation wherein the cation is selected from the group comprising trialkylammonium and tetraalkylammonium wherein the alkyl groups are the same or different and are comprised of between 1 and 3 carbon atoms inclusive, said amount of salt effective to reduce the effect of variations in G:C and A:T content between the probes and the target nucleic acids when hybridizing into duplexes.
69. A method of claim 68 wherein the trialkylammonium salt is triethylammonium chloride.
70. A method of claim 68 wherein the salt is a tetraalkylammonium salt.
71. A method of claim 70 wherein the tetraalkylammonium salt is tetramethylammonium chloride or tetraethylammonium chloride.
72. A method of claim 68 wherein the anions are selected from the group comprising acetate, iodide, perchlorate, thiocyanate, chloride and bromide.
73. A method of claim 70 wherein the concentration of alkylammonium salt is between about 2 M and 3.5 Moles.
74. A solid support for use in a nucleic acid hybridization assay wherein the surface of the support includes surface-modifying moieties bound to the surface through a covalent bond selected from the group of bonds consisting cf disulfide linkage and thiol ether linkage.
75. A support of claim 74 wherein the surface-modifying moiety is hydrophilic, hydrophobic, ionic or metallic.
76. A method of claim 75 wherein the surface modifying moiety is of the formula:
-C:O-NH-R 12-S-S-R13
wherein R 12 and R13 are the same or different and are comprised of organic residues.
77. A method of claim 75 wherein R12 is methylene (C1-C10), alkylaryl (C7-C14) and aryl (C6-C10);
wherein R13 is alkyl (C1-C10), alkylcarboxyl (C1-C10), aryl (C6-C10), aminoalkyl (C2-C10), N-alkylaminoalkyl (C3-C15), N,N dialkylaminoalkyl (C4-C15); substituted aryl (C6-C9) wherein the substituents are the same or different and are alkyl (C1-C3) , amino, sulfo, halo, acyl of R14- (C=0)- or acyloxy of R15-(C=O-)-O- where R14 and R may be the same or different and are alkyl (C 1-C6) or alkylcarboxyl (C 2-C6).
78. A method of claim 77 where R 13 is triphenylmethyl, dimethylaminoethyl, 2-aminoethyl, thio¬cholesteryl or 2-amino-3-methylbuteryl.
79. A method of desensitizing a nucleic acid hybridization assay comprising adding a predetermined ratio of unlabeled signal oligonucleotide probes to labeled oligonucleotide signal probes to a hybridization mixture containing target probes, hybridizing the signal probes to target probes and then detecting the hybridization of labeled signal probes.
80. A method of claim 79 wherein the assay is a sandwich assay.
81. A method of claim 79 wherein the detecting step involves comparing the signal strength of the assay to standardized signal levels.
82. A method of claim 80 wherein the target polynucleotide is derived from bacteria.
83. A method of claim 81 wherein the target polynucleotide is derived from ribosomal RNA.
84. A kit for conducting nucleic acid sandwich assays comprising containers containing signal probes in predetermined ratios of labeled to unlabeled probes.
PCT/US1989/003378 1988-08-09 1989-08-07 Methods for multiple target analyses through nucleic acid hybridization WO1990001564A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US388,202 1982-06-14
US23006688A 1988-08-09 1988-08-09
US230,066 1988-08-09
US38820289A 1989-08-04 1989-08-04

Publications (1)

Publication Number Publication Date
WO1990001564A1 true WO1990001564A1 (en) 1990-02-22

Family

ID=26923886

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1989/003378 WO1990001564A1 (en) 1988-08-09 1989-08-07 Methods for multiple target analyses through nucleic acid hybridization

Country Status (1)

Country Link
WO (1) WO1990001564A1 (en)

Cited By (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993003181A1 (en) * 1991-07-30 1993-02-18 Xenopore Corporation Device for oligonucleotide assay and method of preparation thereof
EP0554355A1 (en) * 1990-10-19 1993-08-11 Microprobe Corporation Mehods and pharmaceutical kits useful for detecting microorganisms associated with vaginal infections
EP0630973A2 (en) * 1993-05-14 1994-12-28 Johnson & Johnson Clinical Diagnostics, Inc. Diagnostic compositions, elements, methods & test kits for amplification & detection of two or more DNA's using primers having matched melting temperatures
EP0742287A2 (en) * 1995-05-10 1996-11-13 McGall, Glenn H. Modified nucleic acid probes
US5605662A (en) * 1993-11-01 1997-02-25 Nanogen, Inc. Active programmable electronic devices for molecular biological analysis and diagnostics
US5633134A (en) * 1992-10-06 1997-05-27 Ig Laboratories, Inc. Method for simultaneously detecting multiple mutations in a DNA sample
US5632957A (en) * 1993-11-01 1997-05-27 Nanogen Molecular biological diagnostic systems including electrodes
US5654418A (en) * 1990-10-19 1997-08-05 Becton Dickinson And Company Nucleic acid probes useful for detecting microorganisms associated with vaginal infections
WO1998017829A2 (en) * 1996-10-25 1998-04-30 Abbott Laboratories Nucleic acid primers and probes for detecting oncogenic human papillomaviruses
WO1998020020A2 (en) * 1996-11-06 1998-05-14 Sequenom, Inc. High density immobilization of nucleic acids
WO1998033808A2 (en) * 1997-02-04 1998-08-06 Hubert Koster A reversible stoichiometric process for conjugating biomolecules
GB2324866A (en) * 1997-04-21 1998-11-04 Randox Lab Ltd Device for multianalyte assays.
US5849486A (en) * 1993-11-01 1998-12-15 Nanogen, Inc. Methods for hybridization analysis utilizing electrically controlled hybridization
EP0910570A1 (en) * 1995-11-14 1999-04-28 Baylor College Of Medicine Integrated nucleic acid hybridization devices based upon active surface chemistry
US5955268A (en) * 1996-04-26 1999-09-21 Abbott Laboratories Method and reagent for detecting multiple nucleic acid sequences in a test sample
US6017696A (en) * 1993-11-01 2000-01-25 Nanogen, Inc. Methods for electronic stringency control for molecular biological analysis and diagnostics
US6024925A (en) * 1997-01-23 2000-02-15 Sequenom, Inc. Systems and methods for preparing low volume analyte array elements
US6048690A (en) * 1991-11-07 2000-04-11 Nanogen, Inc. Methods for electronic fluorescent perturbation for analysis and electronic perturbation catalysis for synthesis
US6051380A (en) * 1993-11-01 2000-04-18 Nanogen, Inc. Methods and procedures for molecular biological analysis and diagnostics
US6068818A (en) * 1993-11-01 2000-05-30 Nanogen, Inc. Multicomponent devices for molecular biological analysis and diagnostics
WO2000053616A2 (en) * 1999-03-09 2000-09-14 Amersham Pharmacia Biotech Uk Ltd Nucleotides and polynucleotides immobilised on a solid support via a disulphide linkage
US6242180B1 (en) 1994-10-21 2001-06-05 Affymetrix, Inc. Computer-aided visualization and analysis system for sequence evaluation
US6254827B1 (en) 1993-11-01 2001-07-03 Nanogen, Inc. Methods for fabricating multi-component devices for molecular biological analysis and diagnostics
US6287517B1 (en) 1993-11-01 2001-09-11 Nanogen, Inc. Laminated assembly for active bioelectronic devices
EP1143015A2 (en) * 1992-04-23 2001-10-10 Massachusetts Institute Of Technology Optical and electrical methods and apparatus for molecule detection
US6309602B1 (en) 1993-11-01 2001-10-30 Nanogen, Inc. Stacked, reconfigurable system for electrophoretic transport of charged materials
US6315953B1 (en) 1993-11-01 2001-11-13 Nanogen, Inc. Devices for molecular biological analysis and diagnostics including waveguides
US6319472B1 (en) 1993-11-01 2001-11-20 Nanogen, Inc. System including functionally separated regions in electrophoretic system
EP1162459A1 (en) * 2000-06-07 2001-12-12 Corning Incorporated Rough charged solid phase for attachment of biomolecules
US6331274B1 (en) 1993-11-01 2001-12-18 Nanogen, Inc. Advanced active circuits and devices for molecular biological analysis and diagnostics
WO2002004671A2 (en) * 2000-07-07 2002-01-17 Helen Lee Improved binding interactions in dipstick assays
WO2002004122A2 (en) * 2000-07-07 2002-01-17 Helen Lee Improved stability of hybridisation interactions in dipstick assays
US6375899B1 (en) 1993-11-01 2002-04-23 Nanogen, Inc. Electrophoretic buss for transport of charged materials in a multi-chamber system
US6403367B1 (en) 1994-07-07 2002-06-11 Nanogen, Inc. Integrated portable biological detection system
GR1003966B (en) * 2001-10-16 2002-08-06 Dipping test strip assay system and assay method for the detection and/or determination of specific nucleic acid sequences
EP1239286A2 (en) * 2001-03-02 2002-09-11 Hitachi, Ltd. Biochemical sensors, methods for their manufacture and biochemical methods and systems for testing substances of interest
US6451996B1 (en) 1987-04-01 2002-09-17 Callida Genomics, Inc. Method of sequencing of genomes by hybridization of oligonucleotide probes
US6458530B1 (en) 1996-04-04 2002-10-01 Affymetrix Inc. Selecting tag nucleic acids
WO2003039703A2 (en) * 2001-11-05 2003-05-15 Hain Lifescience Gmbh Method in the form of a dry rapid test for detecting nucleic acids
US6569382B1 (en) 1991-11-07 2003-05-27 Nanogen, Inc. Methods apparatus for the electronic, homogeneous assembly and fabrication of devices
EP1347060A1 (en) * 2000-12-26 2003-09-24 Takara Bio Inc. Method of detecting pathogenic microorganism
US6638482B1 (en) 1993-11-01 2003-10-28 Nanogen, Inc. Reconfigurable detection and analysis apparatus and method
US6652808B1 (en) 1991-11-07 2003-11-25 Nanotronics, Inc. Methods for the electronic assembly and fabrication of devices
US6664045B1 (en) 1998-06-18 2003-12-16 Boston Probes, Inc. PNA probes, probe sets, methods and kits pertaining to the detection of microorganisms
US6689478B2 (en) 2001-06-21 2004-02-10 Corning Incorporated Polyanion/polycation multilayer film for DNA immobilization
US6706473B1 (en) 1996-12-06 2004-03-16 Nanogen, Inc. Systems and devices for photoelectrophoretic transport and hybridization of oligonucleotides
US6726880B1 (en) 1993-11-01 2004-04-27 Nanogen, Inc. Electronic device for performing active biological operations and method of using same
EP1431398A1 (en) * 2002-12-20 2004-06-23 Evotec OAI AG A method for detecting in a mixture an amount of analytes
EP1473370A2 (en) * 2003-04-24 2004-11-03 BioMerieux, Inc. Genus, group, species and/or strain specific 16S rDNA Sequences
US6893822B2 (en) 2001-07-19 2005-05-17 Nanogen Recognomics Gmbh Enzymatic modification of a nucleic acid-synthetic binding unit conjugate
WO2005121359A1 (en) * 2004-06-11 2005-12-22 Evotec Ag A method for detecting analytes in a sample
US7101661B1 (en) 1993-11-01 2006-09-05 Nanogen, Inc. Apparatus for active programmable matrix devices
US7153955B2 (en) 1997-09-22 2006-12-26 Nanogen Recognomics Gmbh Pentopyranosyl nucleic acid arrays, and uses thereof
EP1745150A2 (en) * 2004-04-20 2007-01-24 Genaco Biomedial Products, Inc. Method for detecting ncrna
US7172864B1 (en) 1993-11-01 2007-02-06 Nanogen Methods for electronically-controlled enzymatic reactions
WO2007123579A2 (en) 2005-12-28 2007-11-01 Translational Therapeutics Translational dysfunction based therapeutics
US7314708B1 (en) 1998-08-04 2008-01-01 Nanogen, Inc. Method and apparatus for electronic synthesis of molecular structures
US7314542B2 (en) 2004-09-23 2008-01-01 Nanogen, Inc. Methods and materials for optimization of electronic transportation and hybridization reactions
US7375198B2 (en) 1993-10-26 2008-05-20 Affymetrix, Inc. Modified nucleic acid probes
EP1964934A1 (en) * 2007-02-28 2008-09-03 Sysmex Corporation Sample treatment solution and reagent kit for preparing sample for detecting DNA methylation
US7473547B2 (en) 1998-08-14 2009-01-06 Fujifilm Corporation Test piece, method of and apparatus for manufacturing the test piece and method of and system for reading the same
USRE41005E1 (en) * 1996-11-06 2009-11-24 Sequenom, Inc. Beads bound to a solid support and to nucleic acids
EP2246438A1 (en) 2001-07-12 2010-11-03 Illumina, Inc. Multiplex nucleic acid reactions
US7828954B2 (en) 2004-09-21 2010-11-09 Gamida For Life B.V. Electrode based patterning of thin film self-assembled nanoparticles
US7857957B2 (en) 1994-07-07 2010-12-28 Gamida For Life B.V. Integrated portable biological detection system
EP2359863A2 (en) 2000-08-03 2011-08-24 The Regents Of The University Of Michigan Isolation and use of solid tumor stem cells
US8772467B2 (en) 2002-07-26 2014-07-08 Gamida For Life B.V. Methods and apparatus for screening and detecting multiple genetic mutations
EP2762886A1 (en) 2006-09-29 2014-08-06 Translational Therapeutics, Inc. EIF4E Regulon-based diagnostics
US8906626B2 (en) 2000-02-07 2014-12-09 Illumina, Inc. Multiplex nucleic acid reactions
US8999266B2 (en) 2000-10-30 2015-04-07 Agena Bioscience, Inc. Method and apparatus for delivery of submicroliter volumes onto a substrate
US9068953B2 (en) 2007-09-17 2015-06-30 Agena Bioscience, Inc. Integrated robotic sample transfer device
US9279148B2 (en) 1999-04-20 2016-03-08 Illumina, Inc. Detection of nucleic acid reactions on bead arrays
US9739773B1 (en) 2010-08-13 2017-08-22 David Gordon Bermudes Compositions and methods for determining successful immunization by one or more vaccines
GB2559638A (en) * 2016-09-08 2018-08-15 Bbi Solutions Oem Ltd Solid phase conjugate
US20190316195A1 (en) * 2018-04-12 2019-10-17 Cellmax, Ltd. Methods of capturing a nucleic acid including a target oligonucleotide sequence and uses thereof
US20190316112A1 (en) * 2018-04-12 2019-10-17 Cellmax, Ltd. Methods of capturing a nucleic acid including a target oligonucleotide sequence and uses thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4391904A (en) * 1979-12-26 1983-07-05 Syva Company Test strip kits in immunoassays and compositions therein
US4775619A (en) * 1984-10-16 1988-10-04 Chiron Corporation Polynucleotide determination with selectable cleavage sites

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4391904A (en) * 1979-12-26 1983-07-05 Syva Company Test strip kits in immunoassays and compositions therein
US4775619A (en) * 1984-10-16 1988-10-04 Chiron Corporation Polynucleotide determination with selectable cleavage sites

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ANALYTICAL BIOCHEMISTRY, Volume 164, published in 1987, (Academic Press, Inc., New York, NY); R. BISCHOFF et al.: "Introduction of 5'-terminal Functional Groups into Synthetic Oligonucleotides for Selective Immobilization", pages 336-344, see entire pages 336 and 337, first column, lines 1-20. *
BIOPOLYMERS, Volume 16, published in 1977, (John Wiley & Sons, Inc., New York, NY), J. OROSZ et al., "DNA Melting Temperatures and Renaturation Rates in Concentrated Alkylammonium Salt Solutions", pages 1183-1199, see especially page 1188, lines 1-15. *
GENE, Volume 21, published in 1983, (Elsevier Biomedical Press, Amsterdam, The Netherlands), M. RANKI et al., "Sandwich hybridization as a convenient method for the detection of nucleic acids in crude samples", pages 77-85, see especially the summary on page 77. *
NUCLEIC ACIDS RESEARCH, Volume 15, Number 13, published in 1987, (IRL Press Limited, Oxford, England); S. GHOSH et al.: "Covalent attachment of oligonucleotides to solid supports", pages 5353-5372, see especially the introduction on pages 5353-5355. *
NUCLEIC ACIDS RESEARCH, Volume 15, Number 7, published in 1987, (IRL Press Limited, Oxford, England); K. KREMSKY et al., "Immobilization of DNA via oligonucleotides containing an aldehyde or carboxylic group at the 5' terminus", pages 2891-2909, see especially the introduction on pages 2891-2892. *
NUCLEIC ACIDS RESEARCH, Volume 15, Number 7, published in 1987, (IRL Press Limited, Oxford, England); S. WOLF et al.: "Rapid hybridization kinetics of DNA attached to submicron latex particles", pages 2911-2926, see section entitled "DNA Attachment to latex particles" on pages 2913-2914. *

Cited By (135)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6451996B1 (en) 1987-04-01 2002-09-17 Callida Genomics, Inc. Method of sequencing of genomes by hybridization of oligonucleotide probes
US5654418A (en) * 1990-10-19 1997-08-05 Becton Dickinson And Company Nucleic acid probes useful for detecting microorganisms associated with vaginal infections
EP0554355A1 (en) * 1990-10-19 1993-08-11 Microprobe Corporation Mehods and pharmaceutical kits useful for detecting microorganisms associated with vaginal infections
EP0554355A4 (en) * 1990-10-19 1993-12-08 Microprobe Corporation Mehods and pharmaceutical kits useful for detecting microorganisms associated with vaginal infections
US5776694A (en) * 1990-10-19 1998-07-07 Becton Dickinson Company Diagnostic kits useful for selectively detecting microorganisms in samples
WO1993003181A1 (en) * 1991-07-30 1993-02-18 Xenopore Corporation Device for oligonucleotide assay and method of preparation thereof
US6569382B1 (en) 1991-11-07 2003-05-27 Nanogen, Inc. Methods apparatus for the electronic, homogeneous assembly and fabrication of devices
US6652808B1 (en) 1991-11-07 2003-11-25 Nanotronics, Inc. Methods for the electronic assembly and fabrication of devices
US6048690A (en) * 1991-11-07 2000-04-11 Nanogen, Inc. Methods for electronic fluorescent perturbation for analysis and electronic perturbation catalysis for synthesis
EP1143015A3 (en) * 1992-04-23 2008-07-09 Massachusetts Institute Of Technology Optical and electrical methods and apparatus for molecule detection
EP1143015A2 (en) * 1992-04-23 2001-10-10 Massachusetts Institute Of Technology Optical and electrical methods and apparatus for molecule detection
US5633134A (en) * 1992-10-06 1997-05-27 Ig Laboratories, Inc. Method for simultaneously detecting multiple mutations in a DNA sample
EP0630973A3 (en) * 1993-05-14 1995-04-26 Eastman Kodak Co Diagnostic compositions, elements, methods & test kits for amplification & detection of two or more DNA's using primers having matched melting temperatures.
EP0630973A2 (en) * 1993-05-14 1994-12-28 Johnson & Johnson Clinical Diagnostics, Inc. Diagnostic compositions, elements, methods & test kits for amplification & detection of two or more DNA's using primers having matched melting temperatures
US7375198B2 (en) 1993-10-26 2008-05-20 Affymetrix, Inc. Modified nucleic acid probes
US7794943B2 (en) 1993-10-26 2010-09-14 Affymetrix, Inc. Modified nucleic acid probes
US7425308B2 (en) 1993-11-01 2008-09-16 Nanogen, Inc. Systems for the active electronic control of biological reactions
US6331274B1 (en) 1993-11-01 2001-12-18 Nanogen, Inc. Advanced active circuits and devices for molecular biological analysis and diagnostics
US5849486A (en) * 1993-11-01 1998-12-15 Nanogen, Inc. Methods for hybridization analysis utilizing electrically controlled hybridization
US8389212B1 (en) 1993-11-01 2013-03-05 Gamida For Life, B.V. Method for the electronic analysis of a sample oligonucleotide sequence
US8313940B2 (en) 1993-11-01 2012-11-20 Gamida For Life B.V. Self-addressable self-assembling microelectronic systems and devices for molecular biological analysis and diagnostics
US5929208A (en) * 1993-11-01 1999-07-27 Nanogen, Inc. Methods for electronic synthesis of polymers
US8114589B2 (en) 1993-11-01 2012-02-14 Gamida For Life B.V. Self-addressable self-assembling microelectronic integrated systems, component devices, mechanisms, methods, and procedures for molecular biological analysis and diagnostics
US6017696A (en) * 1993-11-01 2000-01-25 Nanogen, Inc. Methods for electronic stringency control for molecular biological analysis and diagnostics
US6540961B1 (en) 1993-11-01 2003-04-01 Nanogen, Inc. Multicomponent devices for molecular biological analysis and diagnostics
US6423271B1 (en) 1993-11-01 2002-07-23 Nanogen, Inc. Laminated assembly for active bioelectronic devices
US6051380A (en) * 1993-11-01 2000-04-18 Nanogen, Inc. Methods and procedures for molecular biological analysis and diagnostics
US6068818A (en) * 1993-11-01 2000-05-30 Nanogen, Inc. Multicomponent devices for molecular biological analysis and diagnostics
US7858034B2 (en) 1993-11-01 2010-12-28 Gamida For Life B.V. Circuits for the control of output current in an electronic device for performing active biological operations
US6238624B1 (en) 1993-11-01 2001-05-29 Nanogen, Inc. Methods for transport in molecular biological analysis and diagnostics
US7704726B2 (en) 1993-11-01 2010-04-27 Gamida For Life B.V. Active programmable matrix devices
US6245508B1 (en) 1993-11-01 2001-06-12 Nanogen, Inc. Method for fingerprinting utilizing an electronically addressable array
US6254827B1 (en) 1993-11-01 2001-07-03 Nanogen, Inc. Methods for fabricating multi-component devices for molecular biological analysis and diagnostics
US5605662A (en) * 1993-11-01 1997-02-25 Nanogen, Inc. Active programmable electronic devices for molecular biological analysis and diagnostics
US6287517B1 (en) 1993-11-01 2001-09-11 Nanogen, Inc. Laminated assembly for active bioelectronic devices
US5632957A (en) * 1993-11-01 1997-05-27 Nanogen Molecular biological diagnostic systems including electrodes
US6309602B1 (en) 1993-11-01 2001-10-30 Nanogen, Inc. Stacked, reconfigurable system for electrophoretic transport of charged materials
US6315953B1 (en) 1993-11-01 2001-11-13 Nanogen, Inc. Devices for molecular biological analysis and diagnostics including waveguides
US7172864B1 (en) 1993-11-01 2007-02-06 Nanogen Methods for electronically-controlled enzymatic reactions
US6319472B1 (en) 1993-11-01 2001-11-20 Nanogen, Inc. System including functionally separated regions in electrophoretic system
US7101661B1 (en) 1993-11-01 2006-09-05 Nanogen, Inc. Apparatus for active programmable matrix devices
US6518022B1 (en) 1993-11-01 2003-02-11 Nanogen, Inc. Method for enhancing the hybridization efficiency of target nucleic acids using a self-addressable, self-assembling microelectronic device
US6821729B2 (en) 1993-11-01 2004-11-23 Nanogen, Inc. Devices for molecular biological analysis and diagnostics including waveguides
US6726880B1 (en) 1993-11-01 2004-04-27 Nanogen, Inc. Electronic device for performing active biological operations and method of using same
US6638482B1 (en) 1993-11-01 2003-10-28 Nanogen, Inc. Reconfigurable detection and analysis apparatus and method
US6375899B1 (en) 1993-11-01 2002-04-23 Nanogen, Inc. Electrophoretic buss for transport of charged materials in a multi-chamber system
US6582660B1 (en) 1993-11-01 2003-06-24 Nanogen, Inc. Control system for active programmable electronic microbiology system
US6403367B1 (en) 1994-07-07 2002-06-11 Nanogen, Inc. Integrated portable biological detection system
US7857957B2 (en) 1994-07-07 2010-12-28 Gamida For Life B.V. Integrated portable biological detection system
US7947486B2 (en) 1994-07-07 2011-05-24 Gamida For Life B.V. Self-addressable self-assembling microelectronic systems and devices for molecular biological analysis and diagnostics
US6733964B1 (en) 1994-10-21 2004-05-11 Affymetrix Inc. Computer-aided visualization and analysis system for sequence evaluation
US6242180B1 (en) 1994-10-21 2001-06-05 Affymetrix, Inc. Computer-aided visualization and analysis system for sequence evaluation
US6607887B2 (en) 1994-10-21 2003-08-19 Affymetrix, Inc. Computer-aided visualization and analysis system for sequence evaluation
EP0742287A3 (en) * 1995-05-10 1997-12-29 McGall, Glenn H. Modified nucleic acid probes
EP0742287A2 (en) * 1995-05-10 1996-11-13 McGall, Glenn H. Modified nucleic acid probes
EP0910570A4 (en) * 1995-11-14 2002-01-16 Baylor College Medicine Integrated nucleic acid hybridization devices based upon active surface chemistry
EP0910570A1 (en) * 1995-11-14 1999-04-28 Baylor College Of Medicine Integrated nucleic acid hybridization devices based upon active surface chemistry
US6458530B1 (en) 1996-04-04 2002-10-01 Affymetrix Inc. Selecting tag nucleic acids
US5955268A (en) * 1996-04-26 1999-09-21 Abbott Laboratories Method and reagent for detecting multiple nucleic acid sequences in a test sample
WO1998017829A2 (en) * 1996-10-25 1998-04-30 Abbott Laboratories Nucleic acid primers and probes for detecting oncogenic human papillomaviruses
US6265154B1 (en) 1996-10-25 2001-07-24 Abbott Laboratories Nucleic acid primers and probes for detecting oncogenic human papillomaviruses
WO1998017829A3 (en) * 1996-10-25 1998-06-25 Abbott Lab Nucleic acid primers and probes for detecting oncogenic human papillomaviruses
EP1460083A1 (en) * 1996-11-06 2004-09-22 Sequenom, Inc. High density immobilization of nucleic acids
WO1998020020A2 (en) * 1996-11-06 1998-05-14 Sequenom, Inc. High density immobilization of nucleic acids
USRE44693E1 (en) 1996-11-06 2014-01-07 Sequenom, Inc. Beads bound to a solid support and to nucleic acids
USRE41005E1 (en) * 1996-11-06 2009-11-24 Sequenom, Inc. Beads bound to a solid support and to nucleic acids
WO1998020020A3 (en) * 1996-11-06 1998-10-22 Sequenom Inc High density immobilization of nucleic acids
US6706473B1 (en) 1996-12-06 2004-03-16 Nanogen, Inc. Systems and devices for photoelectrophoretic transport and hybridization of oligonucleotides
US6569385B1 (en) 1997-01-23 2003-05-27 Sequenom, Inc. Systems and methods for preparing and analyzing low volume analyte array elements
US6024925A (en) * 1997-01-23 2000-02-15 Sequenom, Inc. Systems and methods for preparing low volume analyte array elements
AU748806B2 (en) * 1997-02-04 2002-06-13 Sequenom, Inc. A reversible stoichiometric process for conjugating biomolecules
WO1998033808A3 (en) * 1997-02-04 1999-02-25 Hubert Koster A reversible stoichiometric process for conjugating biomolecules
WO1998033808A2 (en) * 1997-02-04 1998-08-06 Hubert Koster A reversible stoichiometric process for conjugating biomolecules
GB2324866B (en) * 1997-04-21 2001-11-14 Randox Lab Ltd Device and apparatus for the simultaneous detection of multiple analytes
GB2324866A (en) * 1997-04-21 1998-11-04 Randox Lab Ltd Device for multianalyte assays.
US7153955B2 (en) 1997-09-22 2006-12-26 Nanogen Recognomics Gmbh Pentopyranosyl nucleic acid arrays, and uses thereof
US6664045B1 (en) 1998-06-18 2003-12-16 Boston Probes, Inc. PNA probes, probe sets, methods and kits pertaining to the detection of microorganisms
US7314708B1 (en) 1998-08-04 2008-01-01 Nanogen, Inc. Method and apparatus for electronic synthesis of molecular structures
US7473547B2 (en) 1998-08-14 2009-01-06 Fujifilm Corporation Test piece, method of and apparatus for manufacturing the test piece and method of and system for reading the same
WO2000053616A3 (en) * 1999-03-09 2002-09-12 Amersham Pharm Biotech Uk Ltd Nucleotides and polynucleotides immobilised on a solid support via a disulphide linkage
WO2000053616A2 (en) * 1999-03-09 2000-09-14 Amersham Pharmacia Biotech Uk Ltd Nucleotides and polynucleotides immobilised on a solid support via a disulphide linkage
US9279148B2 (en) 1999-04-20 2016-03-08 Illumina, Inc. Detection of nucleic acid reactions on bead arrays
US9441267B2 (en) 1999-04-20 2016-09-13 Illumina, Inc. Detection of nucleic acid reactions on bead arrays
US7060224B2 (en) 1999-11-08 2006-06-13 Nanogen, Inc. Methods for the electronic, homogeneous assembly and fabrication of devices
US8906626B2 (en) 2000-02-07 2014-12-09 Illumina, Inc. Multiplex nucleic acid reactions
US9850536B2 (en) 2000-02-07 2017-12-26 Illumina, Inc. Multiplex nucleic acid reactions
US10837059B2 (en) 2000-02-07 2020-11-17 Illumina, Inc. Multiplex nucleic acid reactions
EP1162459A1 (en) * 2000-06-07 2001-12-12 Corning Incorporated Rough charged solid phase for attachment of biomolecules
JP2004512499A (en) * 2000-07-07 2004-04-22 リー,エレン Improved binding interaction in dipstick test
WO2002004671A2 (en) * 2000-07-07 2002-01-17 Helen Lee Improved binding interactions in dipstick assays
WO2002004122A3 (en) * 2000-07-07 2002-12-27 Helen Lee Improved stability of hybridisation interactions in dipstick assays
AU2001269285B2 (en) * 2000-07-07 2007-08-16 Diagnostics For The Real World, Ltd Improved binding interactions in dipstick assays
CN100355905C (en) * 2000-07-07 2007-12-19 真实世界诊疗有限公司 Improved binding interactions in dipstick assays
WO2002004671A3 (en) * 2000-07-07 2003-05-01 Helen Lee Improved binding interactions in dipstick assays
US8431336B2 (en) 2000-07-07 2013-04-30 Diagnostics For The Real World, Ltd. Binding interactions in dipstick assays
JP2012019797A (en) * 2000-07-07 2012-02-02 Diagnostics For The Real World Ltd Advanced binding interaction in dipstick assay
WO2002004122A2 (en) * 2000-07-07 2002-01-17 Helen Lee Improved stability of hybridisation interactions in dipstick assays
EP2359863A2 (en) 2000-08-03 2011-08-24 The Regents Of The University Of Michigan Isolation and use of solid tumor stem cells
US9669376B2 (en) 2000-10-30 2017-06-06 Agena Bioscience, Inc. Method and apparatus for delivery of submicroliter volumes onto a substrate
US8999266B2 (en) 2000-10-30 2015-04-07 Agena Bioscience, Inc. Method and apparatus for delivery of submicroliter volumes onto a substrate
EP1347060A4 (en) * 2000-12-26 2004-08-18 Takara Bio Inc Method of detecting pathogenic microorganism
EP1347060A1 (en) * 2000-12-26 2003-09-24 Takara Bio Inc. Method of detecting pathogenic microorganism
US6756014B2 (en) 2001-03-02 2004-06-29 Hitachi, Ltd. Biochemical sensor and biochemical testing system using the same
EP1239286A3 (en) * 2001-03-02 2002-10-02 Hitachi, Ltd. Biochemical sensors, methods for their manufacture and biochemical methods and systems for testing substances of interest
EP1239286A2 (en) * 2001-03-02 2002-09-11 Hitachi, Ltd. Biochemical sensors, methods for their manufacture and biochemical methods and systems for testing substances of interest
US6689478B2 (en) 2001-06-21 2004-02-10 Corning Incorporated Polyanion/polycation multilayer film for DNA immobilization
EP2246438A1 (en) 2001-07-12 2010-11-03 Illumina, Inc. Multiplex nucleic acid reactions
US6893822B2 (en) 2001-07-19 2005-05-17 Nanogen Recognomics Gmbh Enzymatic modification of a nucleic acid-synthetic binding unit conjugate
GR1003966B (en) * 2001-10-16 2002-08-06 Dipping test strip assay system and assay method for the detection and/or determination of specific nucleic acid sequences
WO2003033735A3 (en) * 2001-10-16 2003-09-12 Giannoula Soufla Test strip assay system and method for the detection of specific nucleic acid sequences
WO2003033735A2 (en) * 2001-10-16 2003-04-24 Giannoula Soufla Test strip assay system and method for the detection of specific nucleic acid sequences
WO2003039703A3 (en) * 2001-11-05 2004-04-01 Hain Lifescience Gmbh Method in the form of a dry rapid test for detecting nucleic acids
WO2003039703A2 (en) * 2001-11-05 2003-05-15 Hain Lifescience Gmbh Method in the form of a dry rapid test for detecting nucleic acids
US8772467B2 (en) 2002-07-26 2014-07-08 Gamida For Life B.V. Methods and apparatus for screening and detecting multiple genetic mutations
WO2004057023A1 (en) * 2002-12-20 2004-07-08 Evotec Oai Ag A method for detecting an analyte in a sample
EP1431398A1 (en) * 2002-12-20 2004-06-23 Evotec OAI AG A method for detecting in a mixture an amount of analytes
US8580577B2 (en) 2002-12-20 2013-11-12 Evotec Ag Method for detecting an analyte in a sample
EP1473370A2 (en) * 2003-04-24 2004-11-03 BioMerieux, Inc. Genus, group, species and/or strain specific 16S rDNA Sequences
EP1473370A3 (en) * 2003-04-24 2005-03-09 BioMerieux, Inc. Genus, group, species and/or strain specific 16S rDNA Sequences
EP1745150A4 (en) * 2004-04-20 2008-02-27 Genaco Biomedial Products Inc Method for detecting ncrna
EP1745150A2 (en) * 2004-04-20 2007-01-24 Genaco Biomedial Products, Inc. Method for detecting ncrna
US7811759B2 (en) 2004-04-20 2010-10-12 Jian Han Method for detecting ncRNA
WO2005121359A1 (en) * 2004-06-11 2005-12-22 Evotec Ag A method for detecting analytes in a sample
US7867707B2 (en) 2004-06-11 2011-01-11 Evotec Ag Method for detecting analytes in a sample
US7828954B2 (en) 2004-09-21 2010-11-09 Gamida For Life B.V. Electrode based patterning of thin film self-assembled nanoparticles
US7314542B2 (en) 2004-09-23 2008-01-01 Nanogen, Inc. Methods and materials for optimization of electronic transportation and hybridization reactions
WO2007123579A2 (en) 2005-12-28 2007-11-01 Translational Therapeutics Translational dysfunction based therapeutics
EP2762886A1 (en) 2006-09-29 2014-08-06 Translational Therapeutics, Inc. EIF4E Regulon-based diagnostics
EP1964934A1 (en) * 2007-02-28 2008-09-03 Sysmex Corporation Sample treatment solution and reagent kit for preparing sample for detecting DNA methylation
US9068953B2 (en) 2007-09-17 2015-06-30 Agena Bioscience, Inc. Integrated robotic sample transfer device
US9739773B1 (en) 2010-08-13 2017-08-22 David Gordon Bermudes Compositions and methods for determining successful immunization by one or more vaccines
GB2559638A (en) * 2016-09-08 2018-08-15 Bbi Solutions Oem Ltd Solid phase conjugate
US20190316195A1 (en) * 2018-04-12 2019-10-17 Cellmax, Ltd. Methods of capturing a nucleic acid including a target oligonucleotide sequence and uses thereof
US20190316112A1 (en) * 2018-04-12 2019-10-17 Cellmax, Ltd. Methods of capturing a nucleic acid including a target oligonucleotide sequence and uses thereof
CN110373456A (en) * 2018-04-12 2019-10-25 合度精密生物科技有限公司 Capture includes the method for nucleic acid and application thereof of target oligonucleotide sequences

Similar Documents

Publication Publication Date Title
WO1990001564A1 (en) Methods for multiple target analyses through nucleic acid hybridization
JP3021036B2 (en) Detection of nucleic acid sequences or changes therein
US5348855A (en) Assay for nucleic acid sequences in an unpurified sample
AU597896B2 (en) Method and kit for performing nucleic acid hybridization assays
EP0478319B1 (en) Gene detection method
AU599083B2 (en) Detection of microorganisms in a nucleic acid containing sample
JP3046837B2 (en) Immobilized oligonucleotide probes and their use
JP2862547B2 (en) Polycationic support for nucleic acid purification, separation and hybridization
EP0504321B1 (en) Enhanced capture of target nucleic acid by the use of oligonucleotides covalently attached to polymers
US5273882A (en) Method and kit for performing nucleic acid hybridization assays
NZ223700A (en) Method of assaying nucleic acids
JPH05508074A (en) Polynucleotide capture assay using in vitro amplification
EP1563100A2 (en) Displacement sandwich immuno-pcr
JPH05507613A (en) Methods and compositions for performing DNA assays
JPH0630637B2 (en) Nucleic acid detection method by separation
AU706205B2 (en) Homogeneous DNA probe titration assay
Dahlén et al. Sensitive detection of genes by sandwich hybridization and time-resolved fluorometry
US5853986A (en) Chemical promotion of nucleic acid hybridization
WO2020033394A1 (en) Enhanced capture of target nucleic acids
JPH10179179A (en) Determination of specific gene sequence and reagent for determination
WO1999058716A1 (en) Method for quantitating specific gene sequence and quantitating reagent
JPH0889294A (en) Method for preparing particle for diagnosing nucleic acid and method for diagnosing target nucleic acid in test specimen using the same particle for dianosing nucleic acid
AU618951C (en) Purification of nucleic acids and hybrids thereof by polycationic solid supports
Tu et al. Enzyme-Labeled Oligonucleotides
JP2003247994A (en) Method for detecting target nucleic acid

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LU NL SE